0001140361-17-041856.txt : 20171109 0001140361-17-041856.hdr.sgml : 20171109 20171109164905 ACCESSION NUMBER: 0001140361-17-041856 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171109 DATE AS OF CHANGE: 20171109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RiceBran Technologies CENTRAL INDEX KEY: 0001063537 STANDARD INDUSTRIAL CLASSIFICATION: GRAIN MILL PRODUCTS [2040] IRS NUMBER: 870673375 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36245 FILM NUMBER: 171191567 BUSINESS ADDRESS: STREET 1: 2928 RAMCO STREET STREET 2: SUITE 120 CITY: WEST SACRAMENTO STATE: CA ZIP: 95691 BUSINESS PHONE: 6025223000 MAIL ADDRESS: STREET 1: 2928 RAMCO STREET STREET 2: SUITE 120 CITY: WEST SACRAMENTO STATE: CA ZIP: 95691 FORMER COMPANY: FORMER CONFORMED NAME: NUTRACEA DATE OF NAME CHANGE: 20030930 FORMER COMPANY: FORMER CONFORMED NAME: NUTRASTAR INC DATE OF NAME CHANGE: 20011221 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCE CONSUMER INTERNATIONAL INC DATE OF NAME CHANGE: 20010418 10-Q 1 form10q.htm 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q

(Mark one)

☒
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

☐
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 0-32565
RiceBran Technologies
(Exact Name of Registrant as Specified in its Charter)

California
  
87-0673375
 (State or other jurisdiction of incorporation or organization)
  
 (I.R.S. Employer Identification No.)
2928 Ramco Street, Suite 120
West Sacramento, CA
  
95691
(Address of Principal Executive Offices)
  
(Zip Code)

Issuer’s telephone number, including area code:  (602) 522-3000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging company.  See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☒
     
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule l2b-2 of the Exchange Act).  Yes ☐ No ☒
 
As of November 3, 2017, shares of the registrant’s common stock outstanding totaled 16,884,017.
 
RiceBran Technologies
Index
Form 10-Q

PART I. FINANCIAL INFORMATION
Page
 
Item 1.
3
    3
    4
    5
    6
    7
 
Item 2.
24
 
Item 3.
27
 
Item 4.
27
PART II. OTHER INFORMATION
  
 
Item 1.
27
 
Item 1A.
27
 
Item 2.
28
 
Item 3.
28
 
Item 4.
28
 
Item 5.
28
 
Item 6.
28
30

Cautionary Note about Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue, liquidity or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services, products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.  Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words.  The forward-looking statements contained herein reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions.  Actual results may differ materially from those projected in such forward-looking statements due to a number of factors, risks and uncertainties, including the factors that may affect future results set forth in this Current Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2016.  We disclaim any obligation to update any forward looking statements as a result of developments occurring after the date of this quarterly report.

Unless the context requires otherwise, references to “we,” “us,” “our” and “the Company” refer to RiceBran Technologies and its consolidated subsidiaries.
 
2
PART I. FINANCIAL INFORMATION

Item 1.
Financial Statements.

RiceBran Technologies
Condensed Consolidated Statements of Operations
Three and Nine Months Ended September 30, 2017 and 2016
(Unaudited) (in thousands, except share and per share amounts)
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
                         
Revenues
  
$
3,445
    
$
3,249
    
$
10,206
    
$
9,748
  
Cost of goods sold
    
2,305
      
2,434
      
7,081
      
7,199
  
Gross profit
    
1,140
      
815
      
3,125
      
2,549
  
Selling, general and administrative expenses
    
2,495
      
3,140
      
7,428
      
9,428
  
Loss from operations
    
(1,355
)
    
(2,325
)
    
(4,303
)
    
(6,879
)
Other (expense) income:
                                
Interest expense
    
(86
)
    
(352
)
    
(1,616
)
    
(1,484
)
Change in fair value of derivative warrant liabilities
    
(313
)
    
1,166
      
808
      
314
  
Loss on extinguishment of debt
    
(6,610
)
    
-
      
(8,290
)
    
-
  
Loss on conversion of preferred stock
    
(85
)
    
-
      
(85
)
    
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
-
      
-
      
1,598
  
Other income
    
157
      
132
      
194
      
132
  
Other expense
    
(28
)
    
-
      
(128
)
    
-
  
Total other (expense) income
    
(6,965
)
    
946
      
(9,117
)
    
560
  
Loss before income taxes
    
(8,320
)
    
(1,379
)
    
(13,420
)
    
(6,319
)
Income tax benefit
    
4,121
      
437
      
5,033
      
1,344
  
Loss from continuing operations
    
(4,199
)
    
(942
)
    
(8,387
)
    
(4,975
)
Income (loss) from discontinued operations, net of tax
    
6,706
      
(608
)
    
6,823
      
(4,829
)
Net income (loss)
    
2,507
      
(1,550
)
    
(1,564
)
    
(9,804
)
Less - Net loss attributable to noncontrolling interest in discontinued operations
    
(792
)
    
(470
)
    
(1,359
)
    
(2,416
)
Net income (loss) attributable to RiceBran Technologies shareholders
    
3,299
      
(1,080
)
    
(205
)
    
(7,388
)
Less - Dividends on preferred stock, beneficial conversion feature
    
-
      
-
      
778
      
551
  
Net income (loss) attributable to RiceBran Technologies common shareholders
  
$
3,299
    
$
(1,080
)
  
$
(983
)
  
$
(7,939
)
                                 
Basic earnings (loss) per common share:
                                
Continuing operations
  
$
(0.38
)
  
$
(0.10
)
  
$
(0.86
)
  
$
(0.60
)
Discontinued operations
    
0.68
      
(0.01
)
    
0.77
      
(0.26
)
Basic earnings (loss) per common share - RiceBran Technologies
  
$
0.30
    
$
(0.11
)
  
$
(0.09
)
  
$
(0.86
)
                                 
Diluted earnings (loss) per common share:
                                
Continuing operations
  
$
(0.38
)
  
$
(0.10
)
  
$
(0.86
)
  
$
(0.60
)
Discontinued operations
    
0.68
      
(0.01
)
    
0.77
      
(0.26
)
Diluted earnings (loss) per common share - RiceBran Technologies
  
$
0.30
    
$
(0.11
)
  
$
(0.09
)
  
$
(0.86
)
                                 
Weighted average number of shares outstanding:
                                
Basic
    
11,129,781
      
9,397,255
      
10,644,372
      
9,281,942
  
Diluted
    
11,129,781
      
9,397,255
      
10,644,372
      
9,281,942
  
 
See Notes to Unaudited Condensed Consolidated Financial Statements
 
3
RiceBran Technologies
Condensed Consolidated Statements of Comprehensive Income (Loss)
Three and Nine Months Ended September 30, 2017 and 2016
(Unaudited) (in thousands)
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
                         
Net income (loss)
  
$
2,507
    
$
(1,550
)
  
$
(1,564
)
  
$
(9,804
)
                                 
Other comprehensive income - foreign currency translation, net of tax
    
(31
)
    
(165
)
    
131
      
694
  
                                 
Comprehensive income (loss), net of tax
    
2,476
      
(1,715
)
    
(1,433
)
    
(9,110
)
                                 
Less - Comprehensive loss attributable to noncontrolling interest, net of tax
    
(803
)
    
(330
)
    
(1,321
)
    
(1,998
)
                                 
Total comprehensive income (loss) attributable to RiceBran Technologies shareholders
  
$
3,279
    
$
(1,385
)
  
$
(112
)
  
$
(7,112
)
 
See Notes to Unaudited Condensed Consolidated Financial Statements
 
4
RiceBran Technologies
Condensed Consolidated Balance Sheets
September 30, 2017 (Unaudited) and December 31, 2016
(in thousands, except share amounts)
 
   
September 30,
2017
    
December 31,
2016
  
ASSETS
            
Current assets:
            
Cash and cash equivalents
  
$
8,187
    
$
342
  
Restricted cash
    
775
      
-
  
Accounts receivable, net of allowance for doubtful accounts of $8 and $12
    
1,384
      
1,094
  
Inventories
    
758
      
933
  
Deposits and other current assets
    
359
      
824
  
Current assets held for sale
    
2,398
      
4,335
  
Total current assets
    
13,861
      
7,528
  
Property and equipment, net
    
7,123
      
7,025
  
Intangible assets, net
    
135
      
242
  
Noncurrent assets held for sale
    
11,785
      
14,050
  
Total assets
  
$
32,904
    
$
28,845
  
                 
LIABILITIES, TEMPORARY EQUITY AND EQUITY (DEFICIT)
                
Current liabilities:
                
Accounts payable
  
$
261
    
$
714
  
Accrued salary, wages and benefits
    
605
      
496
  
Accrued expenses
    
309
      
1,288
  
Income taxes payable
    
268
      
-
  
Current maturities of long-term debt
    
19
      
3,063
  
Current liabilities held for sale
    
18,239
      
15,801
  
Total current liabilities
    
19,701
      
21,362
  
Long-term debt, less current portion
    
13
      
5,964
  
Derivative warrant liabilities
    
769
      
1,527
  
Deferred tax liability
    
29
      
29
  
Noncurrent liabilities held for sale
    
-
      
44
  
Total liabilities
    
20,512
      
28,926
  
Commitments and contingencies
                
Temporary equity
                
Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding
    
-
      
551
  
Total temporary equity
    
-
      
551
  
Equity (deficit):
                
Equity (deficit) attributable to RiceBran Technologies shareholders:
                
Preferred stock, 20,000,000 shares authorized:
                
Series F, convertible, 3,000 shares authorized, 499 shares issued and outstanding
    
92
      
-
  
Series G, convertible, 3,000 shares authorized, 1,300 shares issued and outstanding
    
646
      
-
  
Common stock, no par value, 50,000,000 shares authorized, 16,551,350 and 10,790,351 shares issued and outstanding
    
278,079
      
264,232
  
Accumulated deficit
    
(260,802
)
    
(259,819
)
Accumulated deficit attributable to noncontrolling interest in discontinued operation
    
(1,370
)
    
(699
)
Accumulated other comprehensive loss
    
(4,253
)
    
(4,346
)
Total equity (deficit) attributable to RiceBran Technologies shareholders
    
12,392
      
(632
)
Total liabilities, temporary equity and equity (deficit)
  
$
32,904
    
$
28,845
  
 
See Notes to Unaudited Condensed Consolidated Financial Statements
 
5
RiceBran Technologies
Condensed Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2017 and 2016
(Unaudited) (in thousands)
 
   
2017
    
2016
  
Cash flow from operating activities:
            
Net loss
  
$
(1,564
)
  
$
(9,804
)
Income (loss) from discontinued operations
    
6,823
      
(4,829
)
Loss from continuing operations
    
(8,387
)
    
(4,975
)
Adjustments to reconcile net loss from continuing operation to activities of continuing operations:
          
net cash used in operating activities of continuing operations:
                
Depreciation and amortization
    
571
      
694
  
Stock and share-based compensation
    
904
      
841
  
Change in fair value of derivative warrant and conversion liabilities
    
(808
)
    
(314
)
Loss on extinguishment of debt
    
8,290
      
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
(1,598
)
Interest accreted
    
1,000
      
497
  
Deferred taxes
    
(5,033
)
    
(1,344
)
Other
    
55
      
-
  
Changes in operating assets and liabilities:
                
Accounts receivable
    
(290
)
    
(182
)
Inventories
    
213
      
576
  
Accounts payable and accrued expenses
    
(1,310
)
    
3
  
Other
    
465
      
53
  
Net cash used in operating activities of continuing operations
    
(4,330
)
    
(5,749
)
Net cash provided by operating activities of discontinued operations
    
1,513
      
3,714
  
Net cash used in operating activities
    
(2,817
)
    
(2,035
)
Cash flows from investing activities:
                
Purchases of property
    
(596
)
    
(208
)
Net cash used in investing activities of continuing operations
    
(596
)
    
(208
)
Net cash provided by (used in) investing activities of discontinued operations
    
16,604
      
(252
)
Net cash provided by (used in) investing activities
    
16,008
      
(460
)
Cash flows from financing activities:
                
Payments of debt
    
(19,728
)
    
(24,124
)
Proceeds from issuance of debt, net of issuance costs
    
3,779
      
23,752
  
Proceeds from issuance of debt and warrants, net of issuance costs
    
5,518
      
300
  
Proceeds from issuance of preferred stock and warrants, net of issuance costs
    
1,747
      
2,554
  
Proceeds from issuance of common stock, net of issuance costs
    
2,778
      
-
  
Other
    
(23
)
    
(9
)
Net cash provided by (used in) financing activities of continuing operations
    
(5,929
)
    
2,473
  
Net cash provided by (used in) financing activities of discontinued operations
    
1,232
      
(551
)
Net cash provided by (used in)  financing activities
    
(4,697
)
    
1,922
  
Effect of exchange rate changes on cash and cash equivalents of discontinued operations
    
126
      
(182
)
Net change in cash and cash equivalents and restricted cash
  
$
8,620
    
$
(755
)
                 
Cash and cash equivalents and restricted cash, beginning of period
                
Cash and cash equivalents
  
$
342
    
$
966
  
Restricted cash
    
-
      
1,921
  
Cash and cash equivalents and restricted cash, beginning of period
    
342
      
2,887
  
Cash and cash equivalents and restricted cash, end of period
                
Cash and cash equivalents
    
8,187
      
2,132
  
Restricted cash
    
775
      
-
  
Cash and cash equivalents and restricted cash, end of period
    
8,962
      
2,132
  
Net change in cash and cash equivalents and restricted cash
  
$
8,620
    
$
(755
)
                 
Supplemental disclosures, continuing operations:
                
Cash paid for interest of continuing operations
  
$
729
    
$
780
  
Cash paid for income taxes of continuing operations
    
-
      
20
  
 
See Notes to Unaudited Condensed Consolidated Financial Statements
 
6
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
NOTE 1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in complete financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.
 
These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.

NOTE 2. DISCONTINUED OPERATIONS

Healthy Natural (HN) Discontinued Operations

The Company continuously assesses the composition of our business portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.  In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).  In July 2017, we completed the sale of the assets of HN for $18.3 million in cash.  HN was reported as part of our Corporate and USA segment.  The selling price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.  The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.  A $0.2 million working capital adjustment escrow and a $0.6 million indemnity claim escrow were funded from the proceeds.  We are providing certain support services under transition services agreement for a limited period of time.  These support services are not expected to have a material impact on our consolidated statements of operations in 2017.

On a preliminary basis, we estimate the proceeds, net of expenses, at $16.7 million, the net carrying value of HN as of the date of sale at $3.5 million and the third quarter 2017 gain on sale as $8.8 million, net of a $4.3 million income tax provision.  We currently expect to obtain the amounts held in escrow without adjustment.  The following table summarizes the estimated carrying amount of HN as of the July 2017 sale (in thousands).
 
Accounts receivable, net
  
$
871
  
Inventories
    
1,987
  
Other current assets
    
47
  
Property and equipment
    
871
  
Intangible
    
791
  
Other
    
24
  
Assets
    
4,591
  
Accounts payable
    
759
  
Accrued expenses
    
290
  
Liabilities
    
1,049
  
Net assets sold
  
$
3,542
  
 
We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.  Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.
 
7
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

The operations of HN are included in our results though the July 14, 2017 date of sale.  All following tables represent activity up to the date of the sale.
 
The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestiture of HN (in thousands).
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Revenues
  
$
421
    
$
5,010
    
$
9,902
    
$
15,044
  
Cost of goods sold
    
(293
)
    
(3,330
)
    
(6,651
)
    
(9,991
)
Selling, general and administrative expenses
    
(19
)
    
(396
)
    
(462
)
    
(1,100
)
Income from operations, before income taxes
    
109
      
1,284
      
2,789
      
3,953
  
Income tax expense
    
(36
)
    
(437
)
    
(948
)
    
(1,344
)
Income from operations, net of tax
    
73
      
847
      
1,841
      
2,609
  
Gain on sale, net of $4.3 million income tax expense
    
8,845
      
-
      
8,845
      
-
  
Income from discontinued operations, net of tax
  
$
8,918
    
$
847
    
$
10,686
    
$
2,609
  
 
We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN’s taxable operating income in 2017.  Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset by 90% by net operating loss carryforwards; thereby leaving residual taxable income of 10%, subject to a rate of 20%. We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.
 
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale as of December 31, 2016 (in thousands).
 
   
December 31,
2016
  
Accounts receivable, net
  
$
592
  
Inventories
    
1,915
  
Other current assets held for sale
    
23
  
Property and equipment
    
1,019
  
Intangible
    
791
  
Other noncurrent assets
    
24
  
Total assets held for sale
  
$
4,364
  
Accounts payable
  
$
443
  
Accrued expenses
    
382
  
Long term liabilities
    
44
  
Total liabilities held for sale
  
$
869
  
 
The following table summarizes the major line items included in cash flows from discontinued operations of HN for the nine months ended September 30, 2017 and 2016 (in thousands).
 
   
Nine Months Ended
  
   
2017
    
2016
  
             
Net cash provided by operating activities
  
$
2,803
    
$
3,701
  
Net cash provided by (used in) investing activities
    
16,719
      
(73
)
Net cash used in financing activities
    
(48
)
    
-
  
Net cash provided to continuing operations
  
$
(19,474
)
  
$
(3,628
)
 
In 2017, net cash provided by investing activities in the table above is presented in our consolidated statements of cash flows in net cash provided by (used in) investing activities of discontinued operations and includes the $16.7 million net proceeds from the sale of HN.
 
8
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
The following table summarizes other data for HN (in thousands).
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Depreciation included in cost of goods sold
  
$
7
    
$
42
    
$
96
    
$
130
  
Depreciation included in selling, general and administrative expenses
    
4
      
20
      
49
      
58
  
Amortization included in selling, gneral and administrative expenses
    
-
      
204
      
-
      
659
  
Capital expenditures
    
3
      
22
      
18
      
95
  
 
Nutra SA Discontinued Operations

We hold a variable interest in our equity interest in Nutra SA.  Nutra SA’s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.  We are the primary beneficiary of Nutra SA, and as such, Nutra SA’s assets, liabilities and results of operations are included in the condensed consolidated financial statements.  In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.  Accordingly, the Nutra SA operating results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.  Other equity holders’ (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.

The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and nine months ended September 30, 2017 and 2016 (in thousands).
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Revenues
  
$
3,226
    
$
563
    
$
9,589
    
$
4,627
  
Cost of goods sold
    
(3,539
)
    
(1,154
)
    
(9,814
)
    
(6,103
)
Selling, general and administrative expenses
    
(1,541
)
    
(509
)
    
(2,572
)
    
(1,891
)
Goodwill impairment
    
-
      
-
      
-
      
(3,024
)
Other expense
    
(358
)
    
(355
)
    
(1,066
)
    
(1,047
)
Loss from discontinued operations, before income taxes
    
(2,212
)
    
(1,455
)
    
(3,863
)
    
(7,438
)
Income taxes
    
-
      
-
      
-
      
-
  
Loss from discontinued operations, net of tax
  
$
(2,212
)
  
$
(1,455
)
  
$
(3,863
)
  
$
(7,438
)
 
The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).
 
   
September 30,
2017
    
December 31,
2016
  
Cash and cash equivalents
  
$
54
    
$
109
  
Accounts receivable, net (restricted)
    
781
      
398
  
Inventories
    
1,237
      
925
  
Other current asssets
    
326
      
373
  
Property and equipment, net (restricted $2,662 and $2,599)
    
10,464
      
10,889
  
Other noncurrent assets
    
1,321
      
1,327
  
Total assets held for sale
  
$
14,183
    
$
14,021
  
Accounts payable
  
$
2,338
    
$
2,553
  
Accrued expenses
    
8,274
      
5,607
  
Current maturities of long-term debt (nonrecourse)
    
7,627
      
6,816
  
Total liabilities held for sale
  
$
18,239
    
$
14,976
  
 
Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the LLC Agreement.  Therefore Nutra SA’s consolidated cash is classified as held for sale in our consolidated balance sheets.  Nutra SA’s debt is secured by Irgovel’s accounts receivable and property.  The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA’s debt.
 
9
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the nine months ended September 30, 2017 and 2016 (in thousands).
 
   
Nine Months Ended
  
   
2017
    
2016
  
             
Net cash used in operating activities
  
$
(1,345
)
  
$
(9
)
Net cash used in investing activities
    
(115
)
    
(157
)
Net cash provided (used) by financing activities
    
1,280
      
(551
)
Net cash provided by continuing operations
    
-
      
863
  
Effect of exchange rate changes
    
125
      
(183
)
Net change in cash and cash equivalents
    
(55
)
    
(37
)
Cash and cash equivalents, beginning of period
    
109
      
104
  
Cash and cash equivalents, end of period
  
$
54
    
$
67
  
 
The following table summarizes other data for Nutra SA (in thousands).
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Depreciation included in cost of goods sold
  
$
274
    
$
246
    
$
792
    
$
672
  
Depreciation included in selling, general and administrative expenses
    
15
      
16
      
46
      
42
  
Capital expenditures
    
22
      
1
      
115
      
157
  
 
Nutra SA’s debt consists of the following (in thousands):
 
   
September 30
2017
    
December 31,
2016
  
Capital expansion loans
  
$
2,635
    
$
2,454
  
Working capital lines of credit
    
1,081
      
401
  
Advances on customer export orders
    
785
      
1,113
  
Special tax programs
    
3,014
      
2,767
  
Other
    
112
      
81
  
   
$
7,627
    
$
6,816
  
 
As of September 30, 2017, Irgovel had approximately $0.4 million (USD) of debt installment payments in arrears.  The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current liabilities held for sale in the accompanying condensed consolidated balance sheet as of September 30, 2017.  As of September 30, 2017, Irgovel had approximately $9.3 million of tax and tax related payments in arrears.  Approximately  $0.2 million of the tax payments in arrears is related to certain unpaid employer tax from April 2017 through September 2017.  All tax and tax related payments in arrears, other than the certain unpaid employer tax, can be included in a new Brazil tax amnesty program, but to qualify to do so, an entrance fee of approximately $0.4 million must be paid prior to November 15, 2017.  At this time it is not certain Irgovel will qualify for the new Brazil tax amnesty.  If Irgovel is unable to qualify for the new Brazil tax amnesty, Irgovel will likely petition the tax authorities seeking a favorable payment plan but it is likely the installment payments will not exceed 60 monthly payments.  All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.  The fair value of Nutra SA debt (Level 3 measurement) approximates the carrying value of that debt based on the current market rates for similar debt with similar maturities.

Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).

A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying condensed consolidated balance sheets, for the three and nine months ended September 30, 2017 and 2016 (in thousands) follows.
 
10
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
Redeemable noncontrolling interest in Nutra SA, beginning of period
  
$
(567
)
  
$
(1,599
)
  
$
(699
)
  
$
69
  
Investors' interest in net loss of Nutra SA
    
(792
)
    
(470
)
    
(1,359
)
    
(2,416
)
Investors' interest in other comprehensive loss of Nutra SA
    
(11
)
    
(60
)
    
38
      
218
  
Investors purchase of additional membership interest
    
-
      
200
      
650
      
200
  
Redeemable noncontrolling interest in Nutra SA, end of period
  
$
(1,370
)
  
$
(1,929
)
  
$
(1,370
)
  
$
(1,929
)
                                 
Investors' average interest in Nutra SA during the period
    
35.8
%
    
32.5
%
    
35.5
%
    
32.2
%
Investors' interest in Nutra SA at the end of the period
    
35.8
%
    
32.7
%
    
35.8
%
    
32.7
%
 
The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.  The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).  We may elect to exercise a right of first refusal to purchase the Investors’ interest instead of proceeding to a sale.  We have assessed the likelihood of the Investors exercising these rights as less than probable at September 30, 2017.  We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.  We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.

As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.  In exchange for the termination of this right, we paid the Investors $0.1 million.
 
Under the LLC Agreement, the business of Nutra SA is to be conducted by the manager, currently our EVP of Special Projects, subject to the oversight of the management committee.  The management committee is comprised of three of our representatives and two of Investors’ representatives.  Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investors’ representatives and two of our representatives.  In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.
 
As of September 30, 2017, there have been no unwaived events of default.  Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are the failure of Irgovel to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually.

As of September 30, 2017, there have been no qualifying events.  The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.

In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.  Until there is an event of default or a qualifying event, the Investors’ rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.  The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.  However, the Investors do have drag along rights in the future.  We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.

NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT’S PLAN

Our cash position has improved since December 31, 2016, as a result of a debt and equity raise in February 2017, the sale of HN in July 2017 and an equity raise in September 2017.  However, our continued operations continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.

In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $16.7 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).  In September 2017, as discussed further in Note 8, we received net proceeds of $2.7 million from the sale and issuance of common stock.  We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.  The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.
 
11
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Beginning in the second quarter of 2016 and through the third quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.  In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through September 30, 2017.  In 2016, we invested $1.1 million in Nutra SA.  Our board has determined we will not contribute any additional funds to Nutra SA.
 
NOTE 4. RECENT ACCOUNTING GUIDANCE

Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We expect to transition through a cumulative effect adjustment as of January 1, 2018.  Under the modified retrospective method adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to HN, because we no longer reflect HN operations in our consolidated results after the sale of HN in July 2017.  Similarly, if we dispose of Nutra SA, before December 31, 2017, we expect adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to Nutra SA as well.

In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In May 2017, the FASB issued guidance that clarifies the scope of asset derecognition guidance and accounting for partial sales of nonfinancial assets.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In February 2017, the FASB issued guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In November 2016, the FASB issued guidance that requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.   As a result, changes in restricted cash reported in 2016 as cash flows from investing activities are no longer reported as such.
 
12
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

In August 2016, the FASB issued guidance intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flow, including the classification of (i) payments to extinguish debt and (ii) payments for the settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.  This change did not have an effect on the presentation of our cash flows, as our presentation in previously reported periods had complied with the new guidance.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.

NOTE 5. LOSS PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.  Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.  The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.

Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and nine months ended September 30, 2017 and 2016.
 
   
Three Months Ended
    
Nine Months Ended
  
   
2017
    
2016
    
2017
    
2016
  
NUMERATOR (in thousands):
                        
Basic and diluted - loss from continuing operations
  
$
(4,199
)
  
$
(942
)
  
$
(8,387
)
  
$
(4,975
)
Dividend on preferred stock--beneficial conversion feature
    
-
      
-
      
(778
)
    
(551
)
Basic and diluted - adjusted loss from continuing operations
  
$
(4,199
)
  
$
(942
)
  
$
(9,165
)
  
$
(5,526
)
                                 
DENOMINATOR:
                                
Basic EPS - weighted average number of common shares outstanding
    
11,129,781
      
9,397,255
      
10,644,372
      
9,281,942
  
Effect of dilutive securities outstanding
    
-
      
-
      
-
      
-
  
Diluted EPS - weighted average number of shares outstanding
    
11,129,781
      
9,397,255
      
10,644,372
      
9,281,942
  
                                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                                
Stock options
    
629,969
      
340,037
      
473,498
      
350,203
  
Warrants
    
22,824,888
      
10,842,006
      
21,306,727
      
10,132,045
  
Nonvested stock
    
1,301,725
      
1,114,747
      
1,236,241
      
1,038,019
  
Convertible preferred stock
    
2,128,180
      
2,000,000
      
3,020,739
      
1,611,722
  
Restricted stock unit awards
    
1,175,000
      
-
      
406,066
      
-
  
 
13
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

The impact of potentially dilutive securities outstanding at September 30, 2017 and 2016, was not included in the calculation of the continuing operations diluted EPS for the three and nine months ended September 30, 2017 and 2016 because to do so would be antidilutive.  Those securities listed in the table above which were antidilutive for the periods presented, which remain outstanding, could potentially dilute EPS in the future.

NOTE 6. CONCENTRATIONS OF RISK

Our trade accounts receivable subject us to significant concentrations of credit risk.  We perform ongoing credit evaluations on our customers’ financial condition and generally do not require collateral.

Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the nine months ended September 30, 2017 and 2016.
 
   
% of Total Revenue
Nine Months Ended
    
% of Total Accounts Receivable
Nine Months Ended
  
Customer
  
2017
    
2016
    
2017
    
2016
  
Customer 1
    
17
%
    
12
%
    
31
%
    
28
%
Customer 2
    
15
%
    
15
%
    
*
      
*
  
Customer 3
    
*
      
12
%
    
*
      
*
  
Customer 4
    
*
      
*
      
*
      
*
  
Customer 5
    
*
      
*
      
*
      
11
%
Others
    
68
%
    
61
%
    
69
%
    
61
%
Total
    
100
%
    
100
%
    
100
%
    
100
%
                                 
* Less than 10%
                                
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the nine months ended September 30, 2017 and 2016.
 
   
% of Total Purchases
Nine Months Ended
  
Supplier
  
2017
    
2016
  
Supplier 1
    
*
      
13
%
Supplier 2
    
*
      
*
  
Supplier 3
    
*
      
*
  
Supplier 4
    
*
      
*
  
Supplier 5
    
*
      
*
  
Others
    
100
%
    
87
%
Total
    
100
%
    
100
%
                 
* Less than 10%
                
 
14
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
NOTE 7. DEBT
 
The following table summarizes current and long-term portions of debt (in thousands):
 
   
September 30,
2017
    
December 31,
2016
  
Senior debentures, net, maturing in February 2019, principal $6.6 million
  
$
-
    
$
-
  
Subordinated notes, net, maturing in May 2019, principal $5.9 million
    
-
      
6,310
  
Other
    
32
      
75
  
Senior revolving loan
    
-
      
1,725
  
Senior term loan, net
    
-
      
917
  
     
32
      
9,027
  
Current portion
    
19
      
3,063
  
Long-term portion
  
$
13
    
$
5,964
  
 
We issued senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017.  In connection with the senior debenture private placement, in February 2017, we also entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.  The transactions, and the accounting therefore, are described further in Note 8.

Until July 2017, when we repaid the senior debentures and the subordinated notes in full with the proceeds from the sale of HN in July 2017, we accreted interest on the debentures at an effective rate of 160.6% per year and on the subordinated notes at 15.0% per year.  Upon extinguishment in July 2017, we recognized a loss on extinguishment of $6.6 million for the differences between (i) the $0.6 million carrying amount of the senior debentures and the $6.6 million face value paid and (ii) the $5.3 million carrying amount of the subordinated notes and the $6.0 million face value paid.

In February 2017, we used the net proceeds from the senior debenture private placement discussed further in Note 8 to pay the senior revolving loan and the senior term loan in full.
 
15
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements
 
NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (in thousands)
 
   
Shares
                      
Accumulated
Deficit
Attributable to
Non-controlling
    
Accumulated
Other Comp-
        
   
Preferred
          
Preferred
    
Common
    
Accumulated
    
 Interest in
    
rehensive
    
Equity
  
   
Series F
    
Series G
    
Common
    
Stock
    
Stock
    
Deficit
    
Nutra SA
    
Loss
    
(Deficit)
  
Balance, December 31, 2016
    
-
      
-
      
10,790,351
    
$
-
    
$
264,232
    
$
(259,819
)
  
$
(699
)
  
$
(4,346
)
  
$
(632
)
Issuance of common stock awards under equity incentive plans
    
-
      
-
      
642,839
      
-
      
817
      
-
      
-
      
-
      
817
  
Dividend on preferred stock - beneficial conversion feature
    
-
      
-
      
-
      
-
      
778
      
(778
)
    
-
      
-
      
-
  
Modification of senior debenture holder warrants
    
-
      
-
      
-
      
-
      
582
      
-
      
-
      
-
      
582
  
Modification of subordinated note holder warrants
    
-
      
-
      
-
      
-
      
117
      
-
      
-
      
-
      
117
  
Change in classification of preferred stock to equity from liability
    
3,000
      
2,000
      
-
      
1,545
      
-
      
-
      
-
      
-
      
1,545
  
Change in classification of warrants to equity from liability
    
-
      
-
      
-
      
-
      
7,851
      
-
      
-
      
-
      
7,851
  
Conversion of preferred stock into common stock
    
(2,501
)
    
(700
)
    
2,331,627
      
(807
)
    
807
      
-
      
-
      
-
      
-
  
Proceeds from sale of common stock, net of costs
    
-
      
-
      
2,654,732
      
-
      
2,730
      
-
      
-
      
-
      
2,730
  
Exercise of warrant
    
-
      
-
      
103,008
      
-
      
101
      
-
      
-
      
-
      
101
  
Other
    
-
      
-
      
28,793
      
-
      
64
      
-
      
-
      
-
      
64
  
Proceeds from sale of membership interests
    
-
      
-
      
-
      
-
      
-
      
-
      
650
      
-
      
650
  
Foreign currency translation
    
-
      
-
      
-
      
-
      
-
      
-
      
38
      
93
      
131
  
Net loss
    
-
      
-
      
-
      
-
      
-
      
(205
)
    
(1,359
)
    
-
      
(1,564
)
Balance, September 30, 2017
    
499
      
1,300
      
16,551,350
    
$
738
    
$
278,079
    
$
(260,802
)
  
$
(1,370
)
  
$
(4,253
)
  
$
12,392
  
 
16
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

A summary of warrant activity for the nine months ended September 30, 2017, follows.
 
   
Equity Warrants
    
Liability Warrants
  
   
Shares
Underlying
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
    
Shares
Underlying
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
  
Outstanding, December 31, 2016
    
6,364,110
    
$
5.77
      
2.4
      
4,474,868
    
$
1.82
      
3.3
  
Issued
    
-
    
NA
    
NA
      
11,783,163
      
0.96
      
5.0
  
Impact of repricing debenture purchaser warrants:
                                                
Prior to repricing
    
(875,000
)
    
5.49
      
2.1
      
-
    
NA
    
NA
  
After repricing
    
875,000
      
0.96
      
5.5
      
-
    
NA
    
NA
  
Impact of repricing subordinated note holder warants:
                                                
Prior to repricing
    
(289,669
)
    
5.25
      
3.3
      
-
    
NA
    
NA
  
After repricing
    
289,669
      
0.96
      
3.3
      
-
    
NA
    
NA
  
Impact of anti-dilution clauses:
                                                
Prior to impact
    
-
    
NA
    
NA
      
(1,489,868
)
    
1.50
      
0.8
  
After impact
    
-
    
NA
    
NA
      
2,327,919
      
0.96
      
0.8
  
Transfer from liability to equity
    
14,468,163
      
1.16
      
4.8
      
(14,468,163
)
    
1.16
      
4.8
  
Exercised
    
-
    
NA
    
NA
      
(781,252
)
    
0.96
      
-
  
Forfeited, expired or cancelled
    
-
    
NA
    
NA
      
-
    
NA
    
NA
  
Outstanding, September 30, 2017
    
20,832,273
    
$
2.32
      
3.6
      
1,846,667
    
$
1.06
      
0.7
  
Exercisable, September 30, 2017
    
20,832,273
    
$
2.32
      
3.6
      
1,846,667
    
$
1.06
      
0.7
  
 
Common Stock

In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.

On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.

In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.  The amount was payable in either cash or stock at the chairman’s election.  The chairman elected to receive shares of common stock.

In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.  In August 2017, we issued 35,336 shares of common stock to a director at a grant date fair value of $1.09 per share.  The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.

In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.  We reclassified the $0.1 million carrying value of the related preferred stock to common stock.

In September 2017, we issued and sold 2,654,732 shares of common stock for $1.08 per share.  The net proceeds from the offering of $2.8 million, after deducting commissions and other cash offering expenses of $0.1 million, are included in common stock.   We used the proceeds for general corporate purposes.

In the third quarter of 2017, we issued 2,111,188 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 689 shares of Series G preferred stock.  We reclassified the $0.7 million carrying value of the related preferred stock to common stock.
 
In the fourth quarter of 2017, through the date of this filing, we issued 332,667 shares of common stock upon conversion of 499 shares of Series F preferred stock, with a $0.1 million carrying value.
 
17
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Share Sequencing

From June 2015 until March 2017, the minority interest holders in Nutra SA could elect to exchange units in Nutra SA for shares of our common stock, the number of common stock and warrants issuable upon this election, was variable and indeterminate.  For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.  Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock issued between June 2015 and March 2017, in temporary equity.  We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants’ fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks’ carrying amount on March 31, 2017.

Transactions with Preferred Stock Holders.

In February 2017, we issued and sold 2,000 shares of Series G preferred stock.  The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders’ election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.  The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.  If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.

In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).  A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.  The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.  On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.  We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.

Transactions with Senior Debenture Holders

In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).  We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.  Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.  We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.  We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.  We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.
 
18
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Transaction with Subordinated Note Holders

In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%  to 7% (ii) an extension of the maturity date of the subordinated notes  to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of  $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.  We accounted for the transaction as an extinguishment of debt and issuance of new debt.  In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock equity by $0.1 million for the change in the fair value of the existing warrants.

Full Ratchet Anti-Dilution

As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.  In the third quarter of 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.

Equity Incentive Plan

In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).  The total shares authorized under the 2014 Plan is now 3,300,000 shares.

Option Issuances

In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.  The option vested as to 25,000 shares in August 2017, the remaining shares in monthly installments through August 2020 and the option had a grant date fair value of $0.56 per share.

In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees at an average exercise price of $0.85 per share.  The options vest in four equal annual installments beginning in the second quarter of 2018 and had a grant date fair value of $0.62 per share.

In the third quarter of 2017, we granted an option to purchase an aggregate 20,000 shares of our common stock to an employee at an exercise price of $1.09 per share.  The option vests in four equal annual installments beginning in the third quarter of 2018 and had a grant date fair value of $0.77 per share.

Restricted Stock Unit Awards

In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.  The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.  Each RSU’s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.  The shares had a grant date fair value of $0.2 million which is being expensed ratably over a 3.5-year period beginning in July 2017.

Warrants

In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.  We issued 103,008 shares of common stock to the holder in a cashless transaction and recorded a $0.1 million loss on the conversion equal to the difference between the fair value of the liability and the fair value of the common stock on the date of the conversion.
 
19
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

The following table summarizes information related to outstanding warrants as September 30, 2017 and December 31, 2016:
 
        
September 30, 2017
    
December 31, 2016
  
Range of
Exercise Prices
  
Type of
Warrant
  
Shares
Under
Warrants
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
    
Shares Under
Warrants,
Exercisable
Cashless
    
Shares
Under
Warrants
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
  
                           
(4
)
                  
$
0.96
  
 Liability (1)
    
1,546,667
    
$
0.96
      
0.4
      
1,546,667
      
-
    
$
-
      
-
  
$
0.96
  
 Equity
    
12,947,832
      
0.96
      
4.6
      
3,774,344
      
-
      
-
      
-
  
$
1.50
  
 Liability (2)
    
300,000
      
1.60
      
2.9
      
300,000
      
-
      
-
      
-
  
$
1.50 to $1.60
  
 Liability
    
-
      
-
      
-
      
-
      
1,789,868
      
1.52
      
1.3
  
$
2.00
  
 Liability (3)
    
-
      
-
      
-
      
-
      
2,660,000
      
2.00
      
4.6
  
$
2.00
  
 Equity
    
2,660,000
      
2.00
      
4.2
      
-
      
-
      
-
      
-
  
$
5.25
  
 Liability (3)
    
-
      
-
      
-
      
-
      
25,000
      
5.25
      
3.6
  
$
5.25 to $5.87
  
 Equity
    
3,156,670
      
5.33
      
2.2
      
359,536
      
4,296,339
      
5.36
      
2.7
  
$
6.55 to $16.80
  
 Equity
    
2,067,771
      
6.61
      
1.5
      
190,899
      
2,067,771
      
6.61
      
2.0
  
           
22,678,940
    
$
2.21
      
3.6
      
6,171,446
      
10,838,978
    
$
4.14
      
2.8
  
 
(1)
Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet.  Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
(4)
Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature.  The shares listed, represent the shares holders could exercise cashless as of September 30, 2017.  If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise.  Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.

NOTE 9. FAIR VALUE MEASUREMENTS

The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.  As of September 30, 2017, the fair value of our debt (Level 3 measurement) approximated its carrying value, based on current market rates for similar debt with similar maturities.

Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Certain assets and liabilities are presented in the financial statements at fair value.  Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.  Assets and liabilities measured at fair value on a non-recurring basis may include property.

We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

●
Level 1 – inputs include quoted prices for identical instruments and are the most observable.
●
Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.
●
Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.
 
20
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.

The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
   
Level 1
    
Level 2
    
Level 3
    
Total
  
Total liabilities at fair value, as of September 30, 2017 - derivative warrant liabilities
  
$
-
    
$
-
    
$
769
    
$
769
  
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
  
$
-
    
$
-
    
$
1,527
    
$
1,527
  

Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.  The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.  The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.
 
   
September 30, 2017
    
December 31, 2016
  
Risk-free interest rate
    
1.2%
    
0.6% -1.9%
   
(1.2% weighted average)
    
(1.6% weighted average)
  
Expected volatility
    
67%-72%
    
64%
 
   
(71% weighted average)
    
(64% weighted average)
  
 
The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):
 
Total Level 3 Fair Value
  
Fair Value
as of
Beginning of
Period
    
Total
Realized and
Unrealized
Gains
(Losses)
    
Issuance of
New
Instruments
    
Reclassify to
(Deficit)
Equity
    
Conversion
to Common
Stock
    
Fair Value,
at End of
Period
  
         
(1)
                        
Nine Months Ended September 30, 2017, derivative warrant liabilities
  
$
(1,527
)
  
$
808
    
$
(7,917
)
  
$
7,851
    
$
16
    
$
(769
)
Nine Months Ended September 30, 2016, derivative warrant liabilities
  
$
(678
)
  
$
314
    
$
(2,474
)
  
$
-
    
$
-
    
$
(2,838
)
 
(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.

NOTE 10. COMMITMENTS AND CONTINGENCIES

In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.  These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.  Defense costs are expensed as incurred and are included in professional fees.

Irgovel Litigation

Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.  The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.  None of these labor claims is individually significant.  Management believes it’s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.
 
21
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.  The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.  We record amounts considered sufficient by our management to cover probable losses based on these elements.

In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.

Irgovel - Events of Default

As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.  It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors.

Employment Contracts and Severance Payments

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.  In addition, vesting of outstanding unvested equity grants held by these individuals would accelerate following a change in control.

NOTE 11. INCOME TAXES

We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN’s taxable operating income in 2017.  Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset 90% by net operating loss carryforwards; thereby potentially leaving residual taxable income of 10%, subject to a rate of 20%.  We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.  We have determined that a Section 382 ownership change occurred in September 2017 and our ability to carryforward remaining net operating losses subsequent to the most recent change in ownership will be severely limited.  The Internal Revenue Service rules in this area are complex and our estimates are subject to change.
 
NOTE 12. RELATED PARTY TRANSACTIONS

Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.  As of September 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.  See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.  The notes were paid in full in July 2017 from the proceeds of the sale of HN.  In the three months ended September 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the nine months ended September 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.
 
As discussed in Note 8, in September 2017, we issued and sold 2,654,732 shares of common stock to Continental Grain Company (CGG).  Our director, Ari Gendason is an employee and senior vice president -corporate investments of CGG.  As of the date of this filing, CGG owns approximate 16% of our outstanding common stock.  We have agreed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one nominee to our board of directors.
 
22
RiceBran Technologies
Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 13. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS

On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders’ equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders’ equity for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1).  As of September 30, 2016, we reported stockholders’ deficit of $36,000.

We submitted our plan to regain compliance in October 2016.  On November 15, 2016, Nasdaq granted us a 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders’ equity requirement.  On February 16, 2017, we received a determination letter from Nasdaq stating that we had not regained compliance with the minimum stockholders’ equity requirement.  The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.

We requested and were granted a hearing before the panel to appeal the determination letter on March 30, 2017.  After that hearing, on April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million (it was $7.9 million as of March 31, 2017).  As reported herein our equity is $12.4 million and exceeds the minimum as of September 30, 2017.

On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2) because our common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive trading days.  Nasdaq rules allowed for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.  On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.
 
23
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

See Note 2 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of divestitures and discontinued operations.

See Note 3 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of going concern considerations and management’s plans.

Results of Operations

During the second quarter of 2017, we began to separately report the results of our wholly-owned subsidiary, Healthy Natural, Inc. (HN) and our investment in Nutra SA as discontinued operations in our consolidated statements of operations and present the related assets and liabilities as held for sale in the consolidated balance sheets. These changes have been applied for all periods presented. Unless otherwise noted, amounts and percentages for all periods discussed below reflect the results of operations and financial condition from our continuing operations.  Refer to Note 2 to our consolidated financial statements for additional information on discontinued operations.
 
   
Three Months Ended
    
Change
    
Nine Months Ended
    
Change
  
   
2017
    
2016
    
%
    
2017
    
2016
    
%
  
                                     
Revenues
  
$
3,445
    
$
3,249
      
6.0
    
$
10,206
    
$
9,748
      
4.7
  
Cost of goods sold
    
2,305
      
2,434
      
5.3
      
7,081
      
7,199
      
1.6
  
Gross profit
    
1,140
      
815
      
39.9
      
3,125
      
2,549
      
22.6
  
Gross profit %
    
33.1
%
    
25.1
%
            
30.6
%
    
26.1
%
        
                                                 
Operating selling, general and administrative expenses
    
2,495
      
3,140
      
20.5
      
7,428
      
9,428
      
21.2
  
Loss from operations
    
(1,355
)
    
(2,325
)
    
41.7
      
(4,303
)
    
(6,879
)
    
37.4
  
Other (expense) income:
                                                
Interest expense
    
(86
)
    
(352
)
            
(1,616
)
    
(1,484
)
        
Change in fair value of derivative warrant liabilities
    
(313
)
    
1,166
              
808
      
314
          
Loss on extinguishment of debt
    
(6,610
)
    
-
              
(8,290
)
    
-
          
Loss on conversion of preferred stock
    
(85
)
    
-
              
(85
)
    
-
          
Gain on resolution of Irgovel purchase litigation
    
-
      
-
              
-
      
1,598
          
Other income net
    
129
      
132
              
66
      
132
          
Total other (expense) income
    
(6,965
)
    
946
              
(9,117
)
    
560
          
Loss before income taxes
  
$
(8,320
)
  
$
(1,379
)
          
$
(13,420
)
  
$
(6,319
)
        
 
THREE MONTHS ENDED SEPTEMBER 30, 2017 and 2016

Revenues increased $0.2 million, or 6.0%, quarter over quarter.  Animal nutrition product revenues increased 13% over prior year levels driven by the supply and cooperation agreement entered into with Kentucky Equine Research (KER) at the end of December 2015.  Food product revenues remained relatively constant with an increase of approximately 1.0%, quarter over quarter. The increase in food product revenue was offset primarily due to decreased buying from specialty ingredients accounts.

Gross profit percentage increased eight percentage points for the third quarter of 2017 versus the prior year quarter.  In the third quarter of 2017, our production of raw bran processing volume increased 6% quarter over quarter.  Additionally, raw bran prices decreased approximately 11% when comparing quarter over quarter, leading to improved margin performance during the quarter.

Operating selling, general and administrative expenses (SG&A) were $1.0 million for the third quarter of 2017, compared to $1.3 million for the third quarter of 2016, a decrease of $0.4 million.  The decrease is related to our continued strategic effort to manage costs and expenses.  Due to the reduction of staff and outside sales consultants, the SG&A salary, bonus, wages and benefit related expenses decreased $0.2 million. Marketing and tradeshow related expenses decreased $0.1 million and travel and entertainment expenses decreased $0.1 million.

Corporate SG&A expenses in the third quarter of 2017 were $1.5 million, a decrease of $0.3 million over the prior year quarter that was primarily due to expenses during the third quarter of 2016 as a result of the $0.7 million settlement with former chief executive officer, W. John Short. On August 27, 2016, Mr. Short’s employment as our chief executive officer was terminated. At September 30, 2016, we included the estimated severance payments in the amount of $0.7 million in accrued salary, wages and benefits in our condensed consolidated balance sheets.
 
24
Other income (expense) was $7.0 million of other expense for the third quarter of 2017 compared to $0.9 million of other income for the third quarter of 2016.  The $7.9 million increase in expense is primarily related to the $6.6 million loss on extinguishment of debt related to accreting the senior debentures and subordinated notes (see Note 7) to face value when the notes were fully paid off in July 2017 from the HN divestiture proceeds.  The payoff of the notes also reduced interest expense of $0.3 million during the third quarter compared to the prior year quarter.  Additionally, a $1.5 million increase in other expense is related to the fair value of derivative warrant liabilities in the third quarter compared to the prior year quarter.

NINE MONTHS ENDED SEPTEMBER 30, 2017 and 2016

Revenues increased $0.5 million, or 4.7%, in the nine months ended September 30, 2017 compared to the nine months ended September 30, 2016. Animal feed product revenues increased 10%. Animal nutrition revenue growth was driven by the supply and cooperation agreement entered into with Kentucky Equine Research (KER) at the end of December 2015.  Food product revenues remained relatively constant period over period.

Gross profit percentage increased 4.5 percentage points to 30.6% in the first nine months of 2017, from 26.1% in the first nine months of 2016.  The increase in gross profit was primarily attributable to the approximately 2.3% decrease in raw bran prices during the first nine months of 2017 compared to the same period of the previous year.  Additionally, the improvement in gross profit was attributable to a decrease in obsolete inventory during the first nine months of 2017 compared to the prior year same period.

Operating expenses were $2.9 million for the first nine months of 2017, compared to $3.9 million for the first nine months of 2016, a decrease of $1.0 million, or 26%.  The decrease is related to our continued strategic effort to manage costs and expenses.  Due to the reduction of staff and outside sales consultants, the SG&A salary, bonus, wages and benefit related expenses decreased $0.7 million.  Additionally, travel expenses and marketing expenses decreased $0.4 million.

Corporate SG&A expenses decreased $1.0 million, or 18%, in the first nine months of 2017 compared to the prior year same period.  This was primarily related to the additional expenses during the second quarter of 2016 incurred as a result of the proxy contest in connection with the 2016 Annual Shareholder Meeting.  Additionally, the additional expenses during the third quarter of 2016 incurred as a result of the settlement related to the termination of the former chief executive officer, as described above.

Other expense increased $9.7 million in the first nine months of 2017 compared to the prior year period.  The $9.7 million increase in expense is primarily related to $6.6 million loss on extinguishment of debt related to accreting the senior debentures and subordinated notes (see Note 7) to face value when the notes were fully paid off in July 2017 from the HN divestiture proceeds and to $1.7 million loss on extinguishment of debt related to the extinguishment and replacement of subordinated notes in February 2017 (see Note 8).  Additionally, a $1.6 million increase in expense is associated with the gain on resolution of Irgovel purchase litigation recognized in the prior year period.

Liquidity, Going Concern and Capital Resources

See Note 3 of our Notes to Unaudited Condensed Consolidated Financial Statements for a discussion of going concern considerations and management’s plans.

Cash used in operating activities of continuing operations for the nine months ended September 30, 2017 and 2016, is presented below (in thousands).
 
25
   
2017
    
2016
  
Cash flow from operating activities:
            
Loss from continuing operations
  
$
(8,387
)
  
$
(4,975
)
Adjustments to reconcile net loss to net cash used in operating activities:
                
Depreciation and amortization
    
571
      
694
  
Stock and share-based compensation
    
904
      
841
  
Change in fair value of derivative warrant and conversion liabilities
    
(808
)
    
(314
)
Loss on extinguishment of debt
    
8,290
      
-
  
Gain on resolution of Irgovel purchase litigation
    
-
      
(1,598
)
Interest accreted
    
1,000
      
497
  
Deferred taxes
    
(5,033
)
    
(1,344
)
Other
    
55
      
-
  
Changes in operating assets and liabilities:
                
Accounts receivable
    
(290
)
    
(182
)
Inventories
    
213
      
576
  
Accounts payable and accrued expenses
    
(1,310
)
    
3
  
Other
    
465
      
53
  
Net cash used in operating activities of continuing operations
  
$
(4,330
)
  
$
(5,749
)
 
We used $4.3 million of operating cash during the first nine months of 2017, compared to using $5.7 million of operating cash in the first nine months of 2016.  We funded the use of cash with available cash on hand derived from the sale of the assets of HN for $16.7 million in cash, net of assumed liabilities (see Note 2 of our Notes to Unaudited Condensed Consolidated Financial Statements for additional information).  The net proceeds from the HN divestiture were used in part to pay in full amounts of senior debentures ($6.6 million) and to pay principal and accrued interest on our subordinated notes ($6.0 million) (see Note 7).

Additionally, we funded the use of cash from the debt and equity raise in February 2017 (February 2017 Transactions).  We received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants from the February 2017 Transactions.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  See Note 8 of our Notes to Unaudited Condensed Consolidated Financial Statements for additional information.

As of September 30, 2017, our cash and cash equivalents balance is $8.2 million and our restricted cash balance is $0.8 million (see Note 2), compared to $0.3 million as of December 31, 2016.

Off-Balance Sheet Arrangements

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risk, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing and liquidity support or market risk or credit support risk to us.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses and disclosures on the date of the financial statements.  On an ongoing basis, we evaluate the estimates, including, but not limited to, those related to revenue recognition.  We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments.  Actual results could differ from those estimates.

For further information about other critical accounting policies, see the discussion of critical accounting policies in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Recent Accounting Pronouncements

See Note 4 in the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.
 
26
Item 3.
Quantitative and Qualitative Disclosures about Market Risk

Not applicable

Item 4.
Controls and Procedures 

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosures.

We evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f).  Under the supervision and with the participation of our management, including our Chief Executive Officer, Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2016 based on the guidelines established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO 2013).  Our internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.

Changes in Internal Control over Financial Reporting

During the most recently completed fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.
Legal Proceedings

See Note 10 in the Notes to Unaudited Condensed Consolidated Financial Statements for information regarding certain legal proceedings to which we are a party.

We are involved in or subject to, or may become involved in or subject to, routine litigation, claims, disputes, proceedings and investigations in the ordinary course of business.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position, results of operations or cash flows.  We record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.

In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.

Item 1A.
Risk Factors

In addition to the other information set forth in this Quarterly Report and the risk factor set forth below, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016, which could materially affect our business, financial condition, liquidity or future results.  The risks described in our Annual Report on Form 10-K are not the only risks facing our company.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, liquidity or future results.
 
27
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended September 30, 2017, we issued the securities described below without registration under the Securities Act.  The description below does not include issuances that were disclosed previously on Current Reports on Form 8-K.  Unless otherwise indicated below, the securities were issued pursuant to the private placement exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended.  All issuances below were made without any public solicitation, to a limited number of persons and were acquired for investment purposes only.

During the quarter ended September 30, 2017, we issued 2,111,188 shares of common stock upon the conversion of 2,186 shares of Series F convertible preferred stock and 689 shares of Series G convertible preferred stock.  These issuances were exempt from registration pursuant to Section 3(a)(9) of the Securities Act of 1933.
 
Item 3.
Defaults upon Senior Securities

None

Item 4.
Mine Safety Disclosures

None

Item 5.
Other Information

None

Item 6.
Exhibits

The following exhibits are attached hereto and filed herewith:
 
28
       
Incorporated by Reference
    
Exhibit
Number
  
Exhibit Description
  
Form
  
File No.
  
Exhibit
Number
  
Filing/Effective
Date
  
Filed
Here-
with
 
Asset Purchase Agreement dated July 14, 2017, among the Registrant, Healthy Natural, Inc. and United Laboratories Manufacturing, LLC
  
8-K
  
001-36245
  
2.1
  
July 17, 2017
    
 
Form of Common Stock Purchase Agreement dated September 13, 2017
  
8-K
  
001-36245
  
10.1
  
September 13., 2017
    
 
Form of Registration Rights Agreement dated September 13, 2017
  
8-K
  
001-36245
  
10.2
  
September 13., 2017
    
 
Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
                  
X
 
Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
                  
X
 
Certification by CEO and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
                  
X
101.INS (1)
  
XBRL Instance Document
                  
X
101.SCH (1)
  
XBRL Taxonomy Extension Schema Document
                  
X
101.CAL (1)
  
XBRL Taxonomy Extension Calculation Linkbase Document
                  
X
101.DEF (1)
  
XBRL Taxonomy Extension Calculation Definition Linkbase Document
                  
X
101.LAB (1)
  
XBRL Taxonomy Extension Calculation Label Linkbase Document
                  
X
101.PRE (1)
  
XBRL Taxonomy Extension Calculation Presentation Linkbase Document
                  
X

(1)
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
29
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated:  November 9, 2017
  
 
 
/s/ Robert Smith
  
 
Robert Smith
 
Chief Executive Officer
   
 
/s/ Brent Rystrom
  
 
Brent Rystrom
 
Chief Financial Officer
 
 
30
 EX-31.1 2 ex31_1.htm EXHIBIT 31.1
Exhibit 31.1

Certification of Principal Executive Officer
 Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Robert Smith, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  November 9, 2017
/s/ Robert Smith
  
   
 
Name: Robert Smith
 
Title: Chief Executive Officer
 
 
 EX-31.2 3 ex31_2.htm EXHIBIT 31.2
Exhibit 31.2

Certification of Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brent Rystrom, certify that:

1)
I have reviewed this quarterly report on Form 10-Q of RiceBran Technologies;

2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report was prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s disclosure internal control over financial reporting.

Dated:  November 9, 2017
/s/ Brent Rystrom
  
   
 
Name: Brent Rystrom
 
Title: Chief Financial Officer
 
 
 EX-32.1 4 ex32_1.htm EXHIBIT 32.1
Exhibit 32.1

Certification of Principal Executive Officer and Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of RiceBran Technologies (the Company) for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Company.

Dated:  November 9, 2017
  
   
 
/s/ Robert Smith
  
 
Robert Smith
 
Chief Executive Officer
     
 
/s/ Brent Rystrom
  
 
Brent Rystrom
 
Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No. 34-47551 and shall not be considered filed as part of the Form 10-Q.
 
 
 EX-101.INS 5 ribt-20170930.xml XBRL INSTANCE DOCUMENT 0001063537 2017-01-01 2017-09-30 0001063537 2017-11-03 0001063537 2016-01-01 2016-09-30 0001063537 2016-07-01 2016-09-30 0001063537 2017-07-01 2017-09-30 0001063537 2017-09-30 0001063537 2016-12-31 0001063537 us-gaap:SeriesFPreferredStockMember 2016-12-31 0001063537 us-gaap:SeriesFPreferredStockMember 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember 2016-12-31 0001063537 2015-12-31 0001063537 2016-09-30 0001063537 ribt:NutraSAMember 2017-01-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember 2017-01-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember 2017-07-01 2017-07-31 0001063537 ribt:HealthyNaturalIncMember 2017-09-30 0001063537 ribt:HealthyNaturalIncMember 2017-07-31 0001063537 ribt:HealthyNaturalIncMember 2017-07-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember 2016-01-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember 2016-07-01 2016-09-30 0001063537 ribt:NutraSAMember 2016-07-01 2016-09-30 0001063537 ribt:NutraSAMember 2017-07-01 2017-09-30 0001063537 ribt:NutraSAMember 2016-01-01 2016-09-30 0001063537 ribt:NutraSAMember 2017-09-30 0001063537 ribt:NutraSAMember 2016-12-31 0001063537 ribt:HealthyNaturalIncMember 2016-12-31 0001063537 ribt:NutraSAMember 2015-12-31 0001063537 ribt:NutraSAMember 2016-09-30 0001063537 us-gaap:SellingGeneralAndAdministrativeExpensesMember ribt:NutraSAMember 2016-01-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:CostOfSalesMember 2017-07-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0001063537 us-gaap:CostOfSalesMember ribt:NutraSAMember 2017-01-01 2017-09-30 0001063537 us-gaap:SellingGeneralAndAdministrativeExpensesMember ribt:HealthyNaturalIncMember 2017-01-01 2017-09-30 0001063537 us-gaap:CostOfSalesMember ribt:NutraSAMember 2017-07-01 2017-09-30 0001063537 us-gaap:SellingGeneralAndAdministrativeExpensesMember ribt:NutraSAMember 2017-07-01 2017-09-30 0001063537 ribt:NutraSAMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:CostOfSalesMember 2017-01-01 2017-09-30 0001063537 ribt:NutraSAMember us-gaap:CostOfSalesMember 2016-07-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:CostOfSalesMember 2016-07-01 2016-09-30 0001063537 us-gaap:SellingGeneralAndAdministrativeExpensesMember ribt:NutraSAMember 2016-07-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-09-30 0001063537 us-gaap:CostOfSalesMember ribt:NutraSAMember 2016-01-01 2016-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:CostOfSalesMember 2016-01-01 2016-09-30 0001063537 ribt:NutraSAMember ribt:IrgovelMember 2017-09-30 0001063537 ribt:IrgovelMember ribt:NutraSAMember 2017-04-01 2017-09-30 0001063537 country:BR ribt:NutraSAMember 2017-09-30 0001063537 ribt:NutraSAMember ribt:IrgovelMember 2017-01-01 2017-09-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-06-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2015-12-31 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-06-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-12-31 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2017-07-01 2017-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-07-01 2016-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2016-01-01 2016-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:SegmentDiscontinuedOperationsMember 2017-09-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:InvestorMember us-gaap:SegmentDiscontinuedOperationsMember 2017-09-30 0001063537 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:InvestorMember 2017-01-01 2017-09-30 0001063537 us-gaap:InvestorMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-01-01 2016-12-31 0001063537 2017-02-28 2017-02-28 0001063537 2017-09-01 2017-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-09-30 0001063537 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2016-01-01 2016-12-31 0001063537 us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0001063537 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001063537 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0001063537 us-gaap:RestrictedStockMember 2016-07-01 2016-09-30 0001063537 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0001063537 us-gaap:WarrantMember 2017-07-01 2017-09-30 0001063537 us-gaap:EmployeeStockOptionMember 2016-07-01 2016-09-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-09-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2016-07-01 2016-09-30 0001063537 ribt:TemporaryEquityStockMember 2017-01-01 2017-09-30 0001063537 us-gaap:RestrictedStockMember 2016-01-01 2016-09-30 0001063537 us-gaap:WarrantMember 2016-07-01 2016-09-30 0001063537 us-gaap:WarrantMember 2017-01-01 2017-09-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001063537 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0001063537 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0001063537 ribt:TemporaryEquityStockMember 2016-01-01 2016-09-30 0001063537 ribt:TemporaryEquityStockMember 2016-07-01 2016-09-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001063537 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-09-30 0001063537 us-gaap:WarrantMember 2016-01-01 2016-09-30 0001063537 ribt:TemporaryEquityStockMember 2017-07-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:OtherCustomersMember 2017-01-01 2017-09-30 0001063537 ribt:Supplier4Member us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2017-01-01 2017-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember ribt:Supplier5Member 2016-01-01 2016-09-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-09-30 0001063537 ribt:Customer2Member us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-09-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001063537 ribt:Customer1Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 ribt:OtherCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2016-01-01 2016-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:Supplier1Member ribt:PurchasesMember 2016-01-01 2016-09-30 0001063537 ribt:FifthCustomerMember us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 ribt:Customer3Member us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2017-01-01 2017-09-30 0001063537 ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2017-01-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember ribt:Customer3Member 2017-01-01 2017-09-30 0001063537 ribt:OtherSuppliersMember us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2017-01-01 2017-09-30 0001063537 us-gaap:AccountsReceivableMember ribt:FifthCustomerMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 ribt:Supplier3Member us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2017-01-01 2017-09-30 0001063537 ribt:Customer1Member us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-09-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ribt:Customer2Member 2016-01-01 2016-09-30 0001063537 ribt:Supplier2Member us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2016-01-01 2016-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember ribt:Supplier1Member 2017-01-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember ribt:Customer1Member 2016-01-01 2016-09-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier4Member 2016-01-01 2016-09-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier2Member 2017-01-01 2017-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember ribt:Supplier5Member 2017-01-01 2017-09-30 0001063537 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ribt:Customer2Member 2017-01-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember ribt:FourthCustomerMember 2016-01-01 2016-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-09-30 0001063537 us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember ribt:Customer3Member 2016-01-01 2016-09-30 0001063537 ribt:OtherCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-09-30 0001063537 ribt:OtherSuppliersMember ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2016-01-01 2016-09-30 0001063537 ribt:FourthCustomerMember us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001063537 ribt:FourthCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-09-30 0001063537 us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember ribt:FourthCustomerMember 2016-01-01 2016-09-30 0001063537 us-gaap:SupplierConcentrationRiskMember ribt:PurchasesMember 2017-01-01 2017-09-30 0001063537 us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember ribt:Customer2Member 2017-01-01 2017-09-30 0001063537 ribt:OtherCustomersMember us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-09-30 0001063537 us-gaap:SalesRevenueGoodsNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember ribt:Customer1Member us-gaap:SalesRevenueGoodsNetMember 2017-01-01 2017-09-30 0001063537 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember ribt:Customer3Member 2016-01-01 2016-09-30 0001063537 ribt:PurchasesMember us-gaap:SupplierConcentrationRiskMember ribt:Supplier3Member 2016-01-01 2016-09-30 0001063537 us-gaap:SeniorNotesMember 2016-12-31 0001063537 us-gaap:NotesPayableOtherPayablesMember 2016-12-31 0001063537 us-gaap:SubordinatedDebtMember ribt:DebtDueMay2019Member 2016-12-31 0001063537 ribt:DebtDueFebruary2019Member us-gaap:SecuredDebtMember 2016-12-31 0001063537 us-gaap:RevolvingCreditFacilityMember 2016-12-31 0001063537 us-gaap:SeniorNotesMember 2017-09-30 0001063537 us-gaap:NotesPayableOtherPayablesMember 2017-09-30 0001063537 us-gaap:SubordinatedDebtMember ribt:DebtDueMay2019Member 2017-09-30 0001063537 us-gaap:RevolvingCreditFacilityMember 2017-09-30 0001063537 us-gaap:SecuredDebtMember ribt:DebtDueFebruary2019Member 2017-09-30 0001063537 us-gaap:SecuredDebtMember ribt:HealthyNaturalIncMember 2017-09-30 0001063537 ribt:HealthyNaturalIncMember us-gaap:SubordinatedDebtMember 2017-09-30 0001063537 us-gaap:SecuredDebtMember ribt:DebtDueFebruary2019Member 2017-01-01 2017-09-30 0001063537 ribt:DebtDueMay2019Member us-gaap:SubordinatedDebtMember 2017-01-01 2017-09-30 0001063537 ribt:DebtDueMay2019Member us-gaap:SubordinatedDebtMember 2016-01-01 2016-12-31 0001063537 us-gaap:SubordinatedDebtMember ribt:DebtDueMay2019Member 2017-01-01 2017-03-31 0001063537 2017-07-01 2017-07-31 0001063537 us-gaap:RetainedEarningsMember 2016-12-31 0001063537 us-gaap:CommonStockMember 2016-12-31 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2016-12-31 0001063537 us-gaap:PreferredStockMember 2016-12-31 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001063537 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2016-12-31 0001063537 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2016-12-31 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-09-30 0001063537 us-gaap:CommonStockMember 2017-01-01 2017-09-30 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2017-01-01 2017-09-30 0001063537 us-gaap:RetainedEarningsMember 2017-01-01 2017-09-30 0001063537 us-gaap:PreferredStockMember 2017-01-01 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2017-01-01 2017-09-30 0001063537 us-gaap:PreferredStockMember us-gaap:SeriesFPreferredStockMember 2017-01-01 2017-09-30 0001063537 us-gaap:CommonStockMember 2017-09-30 0001063537 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0001063537 us-gaap:RetainedEarningsMember 2017-09-30 0001063537 us-gaap:PreferredStockMember 2017-09-30 0001063537 ribt:RetainedEarningsAttributableToNoncontrollingInterestMember 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2017-09-30 0001063537 us-gaap:PreferredStockMember us-gaap:SeriesFPreferredStockMember 2017-09-30 0001063537 ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:EquityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:LiabilityWarrantMember 2017-09-30 0001063537 ribt:EquityWarrantMember 2017-09-30 0001063537 ribt:EquityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 2017-02-28 0001063537 2017-01-31 0001063537 ribt:FormerEmployeeMember 2017-02-14 2017-02-14 0001063537 us-gaap:DirectorMember 2017-06-01 2017-06-30 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2017-06-01 2017-06-30 0001063537 us-gaap:DirectorMember 2017-08-02 2017-08-31 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2017-01-01 2017-03-31 0001063537 us-gaap:BoardOfDirectorsChairmanMember 2016-07-01 2016-12-31 0001063537 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2017-10-01 2017-11-09 0001063537 us-gaap:CommonStockMember 2017-04-01 2017-06-30 0001063537 us-gaap:CommonStockMember 2017-07-01 2017-09-30 0001063537 us-gaap:SeriesGPreferredStockMember 2017-07-01 2017-09-30 0001063537 us-gaap:SubsequentEventMember us-gaap:SeriesGPreferredStockMember 2017-10-01 2017-11-09 0001063537 us-gaap:SeriesGPreferredStockMember 2017-04-01 2017-06-30 0001063537 us-gaap:SeriesFPreferredStockMember 2017-04-01 2017-06-30 0001063537 us-gaap:SeriesFPreferredStockMember 2017-07-01 2017-09-30 0001063537 us-gaap:PreferredStockMember us-gaap:SubsequentEventMember 2017-11-09 0001063537 us-gaap:SeriesGPreferredStockMember 2017-02-28 0001063537 us-gaap:SeriesGPreferredStockMember 2017-02-01 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember 2016-12-31 0001063537 us-gaap:SecuredDebtMember us-gaap:WarrantsNotSettleableInCashMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember 2017-09-30 0001063537 ribt:ExpirationFebruary2022Member us-gaap:WarrantsNotSettleableInCashMember 2017-02-28 0001063537 us-gaap:SubordinatedDebtMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember 2017-02-28 0001063537 us-gaap:WarrantsNotSettleableInCashMember us-gaap:SubordinatedDebtMember 2017-02-28 0001063537 us-gaap:SubordinatedDebtMember us-gaap:WarrantsNotSettleableInCashMember 2016-12-31 0001063537 us-gaap:SubordinatedDebtMember 2017-02-01 2017-02-28 0001063537 us-gaap:SecuredDebtMember 2017-02-01 2017-02-28 0001063537 us-gaap:SubordinatedDebtMember us-gaap:WarrantsNotSettleableInCashMember 2017-02-01 2017-02-28 0001063537 us-gaap:SecuredDebtMember us-gaap:WarrantsNotSettleableInCashMember 2017-02-01 2017-02-28 0001063537 us-gaap:SecuredDebtMember us-gaap:WarrantsNotSettleableInCashMember 2017-01-01 2017-09-30 0001063537 us-gaap:SecuredDebtMember 2017-01-01 2017-09-30 0001063537 us-gaap:SubordinatedDebtMember 2016-12-31 0001063537 ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 ribt:EquityIncentivePlan2014Member 2017-09-30 0001063537 ribt:ExecutiveOfficerAndEmployeesMember 2017-04-01 2017-06-30 0001063537 us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-03-31 0001063537 ribt:EmployeeMember 2017-07-01 2017-09-30 0001063537 us-gaap:ChiefExecutiveOfficerMember 2017-08-02 2017-08-31 0001063537 us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-09-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeThreeMember 2017-01-01 2017-09-30 0001063537 ribt:EquityWarrantMember ribt:RangeSixMember 2017-01-01 2017-09-30 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2017-01-01 2017-09-30 0001063537 ribt:RangeFourMember ribt:EquityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:RangeTwoMember ribt:LiabilityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeFiveMember 2017-01-01 2017-09-30 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:RangeFourMember ribt:LiabilityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:RangeOneMember ribt:LiabilityWarrantMember 2017-01-01 2017-09-30 0001063537 ribt:EquityWarrantMember ribt:RangeFourMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeOneMember 2016-12-31 0001063537 ribt:RangeThreeMember ribt:LiabilityWarrantMember 2017-09-30 0001063537 ribt:EquityWarrantMember ribt:RangeFourMember 2017-09-30 0001063537 ribt:RangeFiveMember ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeFiveMember 2017-09-30 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2017-09-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2017-09-30 0001063537 ribt:LiabilityWarrantMember 2017-07-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeThreeMember 2016-12-31 0001063537 ribt:RangeSixMember ribt:EquityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeFourMember 2017-09-30 0001063537 ribt:RangeFourMember ribt:LiabilityWarrantMember 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeOneMember 2017-09-30 0001063537 ribt:RangeSixMember ribt:EquityWarrantMember 2017-09-30 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2016-12-31 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2017-09-30 0001063537 ribt:RangeFiveMember ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeFourMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSevenMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeTwoMember 2016-01-01 2016-12-31 0001063537 2016-01-01 2016-12-31 0001063537 ribt:RangeFourMember ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:RangeThreeMember ribt:LiabilityWarrantMember 2016-01-01 2016-12-31 0001063537 ribt:EquityWarrantMember ribt:RangeSixMember 2016-01-01 2016-12-31 0001063537 ribt:LiabilityWarrantMember ribt:RangeOneMember 2016-01-01 2016-12-31 0001063537 ribt:RangeOneMember ribt:EquityWarrantMember 2016-01-01 2016-12-31 0001063537 us-gaap:RestrictedStockUnitsRSUMember ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 ribt:LiabilityWarrantMember 2017-07-01 2017-07-31 0001063537 ribt:EquityIncentivePlan2014Member us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001063537 ribt:ShareBasedCompensationAwardVestingThreeMember us-gaap:RestrictedStockUnitsRSUMember ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 ribt:ShareBasedCompensationAwardVestingTwoMember ribt:EquityIncentivePlan2014Member us-gaap:RestrictedStockUnitsRSUMember 2017-06-01 2017-06-30 0001063537 us-gaap:RestrictedStockUnitsRSUMember ribt:ShareBasedCompensationAwardVestingOneMember ribt:EquityIncentivePlan2014Member 2017-06-01 2017-06-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0001063537 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0001063537 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001063537 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:WeightedAverageMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0001063537 us-gaap:MaximumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0001063537 us-gaap:MinimumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WeightedAverageMember 2017-01-01 2017-09-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-09-30 0001063537 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-09-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MaximumMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-09-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-09-30 0001063537 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-09-30 0001063537 ribt:IrgovelMember 2017-09-30 0001063537 us-gaap:MinimumMember ribt:IrgovelMember 2017-01-01 2017-09-30 0001063537 us-gaap:DirectorMember 2017-01-01 2017-09-30 0001063537 us-gaap:SubordinatedDebtMember us-gaap:DirectorMember 2017-07-01 2017-09-30 0001063537 us-gaap:DirectorMember us-gaap:SubordinatedDebtMember 2017-01-01 2017-09-30 0001063537 us-gaap:SubordinatedDebtMember us-gaap:DirectorMember 2016-07-01 2016-09-30 0001063537 us-gaap:SubordinatedDebtMember us-gaap:DirectorMember 2016-01-01 2016-09-30 0001063537 ribt:ContinentalGrainCompanyMember 2017-01-01 2017-09-30 0001063537 2016-08-18 0001063537 2017-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ribt:MonthlyPayment ribt:Representative ribt:Investor ribt:Installment ribt:Warrant iso4217:BRL ribt:Nominee false --12-31 2017-09-30 No No Yes Smaller Reporting Company RiceBran Technologies 0001063537 16884017 2017 Q3 10-Q 1094000 1384000 261000 714000 1000000 497000 1288000 309000 -4346000 -4253000 8000 12000 350203 1114747 1301725 22824888 340037 0 0 3020739 1038019 10842006 21306727 406066 473498 1236241 1611722 2000000 1175000 629969 10132045 2128180 28845000 32904000 4591000 4364000 14021000 14183000 2398000 4335000 13861000 7528000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in complete financial statements were condensed or omitted.&#160; The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; </font>The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.</div></div> 157000 18000 95000 22000 3000 1000 22000 115000 342000 2887000 8962000 2132000 8187000 342000 966000 2132000 -755000 8620000 -55000 -37000 16604000 -252000 -157000 -73000 16719000 -115000 1513000 3714000 -9000 3701000 -1345000 2803000 1232000 -551000 1280000 -551000 -48000 0 1489868 6875000 781252 1423488 3484675 2327919 22678940 0 0 0 2660000 25000 0 0 2067771 300000 781522 1789868 4296339 0 2660000 1546667 10838978 3156670 0 2067771 12947832 0.96 1.50 0.96 0.96 0.96 0.96 5.25 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 10. COMMITMENTS AND CONTINGENCIES</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.&#160; These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.&#160; When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.&#160; While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.&#160; Defense costs are expensed as incurred and are included in professional fees.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Irgovel Litigation</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.&#160; The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.&#160; None of these labor claims is individually significant.&#160; Management believes it&#8217;s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.&#160; The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.&#160; We record amounts considered sufficient by our management to cover probable losses based on these elements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.&#160; In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.&#160; In June 2014, Irgovel filed a motion to annul the enforcement proceedings.&#160; The enforcement proceedings were dismissed in September 2015.&#160; In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>Irgovel - Events of Default</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.&#160; It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors. </div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>Employment Contracts and Severance Payments</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.&#160; In addition, vesting of outstanding unvested equity grants held by these individuals would accelerate following a change in control.</div></div> 0 0 50000000 50000000 50000000 25000000 10790351 16551350 6000000 264232000 278079000 10790351 16551350 0 10790351 0 1300 499 16551350 -330000 -803000 -1998000 -1321000 -7112000 -1385000 3279000 -112000 -9110000 -1715000 -1433000 2476000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 6. CONCENTRATIONS OF RISK</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our trade accounts receivable subject us to significant concentrations of credit risk.&#160; We perform ongoing credit evaluations on our customers&#8217; financial condition and generally do not require collateral.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the <font style="font-size: 10pt; font-family: 'Times New Roman';">nine months ended September 30, 2017</font> and 2016.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Revenue</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Accounts Receivable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">17</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">31</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">28</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">68</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">* Less than 10%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the nine<font style="font-size: 10pt; font-family: 'Times New Roman';"> months ended September 30, 2017</font> and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Purchases</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">87</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">* Less than 10%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr></table></div></div> 0.68 1 0.15 1 0.28 0.61 0.13 1 0.11 0.31 0.12 1 0.12 0.69 0.87 1 1 0.15 0.61 1 0.17 1897983 2305000 2434000 7199000 7081000 0.07 0.1175 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 7. DEBT</u></div><div>&#160;</div><div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes current and long-term portions of debt (in thousands):</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior debentures, net, maturing in February 2019, principal $6.6 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Subordinated notes, net, maturing in May 2019, principal $5.9 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,310</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior revolving loan</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior term loan, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,027</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">19</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Long-term portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,964</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We issued senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017<font style="font-size: 10pt; font-family: 'Times New Roman';">.&#160; </font>In connection with the senior debenture private placement, in February 2017, we also entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The transactions, and the accounting therefore, are</font> described further in Note 8.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Until July 2017, when <font style="font-size: 10pt; font-family: 'Times New Roman';">we repaid the senior debentures and the subordinated notes in full with the proceeds from the sale of HN in July 2017, w</font>e accreted interest on the debentures at an effective rate of 160.6% per year and on the subordinated notes at 15.0% per year<font style="font-size: 10pt; font-family: 'Times New Roman';">.&#160; Upon extinguishment in July 2017, </font><font style="font-size: 10pt; font-family: 'Times New Roman';">we recognized a loss on extinguishment of $6.6 million for the differences between (i) the $0.6 million </font><font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">carrying amount of the senior debentures and the $6.6 million face value paid and (ii) the $5.3 million carrying amount of the subordinated notes and the $6.0 million face value paid.</font></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, we used the net proceeds from the senior debenture private placement discussed further in Note 8 to pay the senior revolving loan and the senior term loan in full.</div></div> 100000 948.9915 180 600000 5300000 2019-02-28 2019-05-31 0.07 0.1175 0.150 1.606 6600000 6000000 5900000 6600000 300000 200000 400000 -5033000 -1344000 29000 29000 571000 694000 1527000 769000 -7438000 3953000 -1455000 -2212000 109000 1284000 -3863000 2789000 4300000 0 36000 437000 0 0 948000 0 1344000 8845000 0 8845000 0 759000 2553000 2338000 443000 8274000 5607000 290000 382000 396000 1891000 1541000 19000 1100000 2572000 509000 462000 9814000 293000 6651000 3330000 3539000 9991000 1154000 6103000 10889000 10464000 1019000 871000 1237000 1987000 1915000 925000 398000 592000 871000 781000 54000 109000 104000 67000 11785000 14050000 355000 1047000 358000 1066000 791000 791000 24000 1327000 24000 1321000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 2. DISCONTINUED OPERATIONS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Healthy Natural (HN) Discontinued Operations</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">The Company continuously assesses the composition of our business portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.&#160; In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).&#160; </font>In July 2017, we completed the sale of the assets of HN for $18.3 million in cash.&#160; HN was reported as part of our Corporate and USA segment.&#160; The selling price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.&#160; The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.&#160; A $0.2 million working capital adjustment escrow and a $0.6 million indemnity claim escrow were funded from the proceeds.&#160; We are providing certain support services under transition services agreement for a limited period of time.&#160; These support services are not expected to have a material impact on our consolidated statements of operations in 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On a preliminary basis, we estimate the proceeds, net of expenses, at $16.7 million, the net carrying value of HN as of the date of sale at $3.5 million and the third quarter 2017 gain on sale as $8.8 million, net of a $4.3 million income tax provision.&#160; We currently expect to obtain the amounts held in escrow without adjustment.&#160; The following table summarizes the estimated carrying amount of HN as of the July 2017 sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">871</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,987</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other current assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">47</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">871</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,591</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">759</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">290</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,049</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Net assets sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,542</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.&#160; Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.&#160; In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The operations of HN are included in our results though the July 14, 2017 date of sale.&#160; All following tables represent activity up to the date of the sale.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestiture of HN (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">421</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,010</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,902</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,044</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(293</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,330</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,991</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(396</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(462</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,284</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,789</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,953</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income tax expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(437</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(948</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,344</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,841</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,609</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Gain on sale, net of $4.3 million income tax expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,845</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,845</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,918</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,686</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,609</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN&#8217;s taxable operating income in 2017.&#160; Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset by 90% by net operating loss carryforwards; thereby leaving residual taxable income of 10%, subject to a rate of 20%. We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale as of December 31, 2016 (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other current assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other noncurrent assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,364</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Long term liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">44</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">869</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from discontinued operations of HN for the nine months ended September 30, 2017 and 2016 (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,803</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,701</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by (used in) investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16,719</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(48</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided to continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,628</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In 2017, net cash provided by investing activities in the table above is presented in our consolidated statements of cash flows in net cash provided by (used in) investing activities of discontinued operations and includes the $16.7 million net proceeds from the sale of HN.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes other data for HN (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">130</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">58</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Amortization included in selling, gneral and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">204</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">659</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expenditures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">95</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Nutra SA Discontinued Operations</u></div><div><br /></div><div style="background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We hold a variable interest in our equity interest in Nutra SA.&#160; Nutra SA&#8217;s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.&#160; We are the primary beneficiary of Nutra SA, and as such, Nutra SA&#8217;s assets, liabilities and results of operations are included in the condensed consolidated financial statements.&#160; In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.&#160; Accordingly, the Nutra SA operating results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.&#160; In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.&#160; Other equity holders&#8217; (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.</div><div><br /></div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and nine months ended September 30, 2017 and 2016 (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,226</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">563</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,539</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,154</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,814</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,103</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,541</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(509</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,572</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,891</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Goodwill impairment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(358</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(355</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,066</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,212</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,455</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,438</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,212</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,455</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,438</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">54</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts receivable, net (restricted)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">398</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,237</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">925</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other current asssets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">326</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">373</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Property and equipment, net (restricted $2,662 and $2,599)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,464</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,889</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other noncurrent assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,321</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,327</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,183</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,021</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,338</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,274</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,607</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Current maturities of long-term debt (nonrecourse)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,239</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,976</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the LLC Agreement.&#160; Therefore Nutra SA&#8217;s consolidated cash is classified as held for sale in our consolidated balance sheets.&#160; Nutra SA&#8217;s debt is secured by Irgovel&#8217;s accounts receivable and property.&#160; The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA&#8217;s debt.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the nine months ended September 30, 2017 and 2016 (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,345</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(115</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(157</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided (used) by financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,280</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of exchange rate changes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">125</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(183</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net change in cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(55</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(37</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">104</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">54</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">67</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes other data for Nutra SA (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">274</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">246</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">792</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">672</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">46</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expenditures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">115</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">157</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Nutra SA&#8217;s debt consists of the following (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expansion loans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,454</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Working capital lines of credit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,081</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Advances on customer export orders</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">785</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Special tax programs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,014</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">112</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">81</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 4px; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of September 30, 2017, Irgovel had approximately $0.4 million (USD) of debt installment payments in arrears.&#160; The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current liabilities held for sale in the accompanying condensed consolidated balance sheet as of September 30, 2017.&#160; As of September 30, 2017, Irgovel had approximately $9.3 million of tax and tax related payments in arrears.&#160; Approximately&#160; $0.2 million of the tax payments in arrears is related to certain unpaid employer tax from April 2017 through September 2017.&#160; All tax and tax related payments in arrears, other than the certain unpaid employer tax, can be included in a new Brazil tax amnesty program, but to qualify to do so, an entrance fee of approximately $0.4 million must be paid prior to November 15, 2017.&#160; At this time it is not certain Irgovel will qualify for the new Brazil tax amnesty.&#160; If Irgovel is unable to qualify for the new Brazil tax amnesty, Irgovel will likely petition the tax authorities seeking a favorable payment plan but it is likely the installment payments will not exceed 60 monthly payments.&#160; All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.&#160; The fair value of Nutra SA debt (Level 3 measurement) approximates the carrying value of that debt based on the current market rates for similar debt with similar maturities.</div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying condensed consolidated balance sheets, for the three and nine months ended September 30, 2017 and 2016 (in thousands) follows.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in net loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(792</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(470</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,359</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in other comprehensive loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">218</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors purchase of additional membership interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">200</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">200</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,929</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,929</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' average interest in Nutra SA during the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in Nutra SA at the end of the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.&#160; The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).&#160; We may elect to exercise a right of first refusal to purchase the Investors&#8217; interest instead of proceeding to a sale.&#160; We have assessed the likelihood of the Investors exercising these rights as less than probable at September 30, 2017.&#160; We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.&#160; We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">In exchange for the termination of this right, we paid the Investors $0.1 million.</font></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Under the LLC Agreement, the business of Nutra SA is to be conducted by the manager, currently our EVP of Special Projects, subject to the oversight of the management committee.&#160; The management committee is comprised of three of our representatives and two of Investors&#8217; representatives.&#160; Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investors&#8217; representatives and two of our representatives.&#160; In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of September 30, 2017, there have been no unwaived events of default.&#160; Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are the failure of Irgovel to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As of September 30, 2017, there have been no qualifying events.&#160; The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.&#160; Until there is an event of default or a qualifying event, the Investors&#8217; rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.&#160; The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.&#160; However, the Investors do have drag along rights in the future.&#160; We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.</div></div> 23000 47000 326000 373000 15044000 5010000 563000 421000 3226000 4627000 9589000 9902000 1000 0 -778000 0 0 778000 0 -0.11 -0.86 0.30 -0.09 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 5. LOSS PER SHARE (EPS)</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.&#160; Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.&#160; The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.&#160; The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and nine months ended September 30, 2017 and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">NUMERATOR (in thousands):</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic and diluted - loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,199</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(8,387</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,975</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Dividend on preferred stock--beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic and diluted - adjusted loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,199</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,165</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,526</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">DENOMINATOR:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic EPS - weighted average number of common shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,129,781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,397,255</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,644,372</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,281,942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Effect of dilutive securities outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Diluted EPS - weighted average number of shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,129,781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,397,255</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,644,372</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,281,942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">629,969</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">340,037</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">473,498</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">350,203</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22,824,888</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,842,006</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,306,727</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,132,045</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Nonvested stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,301,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,114,747</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,236,241</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,038,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Convertible preferred stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,128,180</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,020,739</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,611,722</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Restricted stock unit awards</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,175,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">406,066</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The impact of potentially dilutive securities outstanding at September 30, 2017 and 2016, was not included in the calculation of the continuing operations diluted EPS<font style="font-size: 10pt; font-family: 'Times New Roman';"> for the three and nine months ended September 30, 2017</font> and 2016 because to do so would be antidilutive.&#160; Those securities listed in the table above which were antidilutive<font style="font-size: 10pt; font-family: 'Times New Roman';"> for the periods presented</font>, which remain outstanding, could potentially dilute EPS in the future.</div></div> -0.09 0.30 -0.86 -0.11 126000 -182000 -183000 125000 605000 496000 500000 100000 3800000 2300000 4600000 7851000 0 7917000 2474000 0.016 0.019 0.006 0.012 0.012 0.67 0.72 0.71 0.64 0.64 16000 0 678000 1527000 2838000 769000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 9. FAIR VALUE MEASUREMENTS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.&#160; As of September 30, 2017, the fair value of our debt (Level 3 measurement) approximated its carrying value, based on current market rates for similar debt with similar maturities.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160; Certain assets and liabilities are presented in the financial statements at fair value.&#160; Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.&#160; Assets and liabilities measured at fair value on a non-recurring basis may include property.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:</div><div><br /></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 1 &#8211; inputs include quoted prices for identical instruments and are the most observable.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 2 &#8211; inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">&#9679;</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Level 3 &#8211; inputs are not observable in the market and include management&#8217;s judgments about the assumptions market participants would use in pricing the asset or liability.</div></td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of September 30, 2017 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.&#160; The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.&#160; The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.&#160; Additional assumptions that were used to calculate fair value follow.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Risk-free interest rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">1.2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">0.6% -1.9%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.2% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.6% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expected volatility</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">67%-72%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">64%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(71% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(64% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 7.2pt; text-indent: -7.2pt;">Total Level 3 Fair Value</div></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair Value</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">as of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Beginning of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Period</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Total</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Realized and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Gains</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(Losses)</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Issuance of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">New</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Instruments</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Reclassify to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(Deficit)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Equity</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Conversion</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">to Common</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Stock</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair Value,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">at End of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Period</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Nine Months Ended September 30, 2017, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">808</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Nine Months Ended September 30, 2016, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(678</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">314</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,838</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div>&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of September 30, 2017 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 7.2pt; text-indent: -7.2pt;">Total Level 3 Fair Value</div></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair Value</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">as of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Beginning of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Period</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Total</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Realized and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Gains</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(Losses)</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Issuance of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">New</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Instruments</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Reclassify to</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(Deficit)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Equity</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Conversion</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">to Common</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Stock</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair Value,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">at End of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Period</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Nine Months Ended September 30, 2017, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,527</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">808</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(769</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Nine Months Ended September 30, 2016, derivative warrant liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(678</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">314</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,838</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div>&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.</div></td></tr></table></div></div> 314000 808000 0 1598000 0 0 -8290000 0 -6610000 0 6600000 -1500000 -100000 1140000 2549000 3125000 815000 -8320000 -13420000 -6319000 -1379000 -0.60 -0.10 -0.38 -0.86 -0.38 -0.10 -0.86 -0.60 6823000 -4829000 -608000 6706000 -1455000 10686000 -2212000 -3863000 847000 -7438000 8918000 2609000 -0.26 0.68 -0.01 0.77 -0.26 0.68 0.77 -0.01 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 11. INCOME TAXES</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN&#8217;s taxable operating income in 2017.&#160; Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset 90% by net operating loss carryforwards; thereby potentially leaving residual taxable income of 10%, subject to a rate of 20%.&#160; We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.&#160; We have determined that a Section 382 ownership change occurred in September 2017 and our ability to carryforward remaining net operating losses subsequent to the most recent change in ownership will be severely limited.&#160; The Internal Revenue Service rules in this area are complex and our estimates are subject to change.</div></div> -1344000 -4121000 -5033000 -437000 -4975000 -4199000 -8387000 -942000 20000 0 -1359000 -792000 -470000 -2416000 -53000 -465000 290000 182000 -1310000 3000 -213000 -576000 135000 242000 300000 352000 1616000 1484000 86000 729000 780000 100000 200000 100000 200000 933000 758000 28845000 32904000 44000 0 44000 18239000 15801000 14976000 869000 18239000 1049000 28926000 20512000 0 0 0 1527000 0 1527000 769000 769000 21362000 19701000 917000 75000 6310000 0 1725000 9027000 0 32000 0 32000 0 0 3063000 19000 13000 5964000 300000 1100000 0.358 0.327 19474000 0 3628000 -863000 -5929000 2473000 -4697000 1922000 -596000 -208000 -1359000 -792000 -470000 -2416000 -4330000 -5749000 -460000 16008000 -2817000 -2035000 3299000 -1080000 -7939000 -983000 -1080000 -7388000 -205000 3299000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recent accounting standards not yet adopted</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.&#160; Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.&#160; An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.&#160; The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.&#160; We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We expect to transition through a cumulative effect adjustment as of January 1, 2018.&#160; Under the modified retrospective method adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to HN, because we no longer reflect HN operations in our consolidated results after the sale of HN in July 2017.&#160; Similarly, if we dispose of Nutra SA, before December 31, 2017, we expect adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to Nutra SA as well.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2016, the FASB issued guidance which changes the accounting for leases.&#160; Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease&#8217;s classification as a finance or operating lease.&#160; For both types of leases, lessees will recognize a right-of-use asset and a lease liability.&#160; For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.&#160; The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.&#160; Early adoption is allowed.&#160; We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recently adopted accounting standards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2017, the FASB issued guidance that clarifies the scope of asset derecognition guidance and accounting for partial sales of nonfinancial assets.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, the FASB issued guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.&#160; The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In November 2016, the FASB issued guidance that requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.&#160; We were required to adopt the guidance for our annual and interim periods beginning in 2018.&#160; We early adopted the standard in the third quarter of 2017 on a retrospective basis.&#160;&#160; As a result, changes in restricted cash reported in 2016 as cash flows from investing activities are no longer reported as such.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In August 2016, the FASB issued guidance intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flow, including the classification of (i) payments to extinguish debt and<font style="font-size: 10pt; font-family: 'Times New Roman';"> (</font>ii) payments for the settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing.&#160; We were required to adopt the guidance for our annual and interim periods beginning in 2018.&#160; We early adopted the standard in the third quarter of 2017 on a retrospective basis.&#160; This change did not have an effect on the presentation of our cash flows, as our presentation in previously reported periods had complied with the new guidance.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.&#160; The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.&#160; In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.&#160; The guidance also allows us to repurchase more of an employee&#8217;s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee&#8217;s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.&#160; We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.&#160; This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.&#160; Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).&#160; As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.</div></div> -9117000 -6965000 946000 560000 -1355000 -2325000 -4303000 -6879000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 1. BASIS OF PRESENTATION</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form&#160;10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in complete financial statements were condensed or omitted.&#160; The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; </font>The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.</div></div> -31000 694000 131000 -165000 0 -55000 359000 824000 132000 132000 157000 194000 28000 0 0 128000 0 0 38000 93000 0 131000 38000 -60000 218000 -11000 500000 596000 208000 0 646000 0 92000 100000 499 1300 2000 1300 499 20000000 3000 3000 -9000 -23000 23752000 3779000 18300000 700000 1700000 0 2778000 2700000 5518000 300000 5500000 200000 0 200000 650000 1700000 -1564000 -9804000 2507000 -1550000 -1359000 0 -205000 0 0 7123000 7025000 -567000 69000 -1599000 -699000 -1370000 -1929000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 12. RELATED PARTY TRANSACTIONS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.&#160; As of September 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.&#160; See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.&#160; The notes were paid in full in July 2017 from the proceeds of the sale of HN.&#160; In the three months ended September 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the nine months ended September 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As discussed in Note 8, in September 2017, we issued and sold 2,654,732 shares of common stock to Continental Grain Company (CGG).&#160; Our director, Ari Gendason is an employee and senior vice president -corporate investments of CGG.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">As of the date of this filing</font>, CGG owns approximate 16% of our outstanding common stock.&#160; We have a<font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">greed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one nominee to our board of directors.</font></div></div> 6600000 6000000 500000 200000 24124000 19728000 500000 3800000 0 775000 1921000 0 -259819000 -260802000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT&#8217;S PLAN</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our cash position has improved since December 31, 2016, as a result of a debt and equity raise in February 2017, the sale of HN in July 2017 and an equity raise in September 2017.&#160; However, our continued operations continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.&#160; The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).&#160; In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $16.7 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).&#160; In September 2017, as discussed further in Note 8, we received net proceeds of $2.7 million from the sale and issuance of common stock.&#160; We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.&#160; The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Beginning in the second quarter of 2016 and through the third quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.&#160; In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through September 30, 2017.&#160; In 2016, we invested $1.1 million in Nutra SA.&#160; Our board has determined we will not contribute any additional funds to Nutra SA.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (in thousands)</u></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; font-weight: bold; text-align: center;"><div>Accumulated</div><div>Deficit</div><div>Attributable to</div><div>Non-controlling</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; font-weight: bold; text-align: center;"><div>Accumulated</div><div>Other Comp-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;Interest in</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">rehensive</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series F</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series G</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nutra SA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Loss</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,790,351</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">264,232</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(259,819</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(632</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issuance of common stock awards under equity incentive plans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">642,839</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">817</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">817</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock - beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of senior debenture holder warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of subordinated note holder warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Change in classification of preferred stock to equity from liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Change in classification of warrants to equity from liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Conversion of preferred stock into common stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,501</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(700</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,331,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(807</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">807</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of common stock, net of costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,654,732</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,730</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,730</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercise of warrant</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">103,008</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">101</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">101</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">28,793</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">64</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">64</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of membership interests</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Foreign currency translation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">131</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(205</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,359</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,564</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">499</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,300</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16,551,350</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">738</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">278,079</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(260,802</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,253</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,392</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">A summary of warrant activity for the nine months ended September 30, 2017, follows.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Liability Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,364,110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.77</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,474,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.82</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issued</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,783,163</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.0</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing debenture purchaser warrants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.49</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.5</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing subordinated note holder warants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of anti-dilution clauses:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,489,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Transfer from liability to equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(781,252</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited, expired or cancelled</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,846,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.06</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,846,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.06</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Common Stock</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.&#160; The amount was payable in either cash or stock at the chairman&#8217;s election.&#160; The chairman elected to receive shares of common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.&#160; In August 2017, we issued 35,336 shares of common stock to a director at a grant date fair value of $1.09 per share.&#160; The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.&#160; We reclassified the $0.1 million carrying value of the related preferred stock to common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In September 2017, we issued and sold 2,654,732 shares of common stock for $1.08 per share.&#160; The net proceeds from the offering of $2.8 million, after deducting commissions and other cash offering expenses of $0.1 million, are included in common stock.&#160;&#160; We used the proceeds for general corporate purposes.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the third quarter of 2017, we issued 2,111,188 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 689 shares of Series G preferred stock.&#160; We reclassified the $0.7 million carrying value of the related preferred stock to common stock.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the fourth quarter of 2017, <font style="font-size: 10pt; font-family: 'Times New Roman';">through the date of this filing,</font> we issued 332,667 shares of common stock upon conversion of 499 shares of Series F preferred stock, with a $0.1 million carrying value.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Share Sequencing</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">From June 2015 until March 2017, the minority interest holders in Nutra SA could elect </font>to exchange units in Nutra SA for shares of our common stock<font style="font-size: 10pt; font-family: 'Times New Roman';">, the number of common stock and warrants issuable upon this election, was variable and indeterminate.&#160; For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.&#160; Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">issued between June 2015 and March 2017, </font>in temporary equity.&#160; We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants&#8217; fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks&#8217; carrying amount on March 31, 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transactions with Preferred Stock Holders.</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, we issued and sold 2,000 shares of Series G preferred stock.&#160; The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders&#8217; election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.&#160; The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.&#160; If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).&#160; A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.&#160; The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.&#160; On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.&#160; We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transactions with Senior Debenture Holders</u></div><div style="text-align: left;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).&#160; We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.&#160; Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.&#160; We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.&#160; We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.&#160; We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Transaction with Subordinated Note Holders</u></div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%&#160; to 7% (ii) an extension of the maturity date of the subordinated notes&#160; to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of&#160; $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.&#160; We accounted for the transaction as an extinguishment of debt and issuance of new debt.&#160; In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock equity by $0.1 million for the change in the fair value of the existing warrants.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Full Ratchet Anti-Dilution</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.&#160; In the third quarter of 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Equity Incentive Plan</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).&#160; The total shares authorized under the 2014 Plan is now 3,300,000 shares.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Option Issuances</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.&#160; The option vested as to 25,000 shares in August 2017, the remaining shares in monthly installments through August 2020 and the option had a grant date fair value of $0.56 per share.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees at an average exercise price of $0.85 per share.&#160; The options vest in four equal annual installments beginning in the second quarter of 2018 and had a grant date fair value of $0.62 per share.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In the third quarter of 2017, we granted an option to purchase an aggregate 20,000 shares of our common stock to an employee at an exercise price of $1.09 per share.&#160; The option vests in four equal annual installments beginning in the third quarter of 2018 and had a grant date fair value of $0.77 per share.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Restricted Stock Unit Awards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.&#160; The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.&#160; Each RSU&#8217;s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.&#160; The shares had a grant date fair value of $0.2 million which is being expensed ratably over a 3.5-year period beginning in July 2017.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Warrants</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.&#160; We issued 103,008 shares of common stock to the holder in a cashless transaction and recorded a $0.1 million loss on the conversion equal to the difference between the fair value of the liability and the fair value of the common stock on the date of the conversion.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes information related to outstanding warrants as September 30, 2017 and December 31, 2016:</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 2px;">&#160;&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="14" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Range of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise Prices</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Type of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrant</div></td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercisable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cashless</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,546,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,546,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,947,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,774,344</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50 to $1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,789,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.52</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25 to $5.87</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,156,670</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.33</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">359,536</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,296,339</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.55 to $16.80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">190,899</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.0</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22,678,940</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.21</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,171,446</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,838,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.14</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet.&#160; Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(2)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.&#160; Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(3)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(4)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature.&#160; The shares listed, represent the shares holders could exercise cashless as of September 30, 2017.&#160; If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise.&#160; Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.</div></td></tr></table></div></div> 0.6 0.3 0.1 9748000 3249000 10206000 3445000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and nine months ended September 30, 2017 and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">NUMERATOR (in thousands):</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic and diluted - loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,199</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(8,387</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,975</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Dividend on preferred stock--beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic and diluted - adjusted loss from continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,199</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,165</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5,526</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">DENOMINATOR:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Basic EPS - weighted average number of common shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,129,781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,397,255</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,644,372</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,281,942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Effect of dilutive securities outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Diluted EPS - weighted average number of shares outstanding</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,129,781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,397,255</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,644,372</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,281,942</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">629,969</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">340,037</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">473,498</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">350,203</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22,824,888</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,842,006</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,306,727</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,132,045</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Nonvested stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,301,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,114,747</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,236,241</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,038,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Convertible preferred stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,128,180</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,020,739</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,611,722</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 42%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Restricted stock unit awards</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,175,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">406,066</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Shares</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; font-weight: bold; text-align: center;"><div>Accumulated</div><div>Deficit</div><div>Attributable to</div><div>Non-controlling</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; font-weight: bold; text-align: center;"><div>Accumulated</div><div>Other Comp-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Preferred</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Accumulated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">&#160;Interest in</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">rehensive</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series F</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Series G</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Stock</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Deficit</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nutra SA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Loss</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(Deficit)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,790,351</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">264,232</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(259,819</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,346</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(632</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issuance of common stock awards under equity incentive plans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">642,839</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">817</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">817</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Dividend on preferred stock - beneficial conversion feature</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(778</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of senior debenture holder warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">582</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Modification of subordinated note holder warrants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Change in classification of preferred stock to equity from liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,545</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Change in classification of warrants to equity from liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,851</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Conversion of preferred stock into common stock</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,501</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(700</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,331,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(807</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">807</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of common stock, net of costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,654,732</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,730</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,730</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercise of warrant</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">103,008</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">101</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">101</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">28,793</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">64</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">64</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Proceeds from sale of membership interests</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Foreign currency translation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">93</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">131</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(205</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,359</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,564</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">499</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,300</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16,551,350</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">738</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">278,079</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(260,802</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4,253</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 7%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,392</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes current and long-term portions of debt (in thousands):</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior debentures, net, maturing in February 2019, principal $6.6 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Subordinated notes, net, maturing in May 2019, principal $5.9 million</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,310</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior revolving loan</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,725</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Senior term loan, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,027</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">19</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 56%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Long-term portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,964</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>Additional assumptions that were used to calculate fair value follow.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Risk-free interest rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">1.2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">0.6% -1.9%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.2% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(1.6% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Expected volatility</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">67%-72%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">64%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(71% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">(64% weighted average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">A summary of warrant activity for the nine months ended September 30, 2017, follows.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equity Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Liability Warrants</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Underlying</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, December 31, 2016</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,364,110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.77</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,474,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.82</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Issued</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11,783,163</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.0</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing debenture purchaser warrants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.49</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">875,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.5</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of repricing subordinated note holder warants:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After repricing</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">289,669</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Impact of anti-dilution clauses:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Prior to impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,489,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">After impact</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,327,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Transfer from liability to equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,468,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercised</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(781,252</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Forfeited, expired or cancelled</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">NA</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Outstanding, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,846,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.06</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Exercisable, September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20,832,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.32</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,846,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.06</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the <font style="font-size: 10pt; font-family: 'Times New Roman';">nine months ended September 30, 2017</font> and 2016.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Revenue</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Accounts Receivable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">17</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">31</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">28</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Customer 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">68</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 22%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">* Less than 10%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the nine<font style="font-size: 10pt; font-family: 'Times New Roman';"> months ended September 30, 2017</font> and 2016.</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 50%;"><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">% of Total Purchases</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 1</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 2</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 3</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 4</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Supplier 5</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">*</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Others</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">87</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 26%; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">* Less than 10%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr></table></div></div> 9428000 3140000 7428000 2495000 1700000 0 781252 P2Y4M24D P3Y7M6D P0Y8M12D P3Y3M18D P1Y6M P3Y7M6D P4Y7M6D P0Y P0Y P2Y P0Y P0Y P2Y10M24D P2Y9M18D P3Y7M6D P4Y7M6D P0Y P4Y2M12D P1Y3M18D P2Y8M12D P0Y P0Y4M24D P2Y2M12D P0Y 841000 904000 P3Y P4Y 4474868 6364110 1846667 20832273 11783163 0 0 0 0.76 1.09 0.85 355500 100000 20000 3300000 1.09 0.90 0.62 0.56 0.77 345205 96372 35336 1.08 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 4. RECENT ACCOUNTING GUIDANCE</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recent accounting standards not yet adopted</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.&#160; Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.&#160; An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.&#160; The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.&#160; We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We expect to transition through a cumulative effect adjustment as of January 1, 2018.&#160; Under the modified retrospective method adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to HN, because we no longer reflect HN operations in our consolidated results after the sale of HN in July 2017.&#160; Similarly, if we dispose of Nutra SA, before December 31, 2017, we expect adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to Nutra SA as well.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2016, the FASB issued guidance which changes the accounting for leases.&#160; Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease&#8217;s classification as a finance or operating lease.&#160; For both types of leases, lessees will recognize a right-of-use asset and a lease liability.&#160; For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.&#160; The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.&#160; Early adoption is allowed.&#160; We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><u>Recently adopted accounting standards</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2017, the FASB issued guidance that clarifies the scope of asset derecognition guidance and accounting for partial sales of nonfinancial assets.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In February 2017, the FASB issued guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.&#160; The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.&#160; We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In November 2016, the FASB issued guidance that requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.&#160; We were required to adopt the guidance for our annual and interim periods beginning in 2018.&#160; We early adopted the standard in the third quarter of 2017 on a retrospective basis.&#160;&#160; As a result, changes in restricted cash reported in 2016 as cash flows from investing activities are no longer reported as such.</div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In August 2016, the FASB issued guidance intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flow, including the classification of (i) payments to extinguish debt and<font style="font-size: 10pt; font-family: 'Times New Roman';"> (</font>ii) payments for the settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing.&#160; We were required to adopt the guidance for our annual and interim periods beginning in 2018.&#160; We early adopted the standard in the third quarter of 2017 on a retrospective basis.&#160; This change did not have an effect on the presentation of our cash flows, as our presentation in previously reported periods had complied with the new guidance.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.&#160; The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.&#160; In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.&#160; The guidance also allows us to repurchase more of an employee&#8217;s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee&#8217;s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.&#160; We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.&#160; This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.&#160; Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).&#160; As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.</div></div> 0 2730000 0 2730000 0 0 108696 100000 642839 0 0 -700 2331627 -2501 332667 220439 2111188 689 499 11 315 2186 0 2654732 0 1175000 103008 2654732 -807000 0 0 807000 0 0 0 817000 817000 0 0 0 12392000 -632000 -259819000 264232000 -699000 0 -4346000 278079000 -4253000 -260802000 738000 -1370000 -36000 7900000 0 28793 0 0 0 0 0 64000 64000 -900000 -100000 0 268000 551000 0 3000 0 551000 20000000 778000 0 551000 0 3000 808000 -313000 314000 1166000 1100000 0 0 0 0 10644372 11129781 9397255 9281942 11129781 10644372 9281942 9397255 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;"><u>NOTE 13. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders&#8217; equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders&#8217; equity for continued listing<font style="font-size: 10pt; font-family: 'Times New Roman';"> pursuant to Nasdaq Listing Rule 5550(b)(1)</font>.&#160; As of September 30, 2016, we reported stockholders&#8217; deficit of $36,000.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We submitted our plan to regain compliance in October 2016.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">On November 15, 2016, Nasdaq granted us a 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders&#8217; equity requirement.&#160; On February 16, 2017, we received a determination letter from Nasdaq stating that we had not regained compliance with the minimum stockholders&#8217; equity requirement.&#160; The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.</font></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We requested and were granted a hearing before the panel to appeal the determination letter on March 30, 2017.&#160; After that hearing, o<font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">n April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million (it was $7.9 million as of March 31, 2017).&#160; As reported herein our equity is $12.4 million and exceeds the minimum as of September 30, 2017.</font></div><div style="background-color: #ffffff;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2) </font><font style="font-size: 10pt; font-family: 'Times New Roman'; background-color: #ffffff;">because our common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive trading days.</font>&#160; Nasdaq rules allowed for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.</font></div></div> P30D P10D 1.0 P180D 2500000 7627000 6816000 3542000 2662000 2599000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying condensed consolidated balance sheets, for the three and nine months ended September 30, 2017 and 2016 (in thousands) follows.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(567</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,599</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(699</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in net loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(792</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(470</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,359</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in other comprehensive loss of Nutra SA</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">218</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors purchase of additional membership interest</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">200</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">650</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">200</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Redeemable noncontrolling interest in Nutra SA, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,929</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,370</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,929</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' average interest in Nutra SA during the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Investors' interest in Nutra SA at the end of the period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and nine months ended September 30, 2017 and 2016 (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,226</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">563</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,539</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,154</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,814</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,103</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,541</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(509</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,572</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,891</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Goodwill impairment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,024</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(358</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(355</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,066</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,212</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,455</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,438</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Loss from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,212</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,455</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(7,438</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestiture of HN (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">421</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,010</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,902</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,044</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(293</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,330</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,651</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9,991</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(396</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(462</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,100</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from operations, before income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,284</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,789</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,953</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income tax expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(437</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(948</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,344</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,841</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,609</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Gain on sale, net of $4.3 million income tax expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,845</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,845</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Income from discontinued operations, net of tax</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,918</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,686</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,609</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Nutra SA&#8217;s debt consists of the following (in thousands):</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expansion loans</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,454</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Working capital lines of credit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,081</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Advances on customer export orders</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">785</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,113</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Special tax programs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,014</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,767</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">112</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">81</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 4px; padding-left: 9pt; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the nine months ended September 30, 2017 and 2016 (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,345</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(115</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(157</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided (used) by financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,280</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(551</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">863</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Effect of exchange rate changes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">125</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(183</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net change in cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(55</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(37</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">104</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 36%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash and cash equivalents, end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">54</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">67</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the major line items included in cash flows from discontinued operations of HN for the nine months ended September 30, 2017 and 2016 (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,803</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,701</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided by (used in) investing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16,719</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash used in financing activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(48</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Net cash provided to continuing operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,628</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30,</div>2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">54</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">109</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts receivable, net (restricted)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">781</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">398</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,237</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">925</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other current asssets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">326</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">373</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Property and equipment, net (restricted $2,662 and $2,599)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,464</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,889</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other noncurrent assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,321</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,327</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,183</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,021</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,338</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">8,274</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,607</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Current maturities of long-term debt (nonrecourse)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,816</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 46%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,239</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,976</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>The following table summarizes the estimated carrying amount of HN as of the July 2017 sale (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">871</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,987</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other current assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">47</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">871</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,591</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">759</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">290</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,049</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Net assets sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,542</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale as of December 31, 2016 (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 60%;"><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div>2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts receivable, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Inventories</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other current assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Property and equipment</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Intangible</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">791</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other noncurrent assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total assets held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,364</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts payable</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">443</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accrued expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">382</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Long term liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">44</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 48%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities held for sale</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">869</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes other data for Nutra SA (in thousands).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">274</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">246</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">792</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">672</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">46</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expenditures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">115</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">157</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes other data for HN (in thousands).</div><div>&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 80%;"><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Nine Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; padding-bottom: 2px; padding-left: 9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in cost of goods sold</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">130</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Depreciation included in selling, general and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">49</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">58</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Amortization included in selling, gneral and administrative expenses</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">204</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">659</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 32%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Capital expenditures</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">95</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> -85000 0 0 -85000 0.1 0.1 0 0 3024000 0 847000 2609000 73000 1841000 0.9 0.9 300000 300000 0.2 0.2 100000 100000 5.49 25000 P5Y6M P2Y1M6D 800000 1000000 4 4 1200000 289669 875000 -699000 -1370000 0 650000 0 650000 0 0 0 0 7851000 0 0 7851000 0 103008 0 0 0 0 0 582000 582000 1545000 0 0 1545000 0 0 101000 0 0 0 101000 0 0 2000 3000 0 117000 0 0 117000 0 8333 10000 P5Y6M P0Y9M18D P4Y9M18D P4Y9M18D 14468163 -14468163 0 1489868 P0Y9M18D P0Y8M12D P3Y7M6D 100000 700000 0.96 0.96 0.96 5.77 1.82 1.06 2.32 4.14 2.00 2.21 5.33 6.61 0 0.96 0 0 0.96 5.36 5.25 1.60 0.96 0 0 2.00 0 1.52 0 6.61 0.96 2.32 1.06 1.16 1.16 0.96 2327919 0 5.49 5.25 0 289669 P3Y3M18D P3Y3M18D 1.50 0 875000 P0Y 9027 7035 20832273 1846667 P5Y P2Y1M6D 0 875000 289669 0 -5526000 -9165000 -4199000 -942000 659000 0 0 204000 42000 7000 4000 792000 49000 274000 15000 46000 96000 246000 42000 16000 20000 58000 672000 130000 3500000 16700000 P5Y 600000 200000 2554000 1747000 7200000 200000 400000 60 400000 9300000 112000 81000 1081000 401000 785000 1113000 2635000 2454000 3014000 2767000 1 0.16 0.43 200000 P3Y6M 10.00 5.00 15.00 1.50 5.25 6.55 2.00 1.60 1.50 5.25 0.96 2.00 5.87 0.96 16.80 -100000 300000 0 190899 3774344 6171446 0 359536 0 1546667 0 0.98 1 P65D <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following table summarizes information related to outstanding warrants as September 30, 2017 and December 31, 2016:</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 2px;">&#160;&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="14" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">September 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="10" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Range of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise Prices</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 11%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Type of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrant</div></td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercisable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cashless</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Under</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Price</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Weighted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Average</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Remaining</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Contractual</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Life (Years)</div></td><td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (1)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,546,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,546,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12,947,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">0.96</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,774,344</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (2)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.9</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.50 to $1.60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,789,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.52</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,660,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Liability (3)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.25 to $5.87</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,156,670</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.33</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">359,536</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,296,339</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5.36</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.55 to $16.80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">&#160;Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">190,899</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,067,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6.61</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.0</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 10%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22,678,940</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.21</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3.6</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,171,446</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,838,978</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4.14</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2.8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div>&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(1)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet.&#160; Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(2)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.&#160; Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(3)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.</div></td></tr></table></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; width: 18pt; vertical-align: top; align: right;">(4)</td><td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature.&#160; The shares listed, represent the shares holders could exercise cashless as of September 30, 2017.&#160; If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise.&#160; Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.</div></td></tr></table></div></div> 16700000 4000000 4000000 100000 50000000 3 0.325 0.322 0.355 0.358 2 3 2 Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet. Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant. The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017. Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision. Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant. Less than 10% Included in change in fair value of derivative warrant liabilities in our unaudited condensed consolidated statements of operations. Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature. The shares listed, represent the shares holders could exercise cashless as of September 30, 2017. If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise. Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature. EX-101.SCH 6 ribt-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - RECENT ACCOUNTING GUIDANCE link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - LOSS PER SHARE (EPS) link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - CONCENTRATIONS OF RISK link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS link:presentationLink link:calculationLink link:definitionLink 070100 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 070400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - LOSS PER SHARE (EPS) (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - CONCENTRATIONS OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) link:presentationLink link:calculationLink link:definitionLink 090204 - Disclosure - DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 090206 - Disclosure - DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 090208 - Disclosure - DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 090210 - Disclosure - DISCONTINUED OPERATIONS, Other Data (Details) link:presentationLink link:calculationLink link:definitionLink 090212 - Disclosure - DISCONTINUED OPERATIONS, Components of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 090214 - Disclosure - DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - LOSS PER SHARE (EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - CONCENTRATIONS OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090802 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090804 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 090806 - Disclosure - EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 090902 - Disclosure - FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ribt-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ribt-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ribt-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity [Domain] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Legal Entity [Axis] Document Type Award Type [Axis] RECENT ACCOUNTING GUIDANCE [Abstract] Accounts Receivable [Member] Accounts receivable, net of allowance for doubtful accounts of $8 and $12 Accounts payable Interest accreted Accrued expenses Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Adjustments to reconcile net loss from continuing operation to activities of continuing operations: Net cash used in operating activities of continuing operations: Accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount ASSETS Assets [Abstract] Total assets Assets Total assets held for sale Disposal Group, Including Discontinued Operation, Assets Current assets held for sale Current assets: Total current assets Assets, Current BASIS OF PRESENTATION Board of Directors Chairman [Member] Capital Expenditure Cash and cash equivalents and restricted cash, beginning of period Cash and cash equivalents and restricted cash, end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Net change in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net cash provided by (used in) investing activities Net cash provided by (used in) investing activities of discontinued operations Cash Provided by (Used in) Investing Activities, Discontinued Operations Net cash (used in) provided by operating activities Net cash provided by operating activities of discontinued operations Net cash provided (used) by financing activities Net cash provided by (used in) financing activities of discontinued operations Cash Provided by (Used in) Financing Activities, Discontinued Operations Chief Executive Officer [Member] Class of Stock [Domain] Class of Warrant or Right [Axis] Warrants to purchase shares of common stock (in shares) Shares under warrants, outstanding (in shares) Class of Warrant or Right [Domain] Exercise price per warrant (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Variable Interest Entity, Classification [Domain] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Commitments and contingencies Commitments and Contingencies COMMITMENTS AND CONTINGENCIES [Abstract] Common stock, par value (in dollars per share) Common Stock [Member] Common stock, shares authorized (in shares) Increase in authorized number of shares of common stock (in shares) Common stock, shares issued (in shares) Aggregate subscription amount Common Stock, Value, Subscriptions Common stock, no par value, 50,000,000 shares authorized, 16,551,350 and 10,790,351 shares issued and outstanding Common Stock, Value, Issued Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Less - Comprehensive loss attributable to noncontrolling interest, net of tax Total comprehensive income (loss) attributable to RiceBran Technologies shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss), net of tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Concentration Risk Benchmark [Axis] Concentration Risk Type [Domain] CONCENTRATIONS OF RISK Concentration Risk [Line Items] Concentration Risk Type [Axis] Concentration Risk [Table] Concentration Risk Benchmark [Domain] Concentration risk, percentage Preferred shares converted into common stock (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Cost of goods sold Cost of Goods Sold [Member] Credit Facility [Domain] Credit Facility [Axis] Customer Concentration Risk [Member] Debt Instrument, Redemption, Period [Domain] Debt Instrument [Axis] Debt Instrument, Redemption, Period [Axis] Variable interest rate DEBT Debt Disclosure [Text Block] Debt conversion amount Preferred stock conversion ratio to common stock Expiration August, 2021 [Member] Debt Instrument, Redemption, Period Two [Member] DEBT [Abstract] Expiration January, 2021 [Member] Debt Instrument, Redemption, Period One [Member] Debt conversion, stock (in shares) Carrying value of debt Long-term Debt, Gross Maturity date of note Annual interest rate Effective interest rate Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Aggregate principal amount Debt Instrument, Face Amount Debt Instrument, Name [Domain] Payment of accrued note interest Debt Instrument, Periodic Payment, Interest Payment of note principal Debt Instrument, Periodic Payment, Principal Debt issuance cost Debt Issuance Costs, Net Deferred taxes Deferred tax liability Depreciation and amortization Derivative Warrant Liabilities [Member] Derivative warrant liabilities Directors [Member] Halpern [Member] Director [Member] EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract] Income (loss) from discontinued operations, before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax DISCONTINUED OPERATIONS [Abstract] Tax provision for gain on sale of business Income tax expense Discontinued Operation, Tax Effect of Discontinued Operation Gain on sale, net of $4.3 million income tax expense Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group Classification [Axis] Accrued expenses Disposal Group, Including Discontinued Operation, Accrued Liabilities Selling, general and administrative expenses Disposal Group, Including Discontinued Operation, General and Administrative Expense Cost of goods sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Property and equipment, net Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract] Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] Inventories Accounts receivable, net Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Noncurrent assets held for sale Disposal Group, Including Discontinued Operation, Assets, Noncurrent Other expense Disposal Group, Including Discontinued Operation, Other Expense Intangible Disposal Group Classification [Domain] Other noncurrent assets Disposal Group Name [Domain] Income (Loss) from Discontinued Operations [Abstract] Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] DISCONTINUED OPERATIONS Other current assets held for sale Revenues Preferred stock, dividend Dividend on preferred stock - beneficial conversion feature Dividends, Preferred Stock Basic earnings (loss) per common share: Diluted earnings (loss) per common share - RiceBran Technologies (in dollars per share) Earnings Per Share, Diluted LOSS PER SHARE (EPS) Earnings Per Share [Text Block] Diluted earnings (loss) per common share: Weighted average number of shares outstanding: Basic earnings (loss) per common share - RiceBran Technologies (in dollars per share) Earnings Per Share, Basic LOSS PER SHARE (EPS) [Abstract] Effect of exchange rate changes on cash and cash equivalents of discontinued operations Effect of exchange rate changes Stock Options [Member] Employee Stock Option [Member] Accrued salary, wages and benefits Employee-related Liabilities, Current Equity Component [Domain] Fair value increase in common stock Extinguishment of term loan Fair value of derivative warrant liabilities Fair Value Adjustment of Warrants Reclassify to (Deficit) Equity Issuance of New Instruments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Risk-free interest rate Expected volatility Fair Value, Hierarchy [Axis] Measurement Frequency [Axis] Conversion to Common Stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Fair Value, at End of Period Fair Value as of Beginning of Period Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Additional assumptions used to calculate fair value [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Measurement Frequency [Domain] FAIR VALUE MEASUREMENTS [Abstract] Recurring [Member] Fair Value, Measurements, Recurring [Member] Fair Value Hierarchy [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Level 1 [Member] Level 2 [Member] Level 3 [Member] Fair values by input hierarchy of items measured at fair value on a recurring basis Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Changes in level 3 items measured at fair value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Changes in level 3 items measured at fair value on a recurring basis [Roll Forward] Total Realized and Unrealized Gains (Losses) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Financial Instrument [Axis] Gain on resolution of Irgovel purchase litigation Gain on resolution of Irgovel purchase litigation Gain (Loss) Related to Litigation Settlement Loss on extinguishment of debt Loss on extinguishment of debt Gross profit Gross Profit INCOME TAXES [Abstract] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Income Statement Location [Axis] Continuing operations (in dollars per share) Income Statement Location [Domain] Income (loss) from discontinued operations Income (loss) from discontinued operations, net of tax Income (loss) from discontinued operations, net of tax Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Discontinued operations (in dollars per share) Condensed Consolidated Statements of Operations (Unaudited) [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Disposal Groups, Including Discontinued Operations [Table] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Disposal Group Name [Axis] Income tax benefit Income Tax Expense (Benefit) Basic and diluted - loss from continuing operations Loss from continuing operations Loss from continuing operations Cash paid for income taxes of continuing operations Less - Net loss attributable to noncontrolling interest in discontinued operations Other Increase (Decrease) in Other Current Assets Accounts receivable Increase (Decrease) in Accounts Receivable Accounts payable and accrued expenses Changes in operating assets and liabilities: Inventories Increase (Decrease) in Inventories Increase (Decrease) in Stockholders' Equity [Roll Forward] Intangible assets, net Interest expense debt Interest Expense, Debt Interest expense Interest Expense Cash paid for interest of continuing operations Interest paid Inventories Inventory, Net Investors [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Axis] Total liabilities, temporary equity and equity (deficit) Liabilities and Equity Noncurrent liabilities held for sale Long term liabilities Current liabilities held for sale Total liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Total liabilities Liabilities LIABILITIES, TEMPORARY EQUITY AND EQUITY (DEFICIT) Total liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract] Total current liabilities Liabilities, Current Current liabilities: Line of Credit Facility [Abstract] Fair value of debt Long-term Debt, Fair Value Total debt Carrying value of debt Long-term Debt Current maturities of long-term debt Current portion Long-term Debt, Current Maturities Long-term debt, less current portion Long-term portion Loss Contingencies [Table] Loss Contingencies [Line Items] Contingent liability Damages sought by plaintiff Litigation [Abstract] Loss Contingency, Information about Litigation Matters [Abstract] Customers [Axis] Maximum [Member] Minimum [Member] Investors' interest in Nutra SA at the end of the period Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling Interest [Table] Noncontrolling Interest [Line Items] Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Customer [Domain] Net cash provided (by) to continuing operations Net Cash Provided by (Used in) Discontinued Operations Net Cash Provided by (Used in) Discontinued Operations [Abstract] Net cash provided by (used in) financing activities of continuing operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Cash flows from financing activities: Net cash used in investing activities of continuing operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Investors' interest in net loss of Nutra SA Cash flows from investing activities: Cash flow from operating activities: Net cash used in operating activities of continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net income (loss) attributable to RiceBran Technologies common shareholders Net Income (Loss) Available to Common Stockholders, Basic NUMERATOR [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Net income (loss) attributable to RiceBran Technologies shareholders Net Income (Loss) Attributable to Parent New Accounting Pronouncements or Change in Accounting Principle [Table] RECENT ACCOUNTING GUIDANCE New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Total other (expense) income Nonoperating Income (Expense) Other (expense) income: Other [Member] Notes Payable, Other Payables [Member] Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Loss from operations Operating Income (Loss) BASIS OF PRESENTATION [Abstract] BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Irgovel - Events of Default [Abstract] Other Commitments [Abstract] Other comprehensive income - foreign currency translation, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Other Noncash Income (Expense) Deposits and other current assets Other income Other expense Other Nonoperating Expense Foreign currency translation Investors' interest in other comprehensive loss of Nutra SA Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Placement fees and allocation expenses Purchases of property Payments to Acquire Property, Plant, and Equipment Plan Name [Axis] Plan Name [Domain] Preferred Stock [Member] Preferred stock Carrying value of preferred stock Convertible preferred stock, shares issued (in shares) Preferred stock issued (in shares) Convertible preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Other Proceeds from issuance of debt, net of issuance costs Sale of assets Proceeds from Divestiture of Businesses Minority partner contribution amount Net proceeds from issuance of common stock Proceeds from issuance of debt and warrants, net of issuance costs Proceeds from issuance of debt and warrants, net of issuance costs Investors purchase of additional membership interest Proceeds from Noncontrolling Interests Net proceeds from the exchange of subordinated notes Net income (loss) Net income (loss) Net loss Property and equipment, net Property, Plant and Equipment, Net Range [Domain] Range [Axis] Redeemable noncontrolling interest in Nutra SA, beginning of period Redeemable noncontrolling interest in Nutra SA, end of period Redeemable Noncontrolling Interest, Equity, Carrying Amount Related Party Transaction [Line Items] Related Party [Domain] Related Party [Axis] RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS [Abstract] Repayment of senior debentures Repayments of Senior Debt Repayment of subordinated note Repayments of Subordinated Debt Payments of debt Repayment of debt Repayment of debt Repayments of Long-term Debt Nonvested Stock [Member] Restricted Stock [Member] Restricted cash Restricted cash Restricted cash Restricted Cash Restricted Stock Unit Awards [Member] Restricted Stock Award [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated Deficit [Member] Senior Revolving Loan [Member] Revolving Credit Facility [Member] CONCENTRATIONS OF RISK [Abstract] LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Substantial Doubt about Going Concern [Text Block] EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Shareholders' Equity and Share-based Payments [Text Block] Vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Revenue [Member] Revenues Sales Revenue, Goods, Net Reconciliations of numerators and denominators in EPS computations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of equity activity Current and long-term debt Schedule of Debt [Table Text Block] Additional assumptions used to calculate fair value Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Related Party Transactions, by Related Party [Table] Summary of warrant activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Concentrations of risk Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Senior Debentures, Net [Member] Senior Secured Debt [Member] Discontinued Operations [Member] Geographical [Domain] Selling, General and Administrative Expenses [Member] Selling, general and administrative expenses Senior Term Loan, Net [Member] Senior Notes [Member] Series F Convertible Preferred Stock [Member] Series F Preferred Stock [Member] Series F Convertible Preferred Stock [Member] Series G Convertible Preferred Stock [Member] Series G Preferred Stock [Member] Increase in common shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Equity and Liability Warrants, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Shares Under Warrants [Roll Forward] Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Outstanding, weighted average remaining contractual life Weighted average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Stock and share-based compensation Award vesting period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Forfeited, expired or cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Granted exercise price (in dollars per share) Granted (in shares) Number of shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Equity Award [Domain] Supplier [Axis] Shares issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Stock price (in dollars per share) RECENT ACCOUNTING GUIDANCE Class of Stock [Axis] Statement [Line Items] Geographical [Axis] Condensed Consolidated Statements of Cash Flows (Unaudited) [Abstract] Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) [Abstract] Condensed Consolidated Balance Sheets (Unaudited) [Abstract] Statement [Table] Equity Components [Axis] Proceeds from sale of common stock, net of costs Stock Issued During Period, Value, New Issues Common stock issued for former employee (in shares) Stock Issued During Period, Shares, Issued for Services Cash paid in lieu of bonus Issuance of common stock awards under equity incentive plans (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Conversion of preferred stock into common stock (in shares) Number of preferred stock for conversion (in shares) Preferred shares converted into common stock (in shares) Proceeds from sale of common stock, net of costs (in shares) Sale of common stock (in shares) Common stock issued (in shares) Conversion of preferred stock into common stock Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of common stock awards under equity incentive plans Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stockholders' equity (deficit) Total equity (deficit) attributable to RiceBran Technologies shareholders Balance at end of period Balance at beginning of period Equity (deficit): Equity (deficit) attributable to RiceBran Technologies shareholders: Equity (deficit) attributable to RiceBran Technologies shareholders: Stockholders' Equity Attributable to Parent [Abstract] Other (in shares) Stockholders' Equity, Other Shares Other Stockholders' Equity, Other Decrease in subordinated debt Subordinated Debt [Member] Subordinated Notes, Net [Member] Subordinated Notes [Member] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Subsequent Event [Member] Supplemental disclosures, continuing operations: Supplier Concentration Risk [Member] Income taxes payable Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding Convertible preferred stock, shares outstanding (in shares) Total temporary equity Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Preferred stock, shares authorized (in shares) Temporary equity Temporary Equity [Abstract] Dividend on preferred stock--beneficial conversion feature Less - Dividends on preferred stock, beneficial conversion feature Convertible preferred stock, shares issued (in shares) Relationship to Entity [Domain] Title of Individual [Axis] Financial Instruments [Domain] Change in fair value of derivative warrant liabilities Change in fair value of derivative warrant and conversion liabilities Unrealized Gain (Loss) on Derivatives Vesting [Axis] Vesting [Domain] Nutra SA [Member] Variable Interest Entity, Primary Beneficiary [Member] Investments in variable interest entity Variable Interest Entity, Financial or Other Support, Amount Variable Interest Entities [Axis] Warrants [Member] Warrant [Member] Warrants [Member] Warrants Not Settleable in Cash [Member] Effect of dilutive securities outstanding (in shares) Basic (in shares) Basic EPS - weighted average number of common shares outstanding (in shares) Weighted Average [Member] Diluted (in shares) Diluted EPS - weighted average number of shares outstanding (in shares) DENOMINATOR [Abstract] Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Brazil [Member] BRAZIL FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Abstract] The entire disclosure pertaining to the entity's compliance with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1). FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Text Block] FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00. This element represents the number of consecutive days necessary for the listed entity to fall below the minimum bid price to become out of compliance with the Nasdaq Capital Market listing rules. Nasdaq Compliance, Minimum Bid Price Requirement, Number of Consecutive Business Days, Out of Compliance Number of consecutive business days under minimum bid requirement, out of compliance Nasdaq Listing Rule 5550(a)(2) requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00. This element represents the number of consecutive days necessary for the listed entity to maintain the minimum bid price to regain compliance with the Nasdaq Capital Market listing rules. Nasdaq Compliance, Minimum Bid Price Requirement, Number of Consecutive Business Days, Regain Compliance Number of consecutive business days at minimum bid price to regain compliance The Nasdaq Stock Market LLC ("Nasdaq"), under Nasdaq Listing Rule 5550(a)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum bid price. Nasdaq Compliance, Minimum Bid Price Requirement Nasdaq minimum bid price requirement (in dollars per share) A period of time that the Nasdaq may grant an entity that has failed to comply with the Nasdaq Capital Market required minimum level of stockholders' equity for continued listing under the Nasdaq Listing Rule 5550(b)(1). The period is measured in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Nasdaq Compliance, Minimum Stockholders' Equity Requirement, Grant Extension Period Nasdaq grant of extension period to regain compliance under minimum stockholders' equity requirement The Nasdaq Stock Market LLC ("Nasdaq"), under Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain a minimum amount of stockholders' equity to maintain continued listing. Minimum Stockholders Equity Requirement for Nasdaq Capital Market Listing Nasdaq minimum stockholders' equity listing requirement Refers to the disposed or discontinued entity. Healthy Natural Inc [Member] HN [Member] Refers to the disposed or discontinued entity. Nutra SA [Member] Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Long Term Debt, Current Current maturities of long-term debt (nonrecourse) Total debt Amount of net assets (liability) attributable to disposal group held for sale or disposed of. Net Assets (Liability) Sold or Assumed Of Disposal Group Including Discontinued Operation Net assets sold Amount classified as property, plant and equipment restricted, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Property Plant and Equipment Restricted Property and equipment restricted Tabular disclosure of changes redeemable noncontrolling interest reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations of a disposal group. Disposal Groups Including, Discontinued Operations, Summary of Changes in Redeemable Noncontrolling Interest [Table Text Block] Summary of changes in redeemable noncontrolling interest in discontinued operations Tabular disclosure of information related to income (loss) from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary Of Income (Loss) from Discontinued Operations [Table Text Block] Income (loss) from discontinued operations Tabular disclosure of information related to components of debt from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Components of Debt [Table Text Block] Components of debt Tabular disclosure of information related to cash flows from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Cash Flows from Discontinued Operations [Table Text Block] Cash flows from discontinued operations Tabular disclosure of information related to major classes of assets and liabilities classified as held for sale from discontinued operations of a disposal group. Disposal Groups, Including Discontinued Operations, Summary of Assets and Liabilities Classified as Held for Sale [Table Text Block] Assets and liabilities classified as held for sale Tabular disclosure of information related to other data from discontinued operations of a disposal group. Summary of Other Data [Table Text Block] Summary of other data Amount of gain (loss) recognized on the conversion of preferred stock. Convertible Preferred Stock, Gain Loss on Conversion Loss on conversion of preferred stock Refers to the percentage of taxable income remaining after offsetting taxable income from net operating loss carryforwards through the alternative minimum tax calculation. Percentage Of Residual Taxable Income Residual taxable income Residual taxable income Amount of goodwill impairment attributable to disposal group, including, but not limited to, discontinued operations. Disposal Group Including Discontinued Operations Goodwill Impairment Goodwill impairment Amount after tax operations income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Discontinued Operation, Income (Loss) from Operations Net of Tax Income from operations, net of tax Refers to the percentage of taxable income offset by net operating loss carryforwards, allowed through the calculation of alternative minimum taxable income. Percentage Of Taxable Income Offset By Net Operating Loss Carryforwards, Alternative Minimum Tax Percentage of taxable income offset by net operating loss carryforwards Percentage of taxable income offset by net operating loss carryforwards Refers to estimated income taxes payable under the alternative minimum tax. Estimated Income Tax Payable Under Alternative Minimum Tax Estimated tax due Estimated tax due Percentage of domestic federal statutory tax rate applicable to residual taxable income. Income Tax Rate On Residual Taxable Income Rate of income tax on residual taxable income One of the ranking officers of the entity, appointed to the position by the board of directors and employees. Executive Officer and Employees [Member] Executive Officer and Employees [Member] An individual who works part-time or full-time under a contract of employment, whether oral or written, express or implied, and has recognized rights and duties. Employee [Member] The equity-based compensation arrangement plan adopted by the board of directors in 2014. Equity Incentive Plan 2014 [Member] 2014 Equity Incentive Plan [Member] Period eight representing eighth most current period of debt redemption features under terms of the debt agreement. Debt Instrument, Redemption, Period Eight [Member] Expiration April 30, 2021 [Member] Period eight representing eighth most current period of debt redemption features under terms of the debt agreement. Expiration February, 2022 [Member] Expiration February, 2022 [Member] Element represents derivative warrant liability, to record the warrants at fair value. Warrants Recorded At Fair Value Warrants recorded at fair value Refers to the expenses associated with the sale of a borrowing supported by a written promise to pay an obligation. Allocated Cash Offering Expenses For Exchange Of Subordinated Notes Cash offering expenses Exercise price one per share or per unit of warrants or rights outstanding. Exercise Price Per Warrant One Exercise price per warrant one (in dollars per share) Gross number of share options (or share units) vested during the period. Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period One Options vested (in shares) Refers to the exercisable term of warrants. Warrants Exercisable Term Warrants exercisable term The cash inflow from issuing of warrants allocated to dividend for preferred stock. Proceeds Allocated to dividend for preferred stock Recorded dividend for preferred stock The cash inflow from issuance of warrants and other forms of equity identified as being convertible into another form of financial instrument allocated to derivative warrant liability. Proceeds from Offering Allocated to Derivative Warrant Liability Proceeds allocated to derivative warrant liability Refers to number of equal annual installments for options to vest. Number of equal annual installments Number of equal annual installments The cash inflow from issuing of warrants allocated to preferred stock. Proceeds Allocated To Preferred Stock Proceed recorded as preferred stock The amount of increase or decrease due to a change in the terms of an existing plan or the initiation of a new plan. A plan amendment may increase or decrease benefits, including those attributed to years of service already rendered. Amendment Of Existing Warrants Amendment of existing warrants (in shares) The cumulative amount of the reporting entity's undistributed earnings or deficit attributable to noncontrolling interest in discontinued operations. Retained Earnings (Accumulated Deficit) Attributable to Noncontrolling Interest in Discontinued Operations Accumulated deficit attributable to noncontrolling interest in discontinued operation The cumulative amount of the reporting entity's undistributed earnings or deficit attributable to noncontrolling interest. Retained Earnings Attributable To Noncontrolling Interest [Member] Accumulated Deficit Attributable to Non-controlling Interest in Nutra SA [Member] Amount of interest from sale of a portion of the membership interests. Proceeds from sale of membership interests Proceeds from sale of membership interests Element refers to change in classification of warrants to equity from liability. Change in classification of warrants to equity from from liability Change in classification of warrants to equity from liability Refers to number of shares of stock issued during the period upon warrants exercised. Stock Issued During Period Shares Warrants Exercised Exercise of warrant (in shares) Element refers to modification of senior debenture holder warrants. Modification of senior debenture holder warrants Element refers to change in classification of preferred stock to equity from liability. Change in classification of preferred stock to equity from liability Change in classification of preferred stock to equity from liability Refers to value of shares of stock issued during the period upon warrants exercised. Stock Issued During Period Value Warrants Exercised Exercise of warrant Element refers to number of shares from change in classification of preferred stock to equity from liability. Change in classification of preferred stock to equity from liability, shares Change in classification of preferred stock to equity from liability (in shares) Element refers to modification of subordinated note holder warrants. Modification of subordinated note holder warrants Modification of subordinated note holder warrants Monthly expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. Officers' Compensation, Monthly Payment Transitional monthly compensation awarded Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing debenture purchaser warrants after repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Debenture Purchaser Warrants Weighted Average Remaining Contractual Term, After Repricing Impact of repricing debenture purchaser warrants, After repricing Weighted average remaining contractual term for equity-based awards excluding options equity instruments impact of anti dilution clauses prior to impact, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Impact Of Anti Dilution Clauses Weighted Average Remaining Contractual Terms, Prior to Impact Impact of anti-dilution clauses, Prior to impact Weighted average remaining contractual term for equity-based awards excluding options equity instruments transfer from liability to equity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Transfer from Liability to Equity Weighted Average Remaining Contractual Terms Transfer from liability to equity Change in the number of shares of non-option equity instruments due to the transfer of shares from liability to equity. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Transfer from Liability to Equity Transfer from liability to equity (in shares) Change in the number of shares of non-option equity instruments due to the impact of anti-dilution clauses in equity and liability contracts, prior to impact. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Impact of Anti-dilution Clauses Prior to Impact Impact of anti-dilution clauses, Prior to impact (in shares) Weighted average remaining contractual term for equity-based awards excluding options equity instruments impact of anti dilution clauses after impact, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Equity Instruments Impact Of Anti Dilution Clauses Weighted Average Remaining Contractual Terms, After Impact Impact of anti-dilution clauses, After impact Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding and currently exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Exercisable Weighted Average Remaining Contractual Term Exercisable, weighted average remaining contractual life Refers to carrying value of preferred stock reclassified to common stock issued. Stock Issued During Period, Carrying Value, Preferred Stock Reclassified to Common Stock Carrying value of preferred stock to reclassified common stock A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward] Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing debenture purchaser warrants after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants Of Weighted Average Exercise Price, After Repricing Impact of repricing debenture purchaser warrants, After repricing (in dollars per share) Weighted average price at which grantees can acquire the shares reserved for issuance on warrants awarded. Share based Compensation Arrangements by Share based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price Issued (in dollars per share) Change in the weighted average exercise price of non-option equity instruments due to the impact of anti-dilution clauses after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Anti-Dilution Clauses Of Weighted Average Exercise Price, After Repricing Impact of anti-dilution clauses, After impact (in dollars per share) Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price Outstanding at end of period (in dollars per share) Outstanding at beginning of period (in dollars per share) Weighted average exercise price (in dollars per share) Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing subordinated note holder warrants after repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants Of Weighted Average Exercise Price, After Repricing Impact of repricing subordinated note holder warrants, After repricing (in dollars per share) The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the stock option plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price Exercisable at end of period (in dollars per share) Change in the number of shares of non-option equity instruments due to the transfer of shares from liability to equity weighted average exercise price. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Transfer from Liability to Equity Weighted Average Exercise Price Transfer from liability to equity (in dollars per share) Refers to weighted average exercise price of liability warrants. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised (in dollars per share) Change in the number of shares of non-option equity instruments due to the impact of anti-dilution clauses in equity and liability contracts, after impact. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Impact of Anti-dilution Clauses After Impact Impact of anti-dilution clauses, After impact (in shares) Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing debenture purchaser warrants prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants Of Weighted Average Exercise Price, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing (in dollars per share) Change in the weighted average exercise price of non-option equity instruments due to the impact of repricing subordinated note holder warrants prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants Of Weighted Average Exercise Price, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing (in dollars per share) Change in the number of shares of non-option equity instruments due to the impact of repricing subordinated note holder warrants after repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants, After Repricing Impact of repricing subordinated note holder warrants, After repricing (in shares) Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing subordinated note holder warrants after repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Subordinated Note Holder Warrants Weighted Average Remaining Contractual Term, After Repricing Impact of repricing subordinated note holder warrants, After pricing Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing subordinated note holder warrants prior to repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Subordinated Note Holder Warants Weighted Average Remaining Contractual Term, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing Equity warrants. Equity Warrant [Member] Equity Warrants [Member] Equity Warrants [Member] A former employee of the entity. Former Employee [Member] Change in the weighted average exercise price of non-option equity instruments due to the impact of anti-dilution clauses prior to repricing. Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Impact of Anti-Dilution Clauses Of Weighted Average Exercise Price, Prior to Repricing Impact of anti-dilution clauses, Prior to impact (in dollars per share) Change in the number of shares of non-option equity instruments due to the Impact of repricing debenture purchaser warrants after repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants, After Repricing Impact of repricing debenture purchaser warrants, After repricing (in shares) Refers to weighted average remaining contractual terms of liability warrants in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Remaining Contractual Terms Exercised Gross number of shares (or other type of equity) issued on a monthly basis in lieu of cash compensation during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans. Stock Issued During Period, Shares, Share-based Compensation In lieu of Cash, Monthly Gross Transitional monthly compensation awarded in lieu of cash (in shares) The number of shares into which fully or partially vested non options outstanding as of the balance sheet date can be currently converted. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number Exercisable at end of period (in shares) Weighted average remaining contractual term for equity-based awards excluding options issued, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options, Issued, Weighted Average Remaining Contractual Terms Issued Weighted average remaining contractual term for vested portions of 'other than options' equity instruments outstanding with impact of repricing debenture purchaser warrants prior to repricing, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based Compensation Arrangement by Sharebased Payment Award Other Than Options, Impact of Repricing Debenture Purchaser Warrants Weighted Average Remaining Contractual Term, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing Liability warrants. Liability Warrant [Member] Liability Warrants [Member] Liability Warrants [Member] Change in the number of shares of non-option equity instruments due to the Impact of repricing debenture purchaser warrants prior to repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Debenture Purchaser Warrants, Prior to Repricing Impact of repricing debenture purchaser warrants, Prior to repricing (in shares) Change in the number of shares of non-option equity instruments due to the impact of repricing subordinated note holder warrants prior to repricing. Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Impact of Repricing Subordinated Note Holder Warrants, Prior to Repricing Impact of repricing subordinated note holder warrants, Prior to repricing (in shares) Net income after adjustments for dividends on preferred stock. Net Income (Loss) Available to Common Stockholders, Basic and Diluted After Dividend on Preferred Stock Basic and diluted - adjusted loss from continuing operations Temporary equity that may be exchanged into common shares or other types of securities at the owner's option. Temporary Equity Stock [Member] Convertible Preferred Stock [Member] A major external customer. Fourth customer [Member] Customer 4 [Member] A major external customer. Fifth customer [Member] Customer 5 [Member] A major external customer. Customer 2 [Member] Customer 2 [Member] A major external customer. Customer 3 [Member] Customer 3 [Member] Purchases during the period in the normal course of business after deducting returns, allowances and discounts, when it serves as a benchmark in a concentration of risk calculation. Purchases [Member] A major external customer. Other Customers [Member] Others [Member] A major supplier. Supplier 5 [Member] Supplier 5 [Member] A major supplier. Supplier 4 [Member] Supplier 4 [Member] A major supplier. Supplier 2 [Member] Supplier 2 [Member] A major supplier. Supplier 3 [Member] Supplier 3 [Member] Major other suppliers. Other Suppliers [Member] Others [Member] A major supplier. Supplier 1 [Member] Supplier 1 [Member] A major external customer. Customer 1 [Member] Customer 1 [Member] Amount of amortization attributable to discontinued operations. Amortization Discontinued Operations Amortization Amount of deprecation attributable to discontinued operations. Depreciation Discontinued Operations Depreciation Refers to the carrying value of discontinuing operations. Disposal Group Discontinued Operations Carrying Value Net carrying value of discontinued operations Refers to the period of customary indemnification provisions and provisions that restrict the entity from engaging in a business conducted by disposed of or sold entity. Disposal Group, Discontinued Operations, Restriction Period to Engage in Business Conducted by Sold Entity Restriction period to engage in business conducted by sold entity Refers to an escrow account established for indemnity claims. Escrow for Indemnity Claims Escrow for indemnity claims Refers to an escrow account established for working capital adjustments. Escrow for Working Capital Adjustments Escrow for working capital adjustments Cash and cash equivalents and restricted cash, beginning of period [Abstract] Cash and cash equivalents and restricted cash, beginning of period Proceeds from issuance of stock which is not included within permanent equity net of issuance costs. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Proceeds from Issuance of Temporary Equity, and Warrants, Net Proceeds from issuance of preferred stock and warrants, net of issuance costs Proceeds from preference stock and warrants Cash and cash equivalents and restricted cash, end of period [Abstract] Cash and cash equivalents and restricted cash, end of period Amount of unpaid employer taxes attributable to disposal group held for sale or disposed of during the period. Disposal Group Including Discontinued Operations Income Unpaid Employer Taxes Unpaid employer tax Amount of entrance fees payment attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Income Entrance Fees Payment Entrance fee payments Refers to maximum number of monthly payments, if entity is unable to qualify for the new Brazil tax amnesty, entity will likely petition the tax authorities seeking a favorable payment plan but it is likely the installment payments. Maximum Number of Monthly Payments If Unable To Qualify For Tax Amnesty Maximum number of monthly payments, if unable to qualify for Tax amnesty A subsidiary Industrial Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil, which manufactures RBO and DRB products for both the human and animal food markets in Brazil and internationally. Irgovel [Member] Amount classified as installment payments in arrears attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Installment Payments in Arrears Installment payments in arrears Amount of tax payment in arrears attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Income Tax Payment Arrears Tax and tax related payments in arrears Disposal Group Including Discontinued Operation Components of Debt [Abstract] Components of Debt [Abstract] Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations classified as other debt, due within one year or the normal operating cycle, if longer, attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Other Debt, Current Other The carrying value as of the balance sheet date of the current portion of long-term obligations attributable to disposal group held for sale or disposed of drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Disposal Group Including Discontinued Operations Lines of Credit, Current Working capital lines of credit The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from advances on customer export orders attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Advances on Customer Export Orders, Current Advances on customer export orders Amount classified as capital expansion loans attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations Capital Expansion Loans Capital expansion loans The carrying value as of the balance sheet date of the current portion of special tax programs attributable to disposal group held for sale or disposed of. Disposal Group Including Discontinued Operations, Special Tax Programs Current Special tax programs Document and Entity Information [Abstract] This element represents domestic or foreign debt that matures in May 2019. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets. Debt Due May 2019 [Member] Maturity Due May 2019 [Member] This element represents domestic or foreign debt that matures in February 2019. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets. Debt Due February 2019 [Member] Maturity Due February 2019 [Member] Refers to Continental Grain Company, a related party. Continental Grain Company [Member] Refers to the number of nominees the related party has a right to designate as a member of the board of directors (BOD). Related Party, Right to Designate to Board of Directors, Number of Nominees Number of nominee for the Board of Directors related party can designate Refers to the percentage of outstanding debt of the entity held by a related party. Percentage of Outstanding Debt Held by Related Party Percentage of outstanding debt retained by related party Fair value of stock issued during the period. Grant Date Fair Value of Stock Issued During Period Grant date fair value Expensed ratably contractual term for shares issued, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Expensed Ratably Period for shares issued Expensed ratably term Refers to vesting price of share-based compensation awards. Share based Compensation Arrangement By Share based Payment Award Award Vesting price Vesting price (in dollars per share) The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrant awards on all stock warrant plans and other required information pertaining to awards in the customized range. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range, Lower Range Limit Exercise price range, lower range limit (in dollars per share) Third portion of share-based compensation award vesting. Share Based Compensation Award Vesting Three [Member] Vesting Price Equals or Exceeds $15.00 [Member] Second portion of share-based compensation award vesting. Share Based Compensation Award Vesting Two [Member] Vesting Price Equals or Exceeds $10.00 [Member] Option exercise price range. Range Five [Member] $5.25 [Member] Option exercise price range. Range Two [Member] $1.50 [Member] Option exercise price range. Range Six [Member] $5.25 to $5.87 [Member] Option exercise price range. Range Four [Member] $2.00 [Member] Option exercise price range. Range Three [Member] $1.50 to $1.60 [Member] Option exercise price range. Range One [Member] $0.96 [Member] Option exercise price range. Range Seven [Member] $6.55 to $16.80 [Member] First portion of share-based compensation award vesting. Share Based Compensation Award Vesting One [Member] Vesting Price Equals or Exceeds $5.00 [Member] Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding warrants by ranges of exercise prices. Schedule of Share based Compensation, Shares Authorized under Stock Warrant Plans, by Exercise Price Range [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Line Items] Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range [Abstract] Summary of information related to outstanding and exercisable warrants [Abstract] The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock warrant awards on all stock warrant plans and other required information pertaining to awards in the customized range. Share based Compensation, Shares Authorized under Stock Warrant Plans, Exercise Price Range, Upper Range Limit Exercise price range, upper range limit (in dollars per share) Refers to the stock conversion loss between fair value liability and fair value of common stock on the date of conversion. Stock Issued During Period Conversion Loss Between Fair Value Liability and Fair Value of Common Stock Conversion loss between fair value liability and fair value of common stock Refers to number of securities into which the class of warrant, exercisable cashless or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Class of Warrant or Right, Number of Securities Called by Warrants or Rights, Exercisable Cashless Shares under warrants, exercisable cashless (in shares) Conversion price at which grantees can acquire the shares reserved for issuance under the plan. Share based Compensation Arrangement by Share based Payment Award, Non-Option Equity Instruments, Conversion price Conversion price (in dollars per share) Refers to number of warrants. Number of Warrants Number of warrants The number of trading days considered in delivery of shares. Number of trading days Tabular disclosure of warrant exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of warrants, weighted average exercise price and remaining contractual warrant terms. Schedule of Share based Compensation, Warrants, by Exercise Price Range [Table Text Block] Summary of outstanding warrants LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN [Abstract] The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period net of expenses related to the costs to complete the divestiture. Proceeds from Divestiture of Businesses, Net of Expenses Cash proceeds from sale of business, net of expenses The EBITDA that must be achieved to prevent default status. EBITDA triggering default status The amount paid to investors in exchange for the termination of rights. The rights relate to an agreement in which investors have a right to elect to exchange units in a variable interest entity of the parent entity for common stock of the parent entity. Amount Paid In Exchange for Termination of Rights Amount paid exchange for termination of rights The amount of a Nutra SA initial public offering that would trigger the termination of Drag Along rights which would allow the Investors to force the sale of all Nutra SA assets. Drag Along Right termination amount Drag along right, amount of initial public offering Represents the number of representatives on the management committee, which oversees the manager under the LLC agreement. Number of representatives on management committee Number of representatives on management committee The average equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. Average Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Investors' average interest in Nutra SA during the period Represents the number of investors on the management committee, which oversees the manager under the LLC agreement. Number of Investors on Management Committee Number of Investors on Management Committee Represents the number of representatives on the management committee upon an event of default or a qualifying event under the LLC agreement. Number of representatives on management committee upon default Number of representatives on management committee upon default Represents the number of investors on the management committee upon an event of default or a qualifying event under the LLC agreement. Number of Investors on Management Committee Upon Default Number of investors on management committee upon default EX-101.PRE 10 ribt-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2017
Nov. 03, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name RiceBran Technologies  
Entity Central Index Key 0001063537  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   16,884,017
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2017  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Consolidated Statements of Operations (Unaudited) [Abstract]        
Revenues $ 3,445 $ 3,249 $ 10,206 $ 9,748
Cost of goods sold 2,305 2,434 7,081 7,199
Gross profit 1,140 815 3,125 2,549
Selling, general and administrative expenses 2,495 3,140 7,428 9,428
Loss from operations (1,355) (2,325) (4,303) (6,879)
Other (expense) income:        
Interest expense (86) (352) (1,616) (1,484)
Change in fair value of derivative warrant liabilities (313) 1,166 808 314
Loss on extinguishment of debt (6,610) 0 (8,290) 0
Loss on conversion of preferred stock (85) 0 (85) 0
Gain on resolution of Irgovel purchase litigation 0 0 0 1,598
Other income 157 132 194 132
Other expense (28) 0 (128) 0
Total other (expense) income (6,965) 946 (9,117) 560
Loss before income taxes (8,320) (1,379) (13,420) (6,319)
Income tax benefit 4,121 437 5,033 1,344
Loss from continuing operations (4,199) (942) (8,387) (4,975)
Income (loss) from discontinued operations, net of tax 6,706 (608) 6,823 (4,829)
Net income (loss) 2,507 (1,550) (1,564) (9,804)
Less - Net loss attributable to noncontrolling interest in discontinued operations (792) (470) (1,359) (2,416)
Net income (loss) attributable to RiceBran Technologies shareholders 3,299 (1,080) (205) (7,388)
Less - Dividends on preferred stock, beneficial conversion feature 0 0 778 551
Net income (loss) attributable to RiceBran Technologies common shareholders $ 3,299 $ (1,080) $ (983) $ (7,939)
Basic earnings (loss) per common share:        
Continuing operations (in dollars per share) $ (0.38) $ (0.10) $ (0.86) $ (0.60)
Discontinued operations (in dollars per share) 0.68 (0.01) 0.77 (0.26)
Basic earnings (loss) per common share - RiceBran Technologies (in dollars per share) 0.30 (0.11) (0.09) (0.86)
Diluted earnings (loss) per common share:        
Continuing operations (in dollars per share) (0.38) (0.10) (0.86) (0.60)
Discontinued operations (in dollars per share) 0.68 (0.01) 0.77 (0.26)
Diluted earnings (loss) per common share - RiceBran Technologies (in dollars per share) $ 0.30 $ (0.11) $ (0.09) $ (0.86)
Weighted average number of shares outstanding:        
Basic (in shares) 11,129,781 9,397,255 10,644,372 9,281,942
Diluted (in shares) 11,129,781 9,397,255 10,644,372 9,281,942
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) [Abstract]        
Net income (loss) $ 2,507 $ (1,550) $ (1,564) $ (9,804)
Other comprehensive income - foreign currency translation, net of tax (31) (165) 131 694
Comprehensive income (loss), net of tax 2,476 (1,715) (1,433) (9,110)
Less - Comprehensive loss attributable to noncontrolling interest, net of tax (803) (330) (1,321) (1,998)
Total comprehensive income (loss) attributable to RiceBran Technologies shareholders $ 3,279 $ (1,385) $ (112) $ (7,112)
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 8,187 $ 342
Restricted cash 775 0
Accounts receivable, net of allowance for doubtful accounts of $8 and $12 1,384 1,094
Inventories 758 933
Deposits and other current assets 359 824
Current assets held for sale 2,398 4,335
Total current assets 13,861 7,528
Property and equipment, net 7,123 7,025
Intangible assets, net 135 242
Noncurrent assets held for sale 11,785 14,050
Total assets 32,904 28,845
Current liabilities:    
Accounts payable 261 714
Accrued salary, wages and benefits 605 496
Accrued expenses 309 1,288
Income taxes payable 268 0
Current maturities of long-term debt 19 3,063
Current liabilities held for sale 18,239 15,801
Total current liabilities 19,701 21,362
Long-term debt, less current portion 13 5,964
Derivative warrant liabilities 769 1,527
Deferred tax liability 29 29
Noncurrent liabilities held for sale 0 44
Total liabilities 20,512 28,926
Commitments and contingencies
Temporary equity    
Total temporary equity 0 551
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Common stock, no par value, 50,000,000 shares authorized, 16,551,350 and 10,790,351 shares issued and outstanding 278,079 264,232
Accumulated deficit (260,802) (259,819)
Accumulated deficit attributable to noncontrolling interest in discontinued operation (1,370) (699)
Accumulated other comprehensive loss (4,253) (4,346)
Total equity (deficit) attributable to RiceBran Technologies shareholders 12,392 (632)
Total liabilities, temporary equity and equity (deficit) 32,904 28,845
Series F Convertible Preferred Stock [Member]    
Temporary equity    
Preferred stock, Series F, convertible, 20,000,000 shares authorized, 3,000 convertible shares issued and outstanding 0 551
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock 92 0
Series G Convertible Preferred Stock [Member]    
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock $ 646 $ 0
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Accounts receivable, allowance for doubtful accounts $ 8 $ 12
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 20,000,000  
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 16,551,350 10,790,351
Common stock, shares outstanding (in shares) 16,551,350 10,790,351
Series F Convertible Preferred Stock [Member]    
Temporary equity    
Preferred stock, shares authorized (in shares)   20,000,000
Convertible preferred stock, shares issued (in shares)   3,000
Convertible preferred stock, shares outstanding (in shares)   3,000
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 3,000  
Convertible preferred stock, shares issued (in shares) 499  
Convertible preferred stock, shares outstanding (in shares) 499  
Series G Convertible Preferred Stock [Member]    
Equity (deficit) attributable to RiceBran Technologies shareholders:    
Preferred stock, shares authorized (in shares) 3,000  
Convertible preferred stock, shares issued (in shares) 1,300  
Convertible preferred stock, shares outstanding (in shares) 1,300  
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flow from operating activities:    
Net income (loss) $ (1,564) $ (9,804)
Income (loss) from discontinued operations 6,823 (4,829)
Loss from continuing operations (8,387) (4,975)
Net cash used in operating activities of continuing operations:    
Depreciation and amortization 571 694
Stock and share-based compensation 904 841
Change in fair value of derivative warrant and conversion liabilities (808) (314)
Loss on extinguishment of debt 8,290 0
Gain on resolution of Irgovel purchase litigation 0 (1,598)
Interest accreted 1,000 497
Deferred taxes (5,033) (1,344)
Other 55 0
Changes in operating assets and liabilities:    
Accounts receivable (290) (182)
Inventories 213 576
Accounts payable and accrued expenses (1,310) 3
Other 465 53
Net cash used in operating activities of continuing operations (4,330) (5,749)
Net cash provided by operating activities of discontinued operations 1,513 3,714
Net cash used in operating activities (2,817) (2,035)
Cash flows from investing activities:    
Purchases of property (596) (208)
Net cash used in investing activities of continuing operations (596) (208)
Net cash provided by (used in) investing activities of discontinued operations 16,604 (252)
Net cash provided by (used in) investing activities 16,008 (460)
Cash flows from financing activities:    
Payments of debt (19,728) (24,124)
Proceeds from issuance of debt, net of issuance costs 3,779 23,752
Proceeds from issuance of debt and warrants, net of issuance costs 5,518 300
Proceeds from issuance of preferred stock and warrants, net of issuance costs 1,747 2,554
Net proceeds from issuance of common stock 2,778 0
Other (23) (9)
Net cash provided by (used in) financing activities of continuing operations (5,929) 2,473
Net cash provided by (used in) financing activities of discontinued operations 1,232 (551)
Net cash provided by (used in) financing activities (4,697) 1,922
Effect of exchange rate changes on cash and cash equivalents of discontinued operations 126 (182)
Net change in cash and cash equivalents and restricted cash 8,620 (755)
Cash and cash equivalents and restricted cash, beginning of period    
Cash and cash equivalents 342 966
Restricted cash 0 1,921
Cash and cash equivalents and restricted cash, beginning of period 342 2,887
Cash and cash equivalents and restricted cash, end of period    
Cash and cash equivalents 8,187 2,132
Restricted cash 775 0
Cash and cash equivalents and restricted cash, end of period 8,962 2,132
Supplemental disclosures, continuing operations:    
Cash paid for interest of continuing operations 729 780
Cash paid for income taxes of continuing operations $ 0 $ 20
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2017
BASIS OF PRESENTATION [Abstract]  
BASIS OF PRESENTATION
NOTE 1. BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in complete financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.
 
These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS
 9 Months Ended
Sep. 30, 2017
DISCONTINUED OPERATIONS [Abstract]  
DISCONTINUED OPERATIONS
NOTE 2. DISCONTINUED OPERATIONS

Healthy Natural (HN) Discontinued Operations

The Company continuously assesses the composition of our business portfolio to ensure it is aligned with our strategic objectives and positioned to maximize growth and return to our shareholders.  In the second quarter of 2017, we began exploring strategic options for our wholly-owned subsidiary, Healthy Natural, Inc. (HN).  In July 2017, we completed the sale of the assets of HN for $18.3 million in cash.  HN was reported as part of our Corporate and USA segment.  The selling price is subject to adjustment if the estimated closing working capital with respect to the assets sold and the liabilities assumed is different than the actual closing working capital for those assets and liabilities.  The sale agreement contains customary indemnification provisions and provisions that restrict us from engaging in a business conducted by HN for five years from the date of closing.  A $0.2 million working capital adjustment escrow and a $0.6 million indemnity claim escrow were funded from the proceeds.  We are providing certain support services under transition services agreement for a limited period of time.  These support services are not expected to have a material impact on our consolidated statements of operations in 2017.

On a preliminary basis, we estimate the proceeds, net of expenses, at $16.7 million, the net carrying value of HN as of the date of sale at $3.5 million and the third quarter 2017 gain on sale as $8.8 million, net of a $4.3 million income tax provision.  We currently expect to obtain the amounts held in escrow without adjustment.  The following table summarizes the estimated carrying amount of HN as of the July 2017 sale (in thousands).
 
Accounts receivable, net
 
$
871
 
Inventories
  
1,987
 
Other current assets
  
47
 
Property and equipment
  
871
 
Intangible
  
791
 
Other
  
24
 
Assets
  
4,591
 
Accounts payable
  
759
 
Accrued expenses
  
290
 
Liabilities
  
1,049
 
Net assets sold
 
$
3,542
 
 
We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2017.  Accordingly, HN results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, the HN assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.
 
The operations of HN are included in our results though the July 14, 2017 date of sale.  All following tables represent activity up to the date of the sale.
 
The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestiture of HN (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
421
  
$
5,010
  
$
9,902
  
$
15,044
 
Cost of goods sold
  
(293
)
  
(3,330
)
  
(6,651
)
  
(9,991
)
Selling, general and administrative expenses
  
(19
)
  
(396
)
  
(462
)
  
(1,100
)
Income from operations, before income taxes
  
109
   
1,284
   
2,789
   
3,953
 
Income tax expense
  
(36
)
  
(437
)
  
(948
)
  
(1,344
)
Income from operations, net of tax
  
73
   
847
   
1,841
   
2,609
 
Gain on sale, net of $4.3 million income tax expense
  
8,845
   
-
   
8,845
   
-
 
Income from discontinued operations, net of tax
 
$
8,918
  
$
847
  
$
10,686
  
$
2,609
 
 
We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN’s taxable operating income in 2017.  Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset by 90% by net operating loss carryforwards; thereby leaving residual taxable income of 10%, subject to a rate of 20%. We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.
 
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale as of December 31, 2016 (in thousands).
 
  
December 31,
2016
 
Accounts receivable, net
 
$
592
 
Inventories
  
1,915
 
Other current assets held for sale
  
23
 
Property and equipment
  
1,019
 
Intangible
  
791
 
Other noncurrent assets
  
24
 
Total assets held for sale
 
$
4,364
 
Accounts payable
 
$
443
 
Accrued expenses
  
382
 
Long term liabilities
  
44
 
Total liabilities held for sale
 
$
869
 
 
The following table summarizes the major line items included in cash flows from discontinued operations of HN for the nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Nine Months Ended
 
  
2017
  
2016
 
       
Net cash provided by operating activities
 
$
2,803
  
$
3,701
 
Net cash provided by (used in) investing activities
  
16,719
   
(73
)
Net cash used in financing activities
  
(48
)
  
-
 
Net cash provided to continuing operations
 
$
(19,474
)
 
$
(3,628
)
 
In 2017, net cash provided by investing activities in the table above is presented in our consolidated statements of cash flows in net cash provided by (used in) investing activities of discontinued operations and includes the $16.7 million net proceeds from the sale of HN.
 
The following table summarizes other data for HN (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Depreciation included in cost of goods sold
 
$
7
  
$
42
  
$
96
  
$
130
 
Depreciation included in selling, general and administrative expenses
  
4
   
20
   
49
   
58
 
Amortization included in selling, gneral and administrative expenses
  
-
   
204
   
-
   
659
 
Capital expenditures
  
3
   
22
   
18
   
95
 
 
Nutra SA Discontinued Operations

We hold a variable interest in our equity interest in Nutra SA.  Nutra SA’s only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), located in Pelotas, Brazil.  We are the primary beneficiary of Nutra SA, and as such, Nutra SA’s assets, liabilities and results of operations are included in the condensed consolidated financial statements.  In the second quarter of 2017, we determined that our plans to divest our investment in Nutra SA met the criteria for presentation as discontinued operations.  Accordingly, the Nutra SA operating results are presented as discontinued operations in our condensed consolidated statements of operations and are excluded from continuing operations for all periods presented.  In addition, Nutra SA consolidated assets and liabilities are classified as held for sale in our consolidated balance sheets for all periods presented.  Other equity holders’ (Investors) interests in Nutra SA are reflected in net loss attributable to noncontrolling interest in discontinued operations in the condensed consolidated statements of operations and accumulated deficit attributable to noncontrolling interest in discontinued operations in the condensed consolidated balance sheets.

The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
3,226
  
$
563
  
$
9,589
  
$
4,627
 
Cost of goods sold
  
(3,539
)
  
(1,154
)
  
(9,814
)
  
(6,103
)
Selling, general and administrative expenses
  
(1,541
)
  
(509
)
  
(2,572
)
  
(1,891
)
Goodwill impairment
  
-
   
-
   
-
   
(3,024
)
Other expense
  
(358
)
  
(355
)
  
(1,066
)
  
(1,047
)
Loss from discontinued operations, before income taxes
  
(2,212
)
  
(1,455
)
  
(3,863
)
  
(7,438
)
Income taxes
  
-
   
-
   
-
   
-
 
Loss from discontinued operations, net of tax
 
$
(2,212
)
 
$
(1,455
)
 
$
(3,863
)
 
$
(7,438
)
 
The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).
 
  
September 30,
2017
  
December 31,
2016
 
Cash and cash equivalents
 
$
54
  
$
109
 
Accounts receivable, net (restricted)
  
781
   
398
 
Inventories
  
1,237
   
925
 
Other current asssets
  
326
   
373
 
Property and equipment, net (restricted $2,662 and $2,599)
  
10,464
   
10,889
 
Other noncurrent assets
  
1,321
   
1,327
 
Total assets held for sale
 
$
14,183
  
$
14,021
 
Accounts payable
 
$
2,338
  
$
2,553
 
Accrued expenses
  
8,274
   
5,607
 
Current maturities of long-term debt (nonrecourse)
  
7,627
   
6,816
 
Total liabilities held for sale
 
$
18,239
  
$
14,976
 
 
Cash provided by Nutra SA operations are generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the LLC Agreement.  Therefore Nutra SA’s consolidated cash is classified as held for sale in our consolidated balance sheets.  Nutra SA’s debt is secured by Irgovel’s accounts receivable and property.  The non-Brazilian entities within the consolidated ownership group do not guarantee any of Nutra SA’s debt.
 
The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Nine Months Ended
 
  
2017
  
2016
 
       
Net cash used in operating activities
 
$
(1,345
)
 
$
(9
)
Net cash used in investing activities
  
(115
)
  
(157
)
Net cash provided (used) by financing activities
  
1,280
   
(551
)
Net cash provided by continuing operations
  
-
   
863
 
Effect of exchange rate changes
  
125
   
(183
)
Net change in cash and cash equivalents
  
(55
)
  
(37
)
Cash and cash equivalents, beginning of period
  
109
   
104
 
Cash and cash equivalents, end of period
 
$
54
  
$
67
 
 
The following table summarizes other data for Nutra SA (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Depreciation included in cost of goods sold
 
$
274
  
$
246
  
$
792
  
$
672
 
Depreciation included in selling, general and administrative expenses
  
15
   
16
   
46
   
42
 
Capital expenditures
  
22
   
1
   
115
   
157
 
 
Nutra SA’s debt consists of the following (in thousands):
 
  
September 30
2017
  
December 31,
2016
 
Capital expansion loans
 
$
2,635
  
$
2,454
 
Working capital lines of credit
  
1,081
   
401
 
Advances on customer export orders
  
785
   
1,113
 
Special tax programs
  
3,014
   
2,767
 
Other
  
112
   
81
 
  
$
7,627
  
$
6,816
 
 
As of September 30, 2017, Irgovel had approximately $0.4 million (USD) of debt installment payments in arrears.  The banks have not called these loans in default, and management continues to work with the lenders to renegotiate payment terms, however, all Nutra SA debt has been classified as current liabilities held for sale in the accompanying condensed consolidated balance sheet as of September 30, 2017.  As of September 30, 2017, Irgovel had approximately $9.3 million of tax and tax related payments in arrears.  Approximately  $0.2 million of the tax payments in arrears is related to certain unpaid employer tax from April 2017 through September 2017.  All tax and tax related payments in arrears, other than the certain unpaid employer tax, can be included in a new Brazil tax amnesty program, but to qualify to do so, an entrance fee of approximately $0.4 million must be paid prior to November 15, 2017.  At this time it is not certain Irgovel will qualify for the new Brazil tax amnesty.  If Irgovel is unable to qualify for the new Brazil tax amnesty, Irgovel will likely petition the tax authorities seeking a favorable payment plan but it is likely the installment payments will not exceed 60 monthly payments.  All Nutra SA debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.  The fair value of Nutra SA debt (Level 3 measurement) approximates the carrying value of that debt based on the current market rates for similar debt with similar maturities.

Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segment pursuant to the terms of the limited liability company agreement of Nutra SA (LLC Agreement).

A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying condensed consolidated balance sheets, for the three and nine months ended September 30, 2017 and 2016 (in thousands) follows.
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Redeemable noncontrolling interest in Nutra SA, beginning of period
 
$
(567
)
 
$
(1,599
)
 
$
(699
)
 
$
69
 
Investors' interest in net loss of Nutra SA
  
(792
)
  
(470
)
  
(1,359
)
  
(2,416
)
Investors' interest in other comprehensive loss of Nutra SA
  
(11
)
  
(60
)
  
38
   
218
 
Investors purchase of additional membership interest
  
-
   
200
   
650
   
200
 
Redeemable noncontrolling interest in Nutra SA, end of period
 
$
(1,370
)
 
$
(1,929
)
 
$
(1,370
)
 
$
(1,929
)
                 
Investors' average interest in Nutra SA during the period
  
35.8
%
  
32.5
%
  
35.5
%
  
32.2
%
Investors' interest in Nutra SA at the end of the period
  
35.8
%
  
32.7
%
  
35.8
%
  
32.7
%
 
The Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets after January 1, 2018.  The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined in the LLC Agreement).  We may elect to exercise a right of first refusal to purchase the Investors’ interest instead of proceeding to a sale.  We have assessed the likelihood of the Investors exercising these rights as less than probable at September 30, 2017.  We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.  We will begin to accrete the redeemable noncontrolling interest to fair value if and when it is probable the Investors will exercise these rights.

As the result of an amendment effective March 31, 2017, the Investors right to elect to exchange units in Nutra SA for our common stock terminated.  In exchange for the termination of this right, we paid the Investors $0.1 million.
 
Under the LLC Agreement, the business of Nutra SA is to be conducted by the manager, currently our EVP of Special Projects, subject to the oversight of the management committee.  The management committee is comprised of three of our representatives and two of Investors’ representatives.  Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investors’ representatives and two of our representatives.  In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.
 
As of September 30, 2017, there have been no unwaived events of default.  Events of default, as defined in the Membership Interest Purchase Agreement (MIPA) and the October 2013 amendment of investment agreements, are the failure of Irgovel to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually.

As of September 30, 2017, there have been no qualifying events.  The LLC Agreement defines a qualifying event as the bankruptcy of RiceBran Technologies or Nutra SA.

In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.  Until there is an event of default or a qualifying event, the Investors’ rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.  The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.  However, the Investors do have drag along rights in the future.  We will continue to evaluate whether we are the primary beneficiary of Nutra SA each reporting period.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN
 9 Months Ended
Sep. 30, 2017
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN [Abstract]  
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN
NOTE 3. LIQUIDITY, GOING CONCERN AND MANAGEMENT’S PLAN

Our cash position has improved since December 31, 2016, as a result of a debt and equity raise in February 2017, the sale of HN in July 2017 and an equity raise in September 2017.  However, our continued operations continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern for a period of one year from the issue date of these financial statements.

In February 2017, as discussed further in Note 8, we received net proceeds of $7.2 million from the sale and issuance of preferred stock, senior debentures and related warrants.  The net proceeds were used in part to pay in full amounts owing our previous senior lender ($3.8 million) and to pay principal and accrued interest on our subordinated notes ($0.5 million).  In July 2017, as discussed further in Note 2, we received cash proceeds, net of expenses, of $16.7 million from the sale of HN a portion of which was used to pay off our senior debentures ($6.6 million) and subordinated notes ($6.0 million).  In September 2017, as discussed further in Note 8, we received net proceeds of $2.7 million from the sale and issuance of common stock.  We continue to believe that we will be able to obtain additional funds to operate our business, should it be necessary; however, there can be no assurances that our efforts will prove successful.  The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.
 
Beginning in the second quarter of 2016 and through the third quarter of 2017, Irgovel experienced severe cash shortages resulting in an increase in accrued expenses and payroll related tax obligations.  In 2016, our minority partners (the Investors) contributed $1.7 million to Nutra SA and an additional $0.7 million through September 30, 2017.  In 2016, we invested $1.1 million in Nutra SA.  Our board has determined we will not contribute any additional funds to Nutra SA.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECENT ACCOUNTING GUIDANCE
 9 Months Ended
Sep. 30, 2017
RECENT ACCOUNTING GUIDANCE [Abstract]  
RECENT ACCOUNTING GUIDANCE
NOTE 4. RECENT ACCOUNTING GUIDANCE

Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We expect to transition through a cumulative effect adjustment as of January 1, 2018.  Under the modified retrospective method adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to HN, because we no longer reflect HN operations in our consolidated results after the sale of HN in July 2017.  Similarly, if we dispose of Nutra SA, before December 31, 2017, we expect adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to Nutra SA as well.

In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In May 2017, the FASB issued guidance that clarifies the scope of asset derecognition guidance and accounting for partial sales of nonfinancial assets.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In February 2017, the FASB issued guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In November 2016, the FASB issued guidance that requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.   As a result, changes in restricted cash reported in 2016 as cash flows from investing activities are no longer reported as such.
 
In August 2016, the FASB issued guidance intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flow, including the classification of (i) payments to extinguish debt and (ii) payments for the settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.  This change did not have an effect on the presentation of our cash flows, as our presentation in previously reported periods had complied with the new guidance.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
LOSS PER SHARE (EPS)
 9 Months Ended
Sep. 30, 2017
LOSS PER SHARE (EPS) [Abstract]  
LOSS PER SHARE (EPS)
NOTE 5. LOSS PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends.  Our outstanding convertible preferred stocks are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effects of outstanding options, warrants, nonvested shares and restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method.  The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.

Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and nine months ended September 30, 2017 and 2016.
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
NUMERATOR (in thousands):
            
Basic and diluted - loss from continuing operations
 
$
(4,199
)
 
$
(942
)
 
$
(8,387
)
 
$
(4,975
)
Dividend on preferred stock--beneficial conversion feature
  
-
   
-
   
(778
)
  
(551
)
Basic and diluted - adjusted loss from continuing operations
 
$
(4,199
)
 
$
(942
)
 
$
(9,165
)
 
$
(5,526
)
                 
DENOMINATOR:
                
Basic EPS - weighted average number of common shares outstanding
  
11,129,781
   
9,397,255
   
10,644,372
   
9,281,942
 
Effect of dilutive securities outstanding
  
-
   
-
   
-
   
-
 
Diluted EPS - weighted average number of shares outstanding
  
11,129,781
   
9,397,255
   
10,644,372
   
9,281,942
 
                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                
Stock options
  
629,969
   
340,037
   
473,498
   
350,203
 
Warrants
  
22,824,888
   
10,842,006
   
21,306,727
   
10,132,045
 
Nonvested stock
  
1,301,725
   
1,114,747
   
1,236,241
   
1,038,019
 
Convertible preferred stock
  
2,128,180
   
2,000,000
   
3,020,739
   
1,611,722
 
Restricted stock unit awards
  
1,175,000
   
-
   
406,066
   
-
 
 
The impact of potentially dilutive securities outstanding at September 30, 2017 and 2016, was not included in the calculation of the continuing operations diluted EPS for the three and nine months ended September 30, 2017 and 2016 because to do so would be antidilutive.  Those securities listed in the table above which were antidilutive for the periods presented, which remain outstanding, could potentially dilute EPS in the future.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONCENTRATIONS OF RISK
 9 Months Ended
Sep. 30, 2017
CONCENTRATIONS OF RISK [Abstract]  
CONCENTRATIONS OF RISK
NOTE 6. CONCENTRATIONS OF RISK

Our trade accounts receivable subject us to significant concentrations of credit risk.  We perform ongoing credit evaluations on our customers’ financial condition and generally do not require collateral.

Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the nine months ended September 30, 2017 and 2016.
 
  
% of Total Revenue
Nine Months Ended
  
% of Total Accounts Receivable
Nine Months Ended
 
Customer
 
2017
  
2016
  
2017
  
2016
 
Customer 1
  
17
%
  
12
%
  
31
%
  
28
%
Customer 2
  
15
%
  
15
%
  
*
   
*
 
Customer 3
  
*
   
12
%
  
*
   
*
 
Customer 4
  
*
   
*
   
*
   
*
 
Customer 5
  
*
   
*
   
*
   
11
%
Others
  
68
%
  
61
%
  
69
%
  
61
%
Total
  
100
%
  
100
%
  
100
%
  
100
%
                 
* Less than 10%
                
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the nine months ended September 30, 2017 and 2016.
 
  
% of Total Purchases
Nine Months Ended
 
Supplier
 
2017
  
2016
 
Supplier 1
  
*
   
13
%
Supplier 2
  
*
   
*
 
Supplier 3
  
*
   
*
 
Supplier 4
  
*
   
*
 
Supplier 5
  
*
   
*
 
Others
  
100
%
  
87
%
Total
  
100
%
  
100
%
         
* Less than 10%
        
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
DEBT
 9 Months Ended
Sep. 30, 2017
DEBT [Abstract]  
DEBT
NOTE 7. DEBT
 
The following table summarizes current and long-term portions of debt (in thousands):
 
  
September 30,
2017
  
December 31,
2016
 
Senior debentures, net, maturing in February 2019, principal $6.6 million
 
$
-
  
$
-
 
Subordinated notes, net, maturing in May 2019, principal $5.9 million
  
-
   
6,310
 
Other
  
32
   
75
 
Senior revolving loan
  
-
   
1,725
 
Senior term loan, net
  
-
   
917
 
   
32
   
9,027
 
Current portion
  
19
   
3,063
 
Long-term portion
 
$
13
  
$
5,964
 
 
We issued senior debentures in the principal amount of $6.6 million and related warrants in a private placement, in February 2017.  In connection with the senior debenture private placement, in February 2017, we also entered into agreements that resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75% to 7%, (ii) an extension of the maturity date of the subordinated notes to May 2019 from May 2018 and (iii) our first quarter 2017 payment of $0.2 million of note principal and $0.3 million of accrued note interest.  The transactions, and the accounting therefore, are described further in Note 8.

Until July 2017, when we repaid the senior debentures and the subordinated notes in full with the proceeds from the sale of HN in July 2017, we accreted interest on the debentures at an effective rate of 160.6% per year and on the subordinated notes at 15.0% per year.  Upon extinguishment in July 2017, we recognized a loss on extinguishment of $6.6 million for the differences between (i) the $0.6 million carrying amount of the senior debentures and the $6.6 million face value paid and (ii) the $5.3 million carrying amount of the subordinated notes and the $6.0 million face value paid.

In February 2017, we used the net proceeds from the senior debenture private placement discussed further in Note 8 to pay the senior revolving loan and the senior term loan in full.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS
 9 Months Ended
Sep. 30, 2017
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract]  
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS
NOTE 8. EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (in thousands)
 
  
Shares
           
Accumulated
Deficit
Attributable to
Non-controlling
  
Accumulated
Other Comp-
    
  
Preferred
     
Preferred
  
Common
  
Accumulated
  
 Interest in
  
rehensive
  
Equity
 
  
Series F
  
Series G
  
Common
  
Stock
  
Stock
  
Deficit
  
Nutra SA
  
Loss
  
(Deficit)
 
Balance, December 31, 2016
  
-
   
-
   
10,790,351
  
$
-
  
$
264,232
  
$
(259,819
)
 
$
(699
)
 
$
(4,346
)
 
$
(632
)
Issuance of common stock awards under equity incentive plans
  
-
   
-
   
642,839
   
-
   
817
   
-
   
-
   
-
   
817
 
Dividend on preferred stock - beneficial conversion feature
  
-
   
-
   
-
   
-
   
778
   
(778
)
  
-
   
-
   
-
 
Modification of senior debenture holder warrants
  
-
   
-
   
-
   
-
   
582
   
-
   
-
   
-
   
582
 
Modification of subordinated note holder warrants
  
-
   
-
   
-
   
-
   
117
   
-
   
-
   
-
   
117
 
Change in classification of preferred stock to equity from liability
  
3,000
   
2,000
   
-
   
1,545
   
-
   
-
   
-
   
-
   
1,545
 
Change in classification of warrants to equity from liability
  
-
   
-
   
-
   
-
   
7,851
   
-
   
-
   
-
   
7,851
 
Conversion of preferred stock into common stock
  
(2,501
)
  
(700
)
  
2,331,627
   
(807
)
  
807
   
-
   
-
   
-
   
-
 
Proceeds from sale of common stock, net of costs
  
-
   
-
   
2,654,732
   
-
   
2,730
   
-
   
-
   
-
   
2,730
 
Exercise of warrant
  
-
   
-
   
103,008
   
-
   
101
   
-
   
-
   
-
   
101
 
Other
  
-
   
-
   
28,793
   
-
   
64
   
-
   
-
   
-
   
64
 
Proceeds from sale of membership interests
  
-
   
-
   
-
   
-
   
-
   
-
   
650
   
-
   
650
 
Foreign currency translation
  
-
   
-
   
-
   
-
   
-
   
-
   
38
   
93
   
131
 
Net loss
  
-
   
-
   
-
   
-
   
-
   
(205
)
  
(1,359
)
  
-
   
(1,564
)
Balance, September 30, 2017
  
499
   
1,300
   
16,551,350
  
$
738
  
$
278,079
  
$
(260,802
)
 
$
(1,370
)
 
$
(4,253
)
 
$
12,392
 
 
A summary of warrant activity for the nine months ended September 30, 2017, follows.
 
  
Equity Warrants
  
Liability Warrants
 
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
Outstanding, December 31, 2016
  
6,364,110
  
$
5.77
   
2.4
   
4,474,868
  
$
1.82
   
3.3
 
Issued
  
-
  
NA
  
NA
   
11,783,163
   
0.96
   
5.0
 
Impact of repricing debenture purchaser warrants:
                        
Prior to repricing
  
(875,000
)
  
5.49
   
2.1
   
-
  
NA
  
NA
 
After repricing
  
875,000
   
0.96
   
5.5
   
-
  
NA
  
NA
 
Impact of repricing subordinated note holder warants:
                        
Prior to repricing
  
(289,669
)
  
5.25
   
3.3
   
-
  
NA
  
NA
 
After repricing
  
289,669
   
0.96
   
3.3
   
-
  
NA
  
NA
 
Impact of anti-dilution clauses:
                        
Prior to impact
  
-
  
NA
  
NA
   
(1,489,868
)
  
1.50
   
0.8
 
After impact
  
-
  
NA
  
NA
   
2,327,919
   
0.96
   
0.8
 
Transfer from liability to equity
  
14,468,163
   
1.16
   
4.8
   
(14,468,163
)
  
1.16
   
4.8
 
Exercised
  
-
  
NA
  
NA
   
(781,252
)
  
0.96
   
-
 
Forfeited, expired or cancelled
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Outstanding, September 30, 2017
  
20,832,273
  
$
2.32
   
3.6
   
1,846,667
  
$
1.06
   
0.7
 
Exercisable, September 30, 2017
  
20,832,273
  
$
2.32
   
3.6
   
1,846,667
  
$
1.06
   
0.7
 
 
Common Stock

In February 2017, shareholders approved and we filed an amendment to our articles of incorporation increasing our authorized shares of common stock from 25,000,000 to 50,000,000.

On February 14, 2017, we issued a former employee 108,696 shares of our common stock, in lieu of paying $100,000 cash for a 2016 bonus.

In June 2017, we issued 96,372 shares of common stock as transitional director compensation to the chairman of our board, who was awarded transitional director compensation in the amount of (i) $10,000 or 7,035 shares per month for July 2016 through December 2016 and (ii) $8,333 or 9,027 shares per month for January 2017 through March 2017.  The amount was payable in either cash or stock at the chairman’s election.  The chairman elected to receive shares of common stock.

In June 2017, we issued 345,205 shares of common stock to our directors at a grant date fair value of $0.90 per share.  In August 2017, we issued 35,336 shares of common stock to a director at a grant date fair value of $1.09 per share.  The restricted stock awards vest on the earlier of June 2018 or one day before the date of the next annual shareholder meeting.

In the second quarter of 2017, we issued 220,439 shares of common stock upon conversion of 315 shares of Series F preferred stock and 11 shares of Series G preferred stock.  We reclassified the $0.1 million carrying value of the related preferred stock to common stock.

In September 2017, we issued and sold 2,654,732 shares of common stock for $1.08 per share.  The net proceeds from the offering of $2.8 million, after deducting commissions and other cash offering expenses of $0.1 million, are included in common stock.   We used the proceeds for general corporate purposes.

In the third quarter of 2017, we issued 2,111,188 shares of common stock upon conversion of 2,186 shares of Series F preferred stock and 689 shares of Series G preferred stock.  We reclassified the $0.7 million carrying value of the related preferred stock to common stock.
 
In the fourth quarter of 2017, through the date of this filing, we issued 332,667 shares of common stock upon conversion of 499 shares of Series F preferred stock, with a $0.1 million carrying value.
 
Share Sequencing

From June 2015 until March 2017, the minority interest holders in Nutra SA could elect to exchange units in Nutra SA for shares of our common stock, the number of common stock and warrants issuable upon this election, was variable and indeterminate.  For accounting purposes, we were not able to conclude that we had sufficient authorized and unissued shares to settle all contracts subject to the GAAP derivative guidance during the period the minority interest holders had this right, which terminated March 31, 2017.  Our adopted sequencing approach (Share Sequencing) was based on earliest issuance date, therefore, we were required to carry warrants issued between June 2015 and March 2017, at fair value, as derivative warrant liabilities, and preferred stock issued between June 2015 and March 2017, in temporary equity.  We reclassified the affected warrants from derivative liability to equity (deficit) at an amount equal to the warrants’ fair value on March 31, 2017, and we reclassified the amounts related to the 3,000 shares of Series F preferred stock and 2,000 shares of Series G preferred stock from temporary equity to equity (deficit) at the preferred stocks’ carrying amount on March 31, 2017.

Transactions with Preferred Stock Holders.

In February 2017, we issued and sold 2,000 shares of Series G preferred stock.  The Series G preferred stock is non-voting and may be converted into a total of 1,897,983 shares of our common stock at the holders’ election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 948.9915 shares of common stock.  The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of Series G preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock.  If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of Series G preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.

In February 2017, in conjunction with the sale of the Series G preferred stock, we also sold warrants to purchase 1,423,488 shares of common stock (exercise price of $0.96 per share, exercisable beginning in February 2017 and expiring in February 2022).  A subordinated note holder exchanged subordinated notes with a principal and carrying value of $0.1 million and cash for 180 shares of the Series G preferred stock and related warrants, which was treated as an extinguishment of debt.  The net cash proceeds from the sale was $1.7 million, after deducting allocated cash offering expenses of $0.1 million.  On the date of issuance, we allocated $1.0 million of the proceeds to derivative warrant liability, to record the warrants at fair value, recorded a $0.1 million loss on extinguishment and reduced debt $0.1 million related to the subordinated noteholders exchange, and recorded $1.2 million as preferred stock.  We recorded a $0.8 million dividend on preferred stock for the preferred stock beneficial conversion feature equal to the proceeds allocated to the preferred stock issued to purchases who did not exchange debt, as the fair value of the common stock underlying the convertible preferred stock at issuance exceeded the amount recorded in preferred stock.

Transactions with Senior Debenture Holders

In February 2017, we sold and issued in a private placement, for an aggregate subscription amount of $6.0 million: (i) senior debentures in the principal amount of $6.6 million and (ii) warrants to purchase an aggregate of 6,875,000 shares of common stock (exercise price of $0.96 per share, exercisable beginning February 2017 and expiration February 2022).  We received aggregate net proceeds of $5.5 million, after deducting placement agent fees and allocated expenses of $0.5 million.  Concurrently, we amended existing warrants, held by the debenture purchasers, for the purchase of up to 875,000 shares to (i) reduce the exercise prices from an average $5.49 per share to $0.96 per share, providing the warrants are not exercisable until August 2017, and (ii) change the expiration dates to August 2022, which increased the average remaining term of the warrants from 2.1 years to 5.5 years.  We recorded $4.6 million as an increase to derivative warrant liabilities, to record the warrants at their fair value on the date of issuance, the $0.5 million as an increase in common stock to record the change in fair value of existing warrants and the remaining $0.4 million to debt, debt issuance costs and debt discount.  We used the net proceeds from the offering to (i) pay off the senior revolving loan and term loan debt totaling $3.8 million and (ii) pay $0.2 million of principal and $0.3 million of interest due on subordinated notes and (iii) for working capital and general corporate purposes.  We filed a registration statement on Form S-3, which became effective in May 2017, to register the shares under the warrants issued to the senior debenture purchasers.
 
Transaction with Subordinated Note Holders

In connection with the February 2017 senior debenture private placement, we entered into agreements which resulted in (i) a reduction in the annual interest rate on the subordinated notes from 11.75%  to 7% (ii) an extension of the maturity date of the subordinated notes  to May 2019 from May 2018 (iii) the payment of an aggregate amount equal to $0.5 million on the subordinated notes; (iv) the issuance of warrants to purchase up to 3,484,675 shares of our common stock (exercise price of  $0.96 per share, expiration February 2022); and (v) the amendment of existing warrants held by the subordinated note holders for the purchase 289,669 shares of common stock to reduce the exercise price from $5.25 per share to $0.96 per share.  We accounted for the transaction as an extinguishment of debt and issuance of new debt.  In February 2017, we (i) recorded a loss on extinguishment of debt of $1.5 million, (ii) adjusted subordinated notes payable debt down by $0.9 million, to its fair value as of the transaction date, (iii) increased derivative liability $2.3 million, representing the fair value of the newly issued warrants, and (iv) increased common stock equity by $0.1 million for the change in the fair value of the existing warrants.

Full Ratchet Anti-Dilution

As a result of the February 2017 transactions described above, the exercise price of certain warrants that contain full ratchet anti-dilution provisions was reduced from $1.50 per share to $0.96 per share and the number of shares of common stock underlying these warrants increased from 1,489,868 shares to 2,327,919 shares.  In the third quarter of 2017, the holder exercised one of the warrants, for the purchase 781,252 shares, into common stock.

Equity Incentive Plan

In June 2017, shareholders approved a 1,700,000 increase in the authorized shares issuable under the 2014 Equity Incentive Plan (the 2014 Plan).  The total shares authorized under the 2014 Plan is now 3,300,000 shares.

Option Issuances

In the first quarter of 2017, we granted our chief executive officer an option to purchase 100,000 shares of our common stock at an exercise price of $0.76 per share.  The option vested as to 25,000 shares in August 2017, the remaining shares in monthly installments through August 2020 and the option had a grant date fair value of $0.56 per share.

In the second quarter of 2017, we granted options to purchase an aggregate 355,500 shares of our common stock to executive officers and employees at an average exercise price of $0.85 per share.  The options vest in four equal annual installments beginning in the second quarter of 2018 and had a grant date fair value of $0.62 per share.

In the third quarter of 2017, we granted an option to purchase an aggregate 20,000 shares of our common stock to an employee at an exercise price of $1.09 per share.  The option vests in four equal annual installments beginning in the third quarter of 2018 and had a grant date fair value of $0.77 per share.

Restricted Stock Unit Awards

In late June 2017, we issued restricted stock units (RSUs), under the 2014 Plan, to our executive officers covering a total of 1,175,000 shares of our common stock.  The shares subject to the RSUs vest based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days.  Each RSU’s shares vest (i) 10% if the vesting price equals or exceeds $5.00 per share, (ii) 30% if the vesting price equals or exceeds $10.00 per share and (iv) 60% if the vesting price equals or exceeds $15.00 per share.  The shares had a grant date fair value of $0.2 million which is being expensed ratably over a 3.5-year period beginning in July 2017.

Warrants

In July 2017, the holder of a liability warrant to purchase 781,252 shares, at an exercise price of $0.96 per share, exercised the warrant into common stock with a fair value on the date of the conversion of $0.98 per share.  We issued 103,008 shares of common stock to the holder in a cashless transaction and recorded a $0.1 million loss on the conversion equal to the difference between the fair value of the liability and the fair value of the common stock on the date of the conversion.
 
The following table summarizes information related to outstanding warrants as September 30, 2017 and December 31, 2016:
 
     
September 30, 2017
  
December 31, 2016
 
Range of
Exercise Prices
 
Type of
Warrant
 
Shares
Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares Under
Warrants,
Exercisable
Cashless
  
Shares
Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
              
(4
)
         
$
0.96
 
 Liability (1)
  
1,546,667
  
$
0.96
   
0.4
   
1,546,667
   
-
  
$
-
   
-
 
$
0.96
 
 Equity
  
12,947,832
   
0.96
   
4.6
   
3,774,344
   
-
   
-
   
-
 
$
1.50
 
 Liability (2)
  
300,000
   
1.60
   
2.9
   
300,000
   
-
   
-
   
-
 
$
1.50 to $1.60
 
 Liability
  
-
   
-
   
-
   
-
   
1,789,868
   
1.52
   
1.3
 
$
2.00
 
 Liability (3)
  
-
   
-
   
-
   
-
   
2,660,000
   
2.00
   
4.6
 
$
2.00
 
 Equity
  
2,660,000
   
2.00
   
4.2
   
-
   
-
   
-
   
-
 
$
5.25
 
 Liability (3)
  
-
   
-
   
-
   
-
   
25,000
   
5.25
   
3.6
 
$
5.25 to $5.87
 
 Equity
  
3,156,670
   
5.33
   
2.2
   
359,536
   
4,296,339
   
5.36
   
2.7
 
$
6.55 to $16.80
 
 Equity
  
2,067,771
   
6.61
   
1.5
   
190,899
   
2,067,771
   
6.61
   
2.0
 
      
22,678,940
  
$
2.21
   
3.6
   
6,171,446
   
10,838,978
  
$
4.14
   
2.8
 
 
(1)
Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet.  Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
(4)
Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature.  The shares listed, represent the shares holders could exercise cashless as of September 30, 2017.  If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise.  Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2017
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 9. FAIR VALUE MEASUREMENTS

The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.  As of September 30, 2017, the fair value of our debt (Level 3 measurement) approximated its carrying value, based on current market rates for similar debt with similar maturities.

Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Certain assets and liabilities are presented in the financial statements at fair value.  Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.  Assets and liabilities measured at fair value on a non-recurring basis may include property.

We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

●
Level 1 – inputs include quoted prices for identical instruments and are the most observable.
●
Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.
●
Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.
 
For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.

The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
Total liabilities at fair value, as of September 30, 2017 - derivative warrant liabilities
 
$
-
  
$
-
  
$
769
  
$
769
 
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
 
$
-
  
$
-
  
$
1,527
  
$
1,527
 

Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the consolidated statements of operations.  The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.  The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.
 
  
September 30, 2017
  
December 31, 2016
 
Risk-free interest rate
  
1.2%
  
0.6% -1.9%
  
(1.2% weighted average)
  
(1.6% weighted average)
 
Expected volatility
  
67%-72%
  
64%
 
  
(71% weighted average)
  
(64% weighted average)
 
 
The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):
 
Total Level 3 Fair Value
 
Fair Value
as of
Beginning of
Period
  
Total
Realized and
Unrealized
Gains
(Losses)
  
Issuance of
New
Instruments
  
Reclassify to
(Deficit)
Equity
  
Conversion
to Common
Stock
  
Fair Value,
at End of
Period
 
     
(1)
            
Nine Months Ended September 30, 2017, derivative warrant liabilities
 
$
(1,527
)
 
$
808
  
$
(7,917
)
 
$
7,851
  
$
16
  
$
(769
)
Nine Months Ended September 30, 2016, derivative warrant liabilities
 
$
(678
)
 
$
314
  
$
(2,474
)
 
$
-
  
$
-
  
$
(2,838
)
 
(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 10. COMMITMENTS AND CONTINGENCIES

In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business in the USA and Brazil.  These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.  Defense costs are expensed as incurred and are included in professional fees.

Irgovel Litigation

Irgovel is a defendant in several labor claims, mainly related to overtime, illnesses allegedly contracted at work and work-related injuries and salary related matters for periods prior to the acquisition of Irgovel by RiceBran.  The labor suits are mainly in the lower courts, and for the majority of the cases a decision for the dismissal of the claims has been granted.  None of these labor claims is individually significant.  Management believes it’s unlikely there will be a judgment against Irgovel, however, in the event the court does issue a judgment against Irgovel, it could be approximately $1.1 million.
 
Irgovel accrues for losses on tax and other legal contingencies when it has a present obligation, formalized or not, as a result of a past event, it is probable that an outflow of resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Irgovel is a party to several other pending litigations and administrative proceedings at the Federal, State and Municipal level.  The assessment of the likelihood of an unfavorable outcome in these litigations and proceedings includes the analysis of the evidence available, the hierarchy of the applicable laws, available former court decisions, as well as the most recent court decisions and their importance to the Brazilian legal system, as well as the opinions of our external and in-house legal counsels.  We record amounts considered sufficient by our management to cover probable losses based on these elements.

In addition to the above items, Irgovel has a contingent liability of approximately $0.3 million for amounts claimed to be owed in connection with a loan agreement entered into in April 2007 between Irgovel and a former shareholder of Irgovel.  In April 2014, the former shareholder filed an enforcement action against Irgovel to collect such amounts.  In June 2014, Irgovel filed a motion to annul the enforcement proceedings.  The enforcement proceedings were dismissed in September 2015.  In May 2016, the court found in favor of the former shareholder to appeal the stay of execution that was previously granted.

Irgovel - Events of Default

As further described in Note 2, Irgovel is required to meet minimum annual processing targets or to achieve EBITDA on a local currency basis of at least R$4.0 million annually. If not achieved, this would result in an event of default under our existing agreements with the Investors.  It is possible that an event of default may be triggered as of December 31, 2017, and a waiver of non-compliance may not be obtained from the Investors.

Employment Contracts and Severance Payments

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control.  In addition, vesting of outstanding unvested equity grants held by these individuals would accelerate following a change in control.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
INCOME TAXES
 9 Months Ended
Sep. 30, 2017
INCOME TAXES [Abstract]  
INCOME TAXES
NOTE 11. INCOME TAXES

We expect to have sufficient net operating losses to offset the taxable gain related to the sale of HN and HN’s taxable operating income in 2017.  Alternative minimum tax may be due on the sale of HN based on the calculation of alternative minimum taxable income, which allows taxable income to only be offset 90% by net operating loss carryforwards; thereby potentially leaving residual taxable income of 10%, subject to a rate of 20%.  We currently estimate $0.3 million to be payable under the alternative minimum tax but we will continue to evaluate the use of additional current year operating losses to offset the taxable income.  We have determined that a Section 382 ownership change occurred in September 2017 and our ability to carryforward remaining net operating losses subsequent to the most recent change in ownership will be severely limited.  The Internal Revenue Service rules in this area are complex and our estimates are subject to change.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
RELATED PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2017
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 12. RELATED PARTY TRANSACTIONS

Prior to 2017, entities beneficially owned by Baruch Halpern, a director, invested in our subordinated notes and related warrants prior to 2014.  As of September 30, 2017, and throughout the first six months of 2017, Mr. Halpern beneficially held approximately 43% of our outstanding subordinated notes and related warrants.  See Note 8 for information related to the modification of the subordinated notes, repricing of related warrants and the issuance of warrants to subordinated note holders in February 2017.  The notes were paid in full in July 2017 from the proceeds of the sale of HN.  In the three months ended September 30, 2017 and 2016, we expensed $0.1 million of interest on the subordinated notes beneficially owned by Mr. Halpern. In the nine months ended September 30, 2017 and 2016, we expensed $0.2 million of interest on the subordinated notes.
 
As discussed in Note 8, in September 2017, we issued and sold 2,654,732 shares of common stock to Continental Grain Company (CGG).  Our director, Ari Gendason is an employee and senior vice president -corporate investments of CGG.  As of the date of this filing, CGG owns approximate 16% of our outstanding common stock.  We have agreed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one nominee to our board of directors.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS
 9 Months Ended
Sep. 30, 2017
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Abstract]  
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS
NOTE 13. FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS

On August 18, 2016, we received a notification letter from The Nasdaq Stock Market LLC (Nasdaq) indicating that we have failed to comply with the minimum stockholders’ equity requirement of Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires that companies listed on the Nasdaq Capital Market maintain a minimum of $2.5 million in stockholders’ equity for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1).  As of September 30, 2016, we reported stockholders’ deficit of $36,000.

We submitted our plan to regain compliance in October 2016.  On November 15, 2016, Nasdaq granted us a 180-day extension to February 14, 2017 to evidence compliance with the minimum stockholders’ equity requirement.  On February 16, 2017, we received a determination letter from Nasdaq stating that we had not regained compliance with the minimum stockholders’ equity requirement.  The letter also stated our common stock would be delisted from The Nasdaq Capital Market at the opening of business on February 27, 2017 unless we request a hearing before the Nasdaq Hearing Panel.
 
We requested and were granted a hearing before the panel to appeal the determination letter on March 30, 2017.  After that hearing, on April 24, 2017, we received a decision letter from Nasdaq stating that the panel granted the request we made at the hearing for continued listing provided that, on or before May 15, 2017, we have announced that our equity is over $2.5 million (it was $7.9 million as of March 31, 2017).  As reported herein our equity is $12.4 million and exceeds the minimum as of September 30, 2017.

On March 10, 2017, we received a notification letter from Nasdaq indicating that we have failed to comply with the minimum bid price requirement of Nasdaq List Rule 5550(a)(2) because our common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive trading days.  Nasdaq rules allowed for a compliance period of 180 calendar days, or until September 6, 2017, in which to regain compliance.  On August 1, 2017, we received a notification letter from Nasdaq that we regained compliance with Nasdaq List Rule 5550(a)(2) minimum bid price requirement by meeting the closing bid price of $1.00 or more for 10 consecutive trading days on July 31, 2017.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
BASIS OF PRESENTATION (Policies)
 9 Months Ended
Sep. 30, 2017
BASIS OF PRESENTATION [Abstract]  
BASIS OF PRESENTATION
In the opinion of management, the accompanying unaudited condensed consolidated financial statements (interim financial statements) of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in complete financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.
 
These interim financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2016, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying interim financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

The results reported in these interim financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECENT ACCOUNTING GUIDANCE (Policies)
 9 Months Ended
Sep. 30, 2017
RECENT ACCOUNTING GUIDANCE [Abstract]  
RECENT ACCOUNTING GUIDANCE
Recent accounting standards not yet adopted

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers to clarify the principles for recognizing revenue and develop a common revenue standard for GAAP and International Financial Reporting Standards.  Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, applying the following steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation.  An entity may choose to adopt the new standard either retrospectively or through a cumulative effect adjustment as of the start of the first period for which it applies the new standard.  The guidance is effective for our annual and interim periods beginning in 2018, however, early adoption is permitted.  We have begun to evaluate the impact that adoption of this guidance will have on our consolidated financial statements but have not completed the evaluation and implementation process. We expect to transition through a cumulative effect adjustment as of January 1, 2018.  Under the modified retrospective method adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to HN, because we no longer reflect HN operations in our consolidated results after the sale of HN in July 2017.  Similarly, if we dispose of Nutra SA, before December 31, 2017, we expect adoption will have no impact on reported results of operations, financial position and cash flows of discontinued operations, with respect to Nutra SA as well.

In February 2016, the FASB issued guidance which changes the accounting for leases.  Under prior GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease for us as a lessee depend primarily on the lease’s classification as a finance or operating lease.  For both types of leases, lessees will recognize a right-of-use asset and a lease liability.  For capital or finance leases, lessees will recognize amortization of the right-of-use asset separately from interest expense on the lease liability.  The guidance is effective for our annual and interim periods beginning in 2019 and must be adopted on a modified retrospective approach.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations, financial position and cash flows and have not yet determined if we will early adopt the standard.

Recently adopted accounting standards

In May 2017, the FASB issued guidance that clarifies the scope of asset derecognition guidance and accounting for partial sales of nonfinancial assets.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In February 2017, the FASB issued guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In January 2017, the FASB issued a new goodwill impairment standard that simplifies the goodwill impairment testing methodology.  The new standard eliminates Step 2 of the goodwill impairment test, in which an entity determines the fair value at the test date of its assets and liabilities using the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination.  We adopted the standard early, as of January 1, 2017, with no effect on our financial position or results of operations.

In November 2016, the FASB issued guidance that requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.   As a result, changes in restricted cash reported in 2016 as cash flows from investing activities are no longer reported as such.
 
In August 2016, the FASB issued guidance intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flow, including the classification of (i) payments to extinguish debt and (ii) payments for the settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing.  We were required to adopt the guidance for our annual and interim periods beginning in 2018.  We early adopted the standard in the third quarter of 2017 on a retrospective basis.  This change did not have an effect on the presentation of our cash flows, as our presentation in previously reported periods had complied with the new guidance.

In March 2016, the FASB issued new guidance that changes the accounting for certain aspects of share-based payments to employees.  The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled.  In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows.  The guidance also allows us to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting, clarifies that all cash payments made on an employee’s behalf for withheld shares should be presented as a financing activity on our cash flows statement, and provides an accounting policy election to account for forfeitures as they occur.  We adopted the standard in the first quarter of 2017 and changed our accounting policy to recognize forfeitures as they occur.  This change did not have a material effect on our results of operations as we previously did not apply an estimated forfeiture rate to restricted stock awards to our officers and directors.  Additionally, most of our outstanding stock option awards vest on a monthly basis over the vesting period (generally three or four years).  As these awards do not have performance conditions, the expense is recognized each month on a straight-line basis and excludes the effect of the estimated forfeiture rate as there was no risk of expensing awards that would be subsequently forfeited prior to vesting.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS (Tables)
 9 Months Ended
Sep. 30, 2017
Healthy Natural Inc [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Summary of other data
The following table summarizes other data for HN (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Depreciation included in cost of goods sold
 
$
7
  
$
42
  
$
96
  
$
130
 
Depreciation included in selling, general and administrative expenses
  
4
   
20
   
49
   
58
 
Amortization included in selling, gneral and administrative expenses
  
-
   
204
   
-
   
659
 
Capital expenditures
  
3
   
22
   
18
   
95
 
Income (loss) from discontinued operations
The following table summarizes the major line items included in the income (loss) from discontinued operations for the divestiture of HN (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
421
  
$
5,010
  
$
9,902
  
$
15,044
 
Cost of goods sold
  
(293
)
  
(3,330
)
  
(6,651
)
  
(9,991
)
Selling, general and administrative expenses
  
(19
)
  
(396
)
  
(462
)
  
(1,100
)
Income from operations, before income taxes
  
109
   
1,284
   
2,789
   
3,953
 
Income tax expense
  
(36
)
  
(437
)
  
(948
)
  
(1,344
)
Income from operations, net of tax
  
73
   
847
   
1,841
   
2,609
 
Gain on sale, net of $4.3 million income tax expense
  
8,845
   
-
   
8,845
   
-
 
Income from discontinued operations, net of tax
 
$
8,918
  
$
847
  
$
10,686
  
$
2,609
 
Assets and liabilities classified as held for sale
The following table summarizes the estimated carrying amount of HN as of the July 2017 sale (in thousands).
 
Accounts receivable, net
 
$
871
 
Inventories
  
1,987
 
Other current assets
  
47
 
Property and equipment
  
871
 
Intangible
  
791
 
Other
  
24
 
Assets
  
4,591
 
Accounts payable
  
759
 
Accrued expenses
  
290
 
Liabilities
  
1,049
 
Net assets sold
 
$
3,542
 
 
The following table summarizes the carrying amounts of major classes of HN assets and liabilities classified as held for sale as of December 31, 2016 (in thousands).
 
  
December 31,
2016
 
Accounts receivable, net
 
$
592
 
Inventories
  
1,915
 
Other current assets held for sale
  
23
 
Property and equipment
  
1,019
 
Intangible
  
791
 
Other noncurrent assets
  
24
 
Total assets held for sale
 
$
4,364
 
Accounts payable
 
$
443
 
Accrued expenses
  
382
 
Long term liabilities
  
44
 
Total liabilities held for sale
 
$
869
 
Cash flows from discontinued operations
The following table summarizes the major line items included in cash flows from discontinued operations of HN for the nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Nine Months Ended
 
  
2017
  
2016
 
       
Net cash provided by operating activities
 
$
2,803
  
$
3,701
 
Net cash provided by (used in) investing activities
  
16,719
   
(73
)
Net cash used in financing activities
  
(48
)
  
-
 
Net cash provided to continuing operations
 
$
(19,474
)
 
$
(3,628
)
Nutra SA [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Summary of other data
The following table summarizes other data for Nutra SA (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Depreciation included in cost of goods sold
 
$
274
  
$
246
  
$
792
  
$
672
 
Depreciation included in selling, general and administrative expenses
  
15
   
16
   
46
   
42
 
Capital expenditures
  
22
   
1
   
115
   
157
 
Income (loss) from discontinued operations
The following table summarizes the major line items included in income (loss) from discontinued operations for Nutra SA in the three and nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Revenues
 
$
3,226
  
$
563
  
$
9,589
  
$
4,627
 
Cost of goods sold
  
(3,539
)
  
(1,154
)
  
(9,814
)
  
(6,103
)
Selling, general and administrative expenses
  
(1,541
)
  
(509
)
  
(2,572
)
  
(1,891
)
Goodwill impairment
  
-
   
-
   
-
   
(3,024
)
Other expense
  
(358
)
  
(355
)
  
(1,066
)
  
(1,047
)
Loss from discontinued operations, before income taxes
  
(2,212
)
  
(1,455
)
  
(3,863
)
  
(7,438
)
Income taxes
  
-
   
-
   
-
   
-
 
Loss from discontinued operations, net of tax
 
$
(2,212
)
 
$
(1,455
)
 
$
(3,863
)
 
$
(7,438
)
Assets and liabilities classified as held for sale
The following table summarizes the carrying amounts of major classes of Nutra SA assets and liabilities classified as held for sale (in thousands).
 
  
September 30,
2017
  
December 31,
2016
 
Cash and cash equivalents
 
$
54
  
$
109
 
Accounts receivable, net (restricted)
  
781
   
398
 
Inventories
  
1,237
   
925
 
Other current asssets
  
326
   
373
 
Property and equipment, net (restricted $2,662 and $2,599)
  
10,464
   
10,889
 
Other noncurrent assets
  
1,321
   
1,327
 
Total assets held for sale
 
$
14,183
  
$
14,021
 
Accounts payable
 
$
2,338
  
$
2,553
 
Accrued expenses
  
8,274
   
5,607
 
Current maturities of long-term debt (nonrecourse)
  
7,627
   
6,816
 
Total liabilities held for sale
 
$
18,239
  
$
14,976
 
Cash flows from discontinued operations
The following table summarizes the major line items included in cash flows from Nutra SA discontinued operations for the nine months ended September 30, 2017 and 2016 (in thousands).
 
  
Nine Months Ended
 
  
2017
  
2016
 
       
Net cash used in operating activities
 
$
(1,345
)
 
$
(9
)
Net cash used in investing activities
  
(115
)
  
(157
)
Net cash provided (used) by financing activities
  
1,280
   
(551
)
Net cash provided by continuing operations
  
-
   
863
 
Effect of exchange rate changes
  
125
   
(183
)
Net change in cash and cash equivalents
  
(55
)
  
(37
)
Cash and cash equivalents, beginning of period
  
109
   
104
 
Cash and cash equivalents, end of period
 
$
54
  
$
67
 
Components of debt
Nutra SA’s debt consists of the following (in thousands):
 
  
September 30
2017
  
December 31,
2016
 
Capital expansion loans
 
$
2,635
  
$
2,454
 
Working capital lines of credit
  
1,081
   
401
 
Advances on customer export orders
  
785
   
1,113
 
Special tax programs
  
3,014
   
2,767
 
Other
  
112
   
81
 
  
$
7,627
  
$
6,816
 
Summary of changes in redeemable noncontrolling interest in discontinued operations
A summary of changes in redeemable noncontrolling interest in Nutra SA, reflected as accumulated deficit attributable to noncontrolling interest in discontinued operations, in the accompanying condensed consolidated balance sheets, for the three and nine months ended September 30, 2017 and 2016 (in thousands) follows.
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
Redeemable noncontrolling interest in Nutra SA, beginning of period
 
$
(567
)
 
$
(1,599
)
 
$
(699
)
 
$
69
 
Investors' interest in net loss of Nutra SA
  
(792
)
  
(470
)
  
(1,359
)
  
(2,416
)
Investors' interest in other comprehensive loss of Nutra SA
  
(11
)
  
(60
)
  
38
   
218
 
Investors purchase of additional membership interest
  
-
   
200
   
650
   
200
 
Redeemable noncontrolling interest in Nutra SA, end of period
 
$
(1,370
)
 
$
(1,929
)
 
$
(1,370
)
 
$
(1,929
)
                 
Investors' average interest in Nutra SA during the period
  
35.8
%
  
32.5
%
  
35.5
%
  
32.2
%
Investors' interest in Nutra SA at the end of the period
  
35.8
%
  
32.7
%
  
35.8
%
  
32.7
%
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
LOSS PER SHARE (EPS) (Tables)
 9 Months Ended
Sep. 30, 2017
LOSS PER SHARE (EPS) [Abstract]  
Reconciliations of numerators and denominators in EPS computations
Below are reconciliations of the numerators and denominators in the continuing operations EPS computations for the three and nine months ended September 30, 2017 and 2016.
 
  
Three Months Ended
  
Nine Months Ended
 
  
2017
  
2016
  
2017
  
2016
 
NUMERATOR (in thousands):
            
Basic and diluted - loss from continuing operations
 
$
(4,199
)
 
$
(942
)
 
$
(8,387
)
 
$
(4,975
)
Dividend on preferred stock--beneficial conversion feature
  
-
   
-
   
(778
)
  
(551
)
Basic and diluted - adjusted loss from continuing operations
 
$
(4,199
)
 
$
(942
)
 
$
(9,165
)
 
$
(5,526
)
                 
DENOMINATOR:
                
Basic EPS - weighted average number of common shares outstanding
  
11,129,781
   
9,397,255
   
10,644,372
   
9,281,942
 
Effect of dilutive securities outstanding
  
-
   
-
   
-
   
-
 
Diluted EPS - weighted average number of shares outstanding
  
11,129,781
   
9,397,255
   
10,644,372
   
9,281,942
 
                 
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive:
                
Stock options
  
629,969
   
340,037
   
473,498
   
350,203
 
Warrants
  
22,824,888
   
10,842,006
   
21,306,727
   
10,132,045
 
Nonvested stock
  
1,301,725
   
1,114,747
   
1,236,241
   
1,038,019
 
Convertible preferred stock
  
2,128,180
   
2,000,000
   
3,020,739
   
1,611,722
 
Restricted stock unit awards
  
1,175,000
   
-
   
406,066
   
-
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONCENTRATIONS OF RISK (Tables)
 9 Months Ended
Sep. 30, 2017
CONCENTRATIONS OF RISK [Abstract]  
Concentrations of risk
Revenues and accounts receivable from certain significant customers are stated below as a percent of continuing operations total revenue for the nine months ended September 30, 2017 and 2016.
 
  
% of Total Revenue
Nine Months Ended
  
% of Total Accounts Receivable
Nine Months Ended
 
Customer
 
2017
  
2016
  
2017
  
2016
 
Customer 1
  
17
%
  
12
%
  
31
%
  
28
%
Customer 2
  
15
%
  
15
%
  
*
   
*
 
Customer 3
  
*
   
12
%
  
*
   
*
 
Customer 4
  
*
   
*
   
*
   
*
 
Customer 5
  
*
   
*
   
*
   
11
%
Others
  
68
%
  
61
%
  
69
%
  
61
%
Total
  
100
%
  
100
%
  
100
%
  
100
%
                 
* Less than 10%
                
 
Purchases by continuing operations from certain significant suppliers are stated below as a percent of total purchases for the nine months ended September 30, 2017 and 2016.
 
  
% of Total Purchases
Nine Months Ended
 
Supplier
 
2017
  
2016
 
Supplier 1
  
*
   
13
%
Supplier 2
  
*
   
*
 
Supplier 3
  
*
   
*
 
Supplier 4
  
*
   
*
 
Supplier 5
  
*
   
*
 
Others
  
100
%
  
87
%
Total
  
100
%
  
100
%
         
* Less than 10%
        
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
DEBT (Tables)
 9 Months Ended
Sep. 30, 2017
DEBT [Abstract]  
Current and long-term debt
The following table summarizes current and long-term portions of debt (in thousands):
 
  
September 30,
2017
  
December 31,
2016
 
Senior debentures, net, maturing in February 2019, principal $6.6 million
 
$
-
  
$
-
 
Subordinated notes, net, maturing in May 2019, principal $5.9 million
  
-
   
6,310
 
Other
  
32
   
75
 
Senior revolving loan
  
-
   
1,725
 
Senior term loan, net
  
-
   
917
 
   
32
   
9,027
 
Current portion
  
19
   
3,063
 
Long-term portion
 
$
13
  
$
5,964
 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables)
 9 Months Ended
Sep. 30, 2017
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS [Abstract]  
Summary of equity activity
  
Shares
           
Accumulated
Deficit
Attributable to
Non-controlling
  
Accumulated
Other Comp-
    
  
Preferred
     
Preferred
  
Common
  
Accumulated
  
 Interest in
  
rehensive
  
Equity
 
  
Series F
  
Series G
  
Common
  
Stock
  
Stock
  
Deficit
  
Nutra SA
  
Loss
  
(Deficit)
 
Balance, December 31, 2016
  
-
   
-
   
10,790,351
  
$
-
  
$
264,232
  
$
(259,819
)
 
$
(699
)
 
$
(4,346
)
 
$
(632
)
Issuance of common stock awards under equity incentive plans
  
-
   
-
   
642,839
   
-
   
817
   
-
   
-
   
-
   
817
 
Dividend on preferred stock - beneficial conversion feature
  
-
   
-
   
-
   
-
   
778
   
(778
)
  
-
   
-
   
-
 
Modification of senior debenture holder warrants
  
-
   
-
   
-
   
-
   
582
   
-
   
-
   
-
   
582
 
Modification of subordinated note holder warrants
  
-
   
-
   
-
   
-
   
117
   
-
   
-
   
-
   
117
 
Change in classification of preferred stock to equity from liability
  
3,000
   
2,000
   
-
   
1,545
   
-
   
-
   
-
   
-
   
1,545
 
Change in classification of warrants to equity from liability
  
-
   
-
   
-
   
-
   
7,851
   
-
   
-
   
-
   
7,851
 
Conversion of preferred stock into common stock
  
(2,501
)
  
(700
)
  
2,331,627
   
(807
)
  
807
   
-
   
-
   
-
   
-
 
Proceeds from sale of common stock, net of costs
  
-
   
-
   
2,654,732
   
-
   
2,730
   
-
   
-
   
-
   
2,730
 
Exercise of warrant
  
-
   
-
   
103,008
   
-
   
101
   
-
   
-
   
-
   
101
 
Other
  
-
   
-
   
28,793
   
-
   
64
   
-
   
-
   
-
   
64
 
Proceeds from sale of membership interests
  
-
   
-
   
-
   
-
   
-
   
-
   
650
   
-
   
650
 
Foreign currency translation
  
-
   
-
   
-
   
-
   
-
   
-
   
38
   
93
   
131
 
Net loss
  
-
   
-
   
-
   
-
   
-
   
(205
)
  
(1,359
)
  
-
   
(1,564
)
Balance, September 30, 2017
  
499
   
1,300
   
16,551,350
  
$
738
  
$
278,079
  
$
(260,802
)
 
$
(1,370
)
 
$
(4,253
)
 
$
12,392
 
Summary of warrant activity
A summary of warrant activity for the nine months ended September 30, 2017, follows.
 
  
Equity Warrants
  
Liability Warrants
 
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares
Underlying
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
Outstanding, December 31, 2016
  
6,364,110
  
$
5.77
   
2.4
   
4,474,868
  
$
1.82
   
3.3
 
Issued
  
-
  
NA
  
NA
   
11,783,163
   
0.96
   
5.0
 
Impact of repricing debenture purchaser warrants:
                        
Prior to repricing
  
(875,000
)
  
5.49
   
2.1
   
-
  
NA
  
NA
 
After repricing
  
875,000
   
0.96
   
5.5
   
-
  
NA
  
NA
 
Impact of repricing subordinated note holder warants:
                        
Prior to repricing
  
(289,669
)
  
5.25
   
3.3
   
-
  
NA
  
NA
 
After repricing
  
289,669
   
0.96
   
3.3
   
-
  
NA
  
NA
 
Impact of anti-dilution clauses:
                        
Prior to impact
  
-
  
NA
  
NA
   
(1,489,868
)
  
1.50
   
0.8
 
After impact
  
-
  
NA
  
NA
   
2,327,919
   
0.96
   
0.8
 
Transfer from liability to equity
  
14,468,163
   
1.16
   
4.8
   
(14,468,163
)
  
1.16
   
4.8
 
Exercised
  
-
  
NA
  
NA
   
(781,252
)
  
0.96
   
-
 
Forfeited, expired or cancelled
  
-
  
NA
  
NA
   
-
  
NA
  
NA
 
Outstanding, September 30, 2017
  
20,832,273
  
$
2.32
   
3.6
   
1,846,667
  
$
1.06
   
0.7
 
Exercisable, September 30, 2017
  
20,832,273
  
$
2.32
   
3.6
   
1,846,667
  
$
1.06
   
0.7
 
Summary of outstanding warrants
The following table summarizes information related to outstanding warrants as September 30, 2017 and December 31, 2016:
 
     
September 30, 2017
  
December 31, 2016
 
Range of
Exercise Prices
 
Type of
Warrant
 
Shares
Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
  
Shares Under
Warrants,
Exercisable
Cashless
  
Shares
Under
Warrants
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (Years)
 
              
(4
)
         
$
0.96
 
 Liability (1)
  
1,546,667
  
$
0.96
   
0.4
   
1,546,667
   
-
  
$
-
   
-
 
$
0.96
 
 Equity
  
12,947,832
   
0.96
   
4.6
   
3,774,344
   
-
   
-
   
-
 
$
1.50
 
 Liability (2)
  
300,000
   
1.60
   
2.9
   
300,000
   
-
   
-
   
-
 
$
1.50 to $1.60
 
 Liability
  
-
   
-
   
-
   
-
   
1,789,868
   
1.52
   
1.3
 
$
2.00
 
 Liability (3)
  
-
   
-
   
-
   
-
   
2,660,000
   
2.00
   
4.6
 
$
2.00
 
 Equity
  
2,660,000
   
2.00
   
4.2
   
-
   
-
   
-
   
-
 
$
5.25
 
 Liability (3)
  
-
   
-
   
-
   
-
   
25,000
   
5.25
   
3.6
 
$
5.25 to $5.87
 
 Equity
  
3,156,670
   
5.33
   
2.2
   
359,536
   
4,296,339
   
5.36
   
2.7
 
$
6.55 to $16.80
 
 Equity
  
2,067,771
   
6.61
   
1.5
   
190,899
   
2,067,771
   
6.61
   
2.0
 
      
22,678,940
  
$
2.21
   
3.6
   
6,171,446
   
10,838,978
  
$
4.14
   
2.8
 
 
(1)
Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet.  Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.
(2)
Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision.  Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
(3)
The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
(4)
Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature.  The shares listed, represent the shares holders could exercise cashless as of September 30, 2017.  If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise.  Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2017
FAIR VALUE MEASUREMENTS [Abstract]  
Fair values by input hierarchy of items measured at fair value on a recurring basis
The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our condensed consolidated balance sheets (in thousands).
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
Total liabilities at fair value, as of September 30, 2017 - derivative warrant liabilities
 
$
-
  
$
-
  
$
769
  
$
769
 
Total liabilities at fair value, as of December 31, 2016 - derivative warrant liabilities
 
$
-
  
$
-
  
$
1,527
  
$
1,527
 
Additional assumptions used to calculate fair value
Additional assumptions that were used to calculate fair value follow.
 
  
September 30, 2017
  
December 31, 2016
 
Risk-free interest rate
  
1.2%
  
0.6% -1.9%
  
(1.2% weighted average)
  
(1.6% weighted average)
 
Expected volatility
  
67%-72%
  
64%
 
  
(71% weighted average)
  
(64% weighted average)
 
Changes in level 3 items measured at fair value
The following tables summarize the changes in Level 3 items measured at fair value on a recurring basis (in thousands):
 
Total Level 3 Fair Value
 
Fair Value
as of
Beginning of
Period
  
Total
Realized and
Unrealized
Gains
(Losses)
  
Issuance of
New
Instruments
  
Reclassify to
(Deficit)
Equity
  
Conversion
to Common
Stock
  
Fair Value,
at End of
Period
 
     
(1)
            
Nine Months Ended September 30, 2017, derivative warrant liabilities
 
$
(1,527
)
 
$
808
  
$
(7,917
)
 
$
7,851
  
$
16
  
$
(769
)
Nine Months Ended September 30, 2016, derivative warrant liabilities
 
$
(678
)
 
$
314
  
$
(2,474
)
 
$
-
  
$
-
  
$
(2,838
)
 
(1)
Included in change in fair value of derivative warrant liabilities in our consolidated statements of operations.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) - Healthy Natural Inc [Member] - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2017
Sep. 30, 2017
Sep. 30, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Restriction period to engage in business conducted by sold entity     5 years
Sale of assets $ 18.3    
Escrow for working capital adjustments     $ 0.2
Escrow for indemnity claims     0.6
Net carrying value of discontinued operations $ 16.7 $ 3.5 $ 3.5
Tax provision for gain on sale of business   $ 4.3  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income (Loss) from Discontinued Operations [Abstract]        
Income (loss) from discontinued operations, net of tax $ 6,706 $ (608) $ 6,823 $ (4,829)
Percentage of taxable income offset by net operating loss carryforwards     90.00%  
Residual taxable income     10.00%  
Rate of income tax on residual taxable income     20.00%  
Estimated tax due     $ 300  
Healthy Natural Inc [Member]        
Income (Loss) from Discontinued Operations [Abstract]        
Revenues 421 5,010 9,902 15,044
Cost of goods sold (293) (3,330) (6,651) (9,991)
Selling, general and administrative expenses (19) (396) (462) (1,100)
Income (loss) from discontinued operations, before income taxes 109 1,284 2,789 3,953
Income tax expense (36) (437) (948) (1,344)
Income from operations, net of tax 73 847 1,841 2,609
Gain on sale, net of $4.3 million income tax expense 8,845 0 8,845 0
Income (loss) from discontinued operations, net of tax 8,918 847 $ 10,686 2,609
Percentage of taxable income offset by net operating loss carryforwards     90.00%  
Residual taxable income     10.00%  
Rate of income tax on residual taxable income     20.00%  
Estimated tax due     $ 300  
Nutra SA [Member]        
Income (Loss) from Discontinued Operations [Abstract]        
Revenues 3,226 563 9,589 4,627
Cost of goods sold (3,539) (1,154) (9,814) (6,103)
Selling, general and administrative expenses (1,541) (509) (2,572) (1,891)
Goodwill impairment 0 0 0 (3,024)
Other expense (358) (355) (1,066) (1,047)
Income (loss) from discontinued operations, before income taxes (2,212) (1,455) (3,863) (7,438)
Income tax expense 0 0 0 0
Income (loss) from discontinued operations, net of tax $ (2,212) $ (1,455) $ (3,863) $ (7,438)
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Jul. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Dec. 31, 2015
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]          
Long term liabilities $ 0   $ 44    
Healthy Natural Inc [Member]          
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]          
Accounts receivable, net   $ 871 592    
Inventories   1,987 1,915    
Other current assets held for sale   47 23    
Property and equipment, net   871 1,019    
Intangible   791 791    
Other noncurrent assets   24 24    
Total assets held for sale   4,591 4,364    
Accounts payable   759 443    
Accrued expenses   290 382    
Long term liabilities     44    
Total liabilities held for sale   1,049 869    
Net assets sold   $ 3,542      
Nutra SA [Member]          
Major Classes of Assets and Liabilities Classified as Held for Sale [Abstract]          
Cash and cash equivalents 54   109 $ 67 $ 104
Accounts receivable, net 781   398    
Inventories 1,237   925    
Other current assets held for sale 326   373    
Property and equipment, net 10,464   10,889    
Other noncurrent assets 1,321   1,327    
Total assets held for sale 14,183   14,021    
Accounts payable 2,338   2,553    
Accrued expenses 8,274   5,607    
Current maturities of long-term debt (nonrecourse) 7,627   6,816    
Total liabilities held for sale 18,239   14,976    
Property and equipment restricted $ 2,662   $ 2,599    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used in) provided by operating activities $ 1,513 $ 3,714
Net cash provided by (used in) investing activities 16,604 (252)
Net cash provided (used) by financing activities 1,232 (551)
Effect of exchange rate changes 126 (182)
Net change in cash and cash equivalents and restricted cash 8,620 (755)
Healthy Natural Inc [Member]    
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used in) provided by operating activities 2,803 3,701
Net cash provided by (used in) investing activities 16,719 (73)
Net cash provided (used) by financing activities (48) 0
Net cash provided (by) to continuing operations (19,474) (3,628)
Nutra SA [Member]    
Net Cash Provided by (Used in) Discontinued Operations [Abstract]    
Net cash (used in) provided by operating activities (1,345) (9)
Net cash provided by (used in) investing activities (115) (157)
Net cash provided (used) by financing activities 1,280 (551)
Net cash provided (by) to continuing operations 0 863
Effect of exchange rate changes 125 (183)
Net change in cash and cash equivalents and restricted cash (55) (37)
Cash and cash equivalents, beginning of period 109 104
Cash and cash equivalents, end of period $ 54 $ 67
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Other Data (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Healthy Natural Inc [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Capital Expenditure $ 3 $ 22 $ 18 $ 95
Healthy Natural Inc [Member] | Cost of Goods Sold [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Depreciation 7 42 96 130
Healthy Natural Inc [Member] | Selling, General and Administrative Expenses [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Depreciation 4 20 49 58
Amortization 0 204 0 659
Nutra SA [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Capital Expenditure 22 1 115 157
Nutra SA [Member] | Cost of Goods Sold [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Depreciation 274 246 792 672
Nutra SA [Member] | Selling, General and Administrative Expenses [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Depreciation $ 15 $ 16 $ 46 $ 42
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Components of Debt (Details) - Nutra SA [Member]
$ in Thousands
 6 Months Ended 9 Months Ended
Sep. 30, 2017
USD ($)
Sep. 30, 2017
USD ($)
MonthlyPayment
Dec. 31, 2016
USD ($)
Components of Debt [Abstract]      
Capital expansion loans $ 2,635 $ 2,635 $ 2,454
Working capital lines of credit 1,081 1,081 401
Advances on customer export orders 785 785 1,113
Special tax programs 3,014 3,014 2,767
Other 112 112 81
Total debt 7,627 7,627 $ 6,816
Brazil [Member]      
Components of Debt [Abstract]      
Entrance fee payments 400 400  
Irgovel [Member]      
Components of Debt [Abstract]      
Installment payments in arrears 400 400  
Tax and tax related payments in arrears 9,300 $ 9,300  
Unpaid employer tax $ 200    
Maximum number of monthly payments, if unable to qualify for Tax amnesty | MonthlyPayment   60  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) - Discontinued Operations [Member] - Nutra SA [Member]
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
USD ($)
Representative
Investor
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
Representative
Investor
Sep. 30, 2016
USD ($)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Redeemable noncontrolling interest in Nutra SA, beginning of period $ (567) $ (1,599) $ (699) $ 69
Investors' interest in net loss of Nutra SA (792) (470) (1,359) (2,416)
Investors' interest in other comprehensive loss of Nutra SA (11) (60) 38 218
Investors purchase of additional membership interest 0 200 650 200
Redeemable noncontrolling interest in Nutra SA, end of period $ (1,370) $ (1,929) $ (1,370) $ (1,929)
Investors' average interest in Nutra SA during the period 35.80% 32.50% 35.50% 32.20%
Investors' interest in Nutra SA at the end of the period 35.80% 32.70% 35.80% 32.70%
Number of representatives on management committee | Representative 3   3  
Number of Investors on Management Committee | Investor 2   2  
Number of representatives on management committee upon default | Representative 3   3  
Number of investors on management committee upon default | Investor 2   2  
EBITDA triggering default status     $ 4,000  
Investors [Member]        
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Drag along right, amount of initial public offering $ 50,000   50,000  
Amount paid exchange for termination of rights     $ 100  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) - USD ($)
$ in Thousands
 1 Months Ended 9 Months Ended 12 Months Ended
Feb. 28, 2017
Sep. 30, 2017
Jul. 31, 2017
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Line of Credit Facility [Abstract]            
Proceeds from preference stock and warrants $ 7,200     $ 1,747 $ 2,554  
Repayment of debt 3,800          
Repayment of subordinated note $ 500          
Net proceeds from issuance of common stock   $ 2,700   2,778 $ 0  
HN [Member]            
Line of Credit Facility [Abstract]            
Cash proceeds from sale of business, net of expenses     $ 16,700      
Repayment of senior debentures     6,600      
Repayment of subordinated note     $ 6,000      
Nutra SA [Member]            
Line of Credit Facility [Abstract]            
Minority partner contribution amount       $ 700   $ 1,700
Investors [Member] | Nutra SA [Member]            
Noncontrolling Interest [Abstract]            
Investments in variable interest entity           $ 1,100
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECENT ACCOUNTING GUIDANCE (Details) - Stock Options [Member]
 9 Months Ended
Sep. 30, 2017
Minimum [Member]  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Award vesting period 3 years
Maximum [Member]  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Award vesting period 4 years
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
LOSS PER SHARE (EPS) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
NUMERATOR [Abstract]        
Basic and diluted - loss from continuing operations $ (4,199) $ (942) $ (8,387) $ (4,975)
Dividend on preferred stock--beneficial conversion feature 0 0 (778) (551)
Basic and diluted - adjusted loss from continuing operations $ (4,199) $ (942) $ (9,165) $ (5,526)
DENOMINATOR [Abstract]        
Basic EPS - weighted average number of common shares outstanding (in shares) 11,129,781 9,397,255 10,644,372 9,281,942
Effect of dilutive securities outstanding (in shares) 0 0 0 0
Diluted EPS - weighted average number of shares outstanding (in shares) 11,129,781 9,397,255 10,644,372 9,281,942
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 629,969 340,037 473,498 350,203
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 22,824,888 10,842,006 21,306,727 10,132,045
Nonvested Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 1,301,725 1,114,747 1,236,241 1,038,019
Convertible Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 2,128,180 2,000,000 3,020,739 1,611,722
Restricted Stock Unit Awards [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares) 1,175,000 0 406,066 0
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONCENTRATIONS OF RISK (Details)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Revenue [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Revenue [Member] | Customer 1 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 17.00% 12.00%
Revenue [Member] | Customer 2 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 15.00% 15.00%
Revenue [Member] | Customer 3 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1] 12.00%
Revenue [Member] | Customer 4 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Revenue [Member] | Customer 5 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Revenue [Member] | Others [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 68.00% 61.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Accounts Receivable [Member] | Customer 1 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 31.00% 28.00%
Accounts Receivable [Member] | Customer 2 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Accounts Receivable [Member] | Customer 3 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Accounts Receivable [Member] | Customer 4 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Accounts Receivable [Member] | Customer 5 [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1] 11.00%
Accounts Receivable [Member] | Others [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 69.00% 61.00%
Purchases [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 100.00%
Purchases [Member] | Supplier 1 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1] 13.00%
Purchases [Member] | Supplier 2 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 3 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 4 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Supplier 5 [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage [1]
Purchases [Member] | Others [Member] | Supplier Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 100.00% 87.00%
[1] Less than 10%
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
DEBT (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2017
Feb. 28, 2017
Sep. 30, 2017
Mar. 31, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Debt Instrument [Line Items]                
Total debt     $ 32     $ 32   $ 9,027
Current portion     19     19   3,063
Long-term portion     13     13   5,964
Loss on extinguishment of debt $ 6,600   (6,610)   $ 0 (8,290) $ 0  
Senior Debentures, Net [Member] | HN [Member]                
Debt Instrument [Line Items]                
Carrying value of debt     600     600    
Senior Debentures, Net [Member] | Maturity Due February 2019 [Member]                
Debt Instrument [Line Items]                
Total debt     0     0   0
Aggregate principal amount     $ 6,600     $ 6,600    
Maturity date of note           Feb. 28, 2019    
Effective interest rate     160.60%     160.60%    
Subordinated Notes, Net [Member]                
Debt Instrument [Line Items]                
Loss on extinguishment of debt   $ (1,500)            
Subordinated Notes, Net [Member] | HN [Member]                
Debt Instrument [Line Items]                
Carrying value of debt     $ 5,300     $ 5,300    
Aggregate principal amount     6,000     6,000    
Subordinated Notes, Net [Member] | Maturity Due May 2019 [Member]                
Debt Instrument [Line Items]                
Total debt     0     0   $ 6,310
Aggregate principal amount     $ 5,900     $ 5,900    
Maturity date of note           May 31, 2019    
Effective interest rate     15.00%     15.00%    
Variable interest rate           7.00%   11.75%
Payment of note principal       $ 200        
Payment of accrued note interest       $ 300        
Other [Member]                
Debt Instrument [Line Items]                
Total debt     $ 32     $ 32   $ 75
Senior Revolving Loan [Member]                
Debt Instrument [Line Items]                
Total debt     0     0   1,725
Senior Term Loan, Net [Member]                
Debt Instrument [Line Items]                
Total debt     $ 0     $ 0   $ 917
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Jun. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period   $ 7,900   $ (632)  
Balance at beginning of period (in shares)       10,790,351  
Issuance of common stock awards under equity incentive plans       $ 817  
Dividend on preferred stock - beneficial conversion feature       0  
Modification of senior debenture holder warrants       582  
Modification of subordinated note holder warrants       117  
Change in classification of preferred stock to equity from liability       1,545  
Change in classification of warrants to equity from liability       7,851  
Conversion of preferred stock into common stock       0  
Proceeds from sale of common stock, net of costs       $ 2,730  
Proceeds from sale of common stock, net of costs (in shares)       2,654,732  
Exercise of warrant       $ 101  
Other       64  
Proceeds from sale of membership interests       650  
Foreign currency translation       131  
Net loss $ 2,507   $ (1,550) (1,564) $ (9,804)
Balance at end of period $ 12,392   $ (36) $ 12,392 $ (36)
Balance at end of period (in shares) 16,551,350     16,551,350  
Series F Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of preferred stock into common stock (in shares) 2,186 315      
Series G Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of preferred stock into common stock (in shares) 689 11      
Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period       $ 0  
Issuance of common stock awards under equity incentive plans       0  
Dividend on preferred stock - beneficial conversion feature       0  
Modification of senior debenture holder warrants       0  
Modification of subordinated note holder warrants       0  
Change in classification of preferred stock to equity from liability       1,545  
Change in classification of warrants to equity from liability       0  
Conversion of preferred stock into common stock       (807)  
Proceeds from sale of common stock, net of costs       0  
Exercise of warrant       0  
Other       0  
Proceeds from sale of membership interests       0  
Foreign currency translation       0  
Net loss       0  
Balance at end of period $ 738     $ 738  
Preferred Stock [Member] | Series F Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period (in shares)       0  
Issuance of common stock awards under equity incentive plans (in shares)       0  
Change in classification of preferred stock to equity from liability (in shares)       3,000  
Conversion of preferred stock into common stock (in shares)       (2,501)  
Proceeds from sale of common stock, net of costs (in shares)       0  
Exercise of warrant (in shares)       0  
Other (in shares)       0  
Balance at end of period (in shares) 499     499  
Preferred Stock [Member] | Series G Preferred Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period (in shares)       0  
Issuance of common stock awards under equity incentive plans (in shares)       0  
Change in classification of preferred stock to equity from liability (in shares)       2,000  
Conversion of preferred stock into common stock (in shares)       (700)  
Proceeds from sale of common stock, net of costs (in shares)       0  
Exercise of warrant (in shares)       0  
Other (in shares)       0  
Balance at end of period (in shares) 1,300     1,300  
Common Stock [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period       $ 264,232  
Balance at beginning of period (in shares)       10,790,351  
Issuance of common stock awards under equity incentive plans       $ 817  
Issuance of common stock awards under equity incentive plans (in shares)       642,839  
Dividend on preferred stock - beneficial conversion feature       $ 778  
Modification of senior debenture holder warrants       582  
Modification of subordinated note holder warrants       117  
Change in classification of preferred stock to equity from liability       $ 0  
Change in classification of preferred stock to equity from liability (in shares)       0  
Change in classification of warrants to equity from liability       $ 7,851  
Conversion of preferred stock into common stock       $ 807  
Conversion of preferred stock into common stock (in shares) 2,111,188 220,439   2,331,627  
Proceeds from sale of common stock, net of costs       $ 2,730  
Proceeds from sale of common stock, net of costs (in shares)       2,654,732  
Exercise of warrant       $ 101  
Exercise of warrant (in shares)       103,008  
Other       $ 64  
Other (in shares)       28,793  
Proceeds from sale of membership interests       $ 0  
Foreign currency translation       0  
Net loss       0  
Balance at end of period $ 278,079     $ 278,079  
Balance at end of period (in shares) 16,551,350     16,551,350  
Accumulated Deficit [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period       $ (259,819)  
Issuance of common stock awards under equity incentive plans       0  
Dividend on preferred stock - beneficial conversion feature       (778)  
Modification of senior debenture holder warrants       0  
Modification of subordinated note holder warrants       0  
Change in classification of preferred stock to equity from liability       0  
Change in classification of warrants to equity from liability       0  
Conversion of preferred stock into common stock       0  
Proceeds from sale of common stock, net of costs       0  
Exercise of warrant       0  
Other       0  
Proceeds from sale of membership interests       0  
Foreign currency translation       0  
Net loss       (205)  
Balance at end of period $ (260,802)     (260,802)  
Accumulated Deficit Attributable to Non-controlling Interest in Nutra SA [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period       (699)  
Issuance of common stock awards under equity incentive plans       0  
Dividend on preferred stock - beneficial conversion feature       0  
Modification of senior debenture holder warrants       0  
Modification of subordinated note holder warrants       0  
Change in classification of preferred stock to equity from liability       0  
Change in classification of warrants to equity from liability       0  
Conversion of preferred stock into common stock       0  
Proceeds from sale of common stock, net of costs       0  
Exercise of warrant       0  
Other       0  
Proceeds from sale of membership interests       650  
Foreign currency translation       38  
Net loss       (1,359)  
Balance at end of period (1,370)     (1,370)  
Accumulated Other Comprehensive Loss [Member]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance at beginning of period       (4,346)  
Issuance of common stock awards under equity incentive plans       0  
Dividend on preferred stock - beneficial conversion feature       0  
Modification of senior debenture holder warrants       0  
Modification of subordinated note holder warrants       0  
Change in classification of preferred stock to equity from liability       0  
Change in classification of warrants to equity from liability       0  
Conversion of preferred stock into common stock       0  
Proceeds from sale of common stock, net of costs       0  
Exercise of warrant       0  
Other       0  
Proceeds from sale of membership interests       0  
Foreign currency translation       93  
Net loss       0  
Balance at end of period $ (4,253)     $ (4,253)  
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Feb. 14, 2017
Nov. 09, 2017
Aug. 31, 2017
Jun. 30, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2017
Dec. 31, 2016
Feb. 28, 2017
Jan. 31, 2017
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                        
Outstanding at beginning of period (in dollars per share)   $ 2.21         $ 4.14   $ 4.14      
Outstanding at end of period (in dollars per share)         $ 2.21     $ 4.14 $ 2.21 $ 4.14    
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Outstanding, weighted average remaining contractual life                 3 years 7 months 6 days 2 years 9 months 18 days    
Increase in authorized number of shares of common stock (in shares)         50,000,000     50,000,000 50,000,000 50,000,000 50,000,000 25,000,000
Former Employee [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Common stock issued for former employee (in shares) 108,696                      
Cash paid in lieu of bonus $ 100,000                      
Board of Directors Chairman [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Shares issued (in shares)       96,372                
Transitional monthly compensation awarded             $ 8,333 $ 10,000        
Transitional monthly compensation awarded in lieu of cash (in shares)             9,027 7,035        
Director [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Shares issued (in shares)     35,336 345,205                
Grant date fair value (in dollars per share)     $ 1.09 $ 0.90                
Equity Warrants [Member]                        
Shares Under Warrants [Roll Forward]                        
Outstanding at beginning of period (in shares)   20,832,273         6,364,110   6,364,110      
Issued (in shares)                 0      
Impact of repricing debenture purchaser warrants, Prior to repricing (in shares)                 (875,000)      
Impact of repricing debenture purchaser warrants, After repricing (in shares)                 875,000      
Impact of repricing subordinated note holder warrants, Prior to repricing (in shares)                 (289,669)      
Impact of repricing subordinated note holder warrants, After repricing (in shares)                 289,669      
Impact of anti-dilution clauses, Prior to impact (in shares)                 0      
Impact of anti-dilution clauses, After impact (in shares)                 0      
Transfer from liability to equity (in shares)                 14,468,163      
Exercised (in shares)                 0      
Forfeited, expired or cancelled (in shares)                 0      
Outstanding at end of period (in shares)         20,832,273     6,364,110 20,832,273 6,364,110    
Exercisable at end of period (in shares)         20,832,273       20,832,273      
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                        
Outstanding at beginning of period (in dollars per share)   $ 2.32         $ 5.77   $ 5.77      
Impact of repricing debenture purchaser warrants, Prior to repricing (in dollars per share)                 5.49      
Impact of repricing debenture purchaser warrants, After repricing (in dollars per share)                 0.96      
Impact of repricing subordinated note holder warrants, Prior to repricing (in dollars per share)                 5.25      
Impact of repricing subordinated note holder warrants, After repricing (in dollars per share)                 0.96      
Transfer from liability to equity (in dollars per share)                 1.16      
Outstanding at end of period (in dollars per share)         $ 2.32     $ 5.77 2.32 $ 5.77    
Exercisable at end of period (in dollars per share)         $ 2.32       $ 2.32      
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Outstanding, weighted average remaining contractual life                 3 years 7 months 6 days 2 years 4 months 24 days    
Impact of repricing debenture purchaser warrants, Prior to repricing                 2 years 1 month 6 days      
Impact of repricing debenture purchaser warrants, After repricing                 5 years 6 months      
Impact of repricing subordinated note holder warrants, Prior to repricing                 3 years 3 months 18 days      
Impact of repricing subordinated note holder warrants, After pricing                 3 years 3 months 18 days      
Transfer from liability to equity                 4 years 9 months 18 days      
Exercisable, weighted average remaining contractual life                 3 years 7 months 6 days      
Liability Warrants [Member]                        
Shares Under Warrants [Roll Forward]                        
Outstanding at beginning of period (in shares)   1,846,667         4,474,868   4,474,868      
Issued (in shares)                 11,783,163      
Impact of repricing debenture purchaser warrants, Prior to repricing (in shares)                 0      
Impact of repricing debenture purchaser warrants, After repricing (in shares)                 0      
Impact of repricing subordinated note holder warrants, Prior to repricing (in shares)                 0      
Impact of repricing subordinated note holder warrants, After repricing (in shares)                 0      
Impact of anti-dilution clauses, Prior to impact (in shares)                 (1,489,868)      
Impact of anti-dilution clauses, After impact (in shares)                 2,327,919      
Transfer from liability to equity (in shares)                 (14,468,163)      
Exercised (in shares)                 (781,252)      
Forfeited, expired or cancelled (in shares)                 0      
Outstanding at end of period (in shares)         1,846,667     4,474,868 1,846,667 4,474,868    
Exercisable at end of period (in shares)         1,846,667       1,846,667      
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]                        
Outstanding at beginning of period (in dollars per share)   $ 1.06         $ 1.82   $ 1.82      
Issued (in dollars per share)                 0.96      
Impact of anti-dilution clauses, Prior to impact (in dollars per share)                 1.50      
Impact of anti-dilution clauses, After impact (in dollars per share)                 0.96      
Transfer from liability to equity (in dollars per share)                 1.16      
Exercised (in dollars per share)                 0.96      
Outstanding at end of period (in dollars per share)         $ 1.06     $ 1.82 1.06 $ 1.82    
Exercisable at end of period (in dollars per share)         $ 1.06       $ 1.06      
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Outstanding, weighted average remaining contractual life                 8 months 12 days 3 years 3 months 18 days    
Issued                 5 years      
Impact of anti-dilution clauses, Prior to impact                 9 months 18 days      
Impact of anti-dilution clauses, After impact                 9 months 18 days      
Transfer from liability to equity                 4 years 9 months 18 days      
Exercised                 0 years      
Exercisable, weighted average remaining contractual life                 8 months 12 days      
Series F Convertible Preferred Stock [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)         2,186 315            
Number of preferred stock for conversion (in shares)         2,186 315            
Carrying value of preferred stock         $ 92,000     $ 0 $ 92,000 $ 0    
Series G Convertible Preferred Stock [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)         689 11            
Number of preferred stock for conversion (in shares)         689 11            
Carrying value of preferred stock         $ 646,000     $ 0 $ 646,000 $ 0    
Series G Convertible Preferred Stock [Member] | Subsequent Event [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)   499                    
Number of preferred stock for conversion (in shares)   499                    
Common Stock [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)         2,111,188 220,439     2,331,627      
Number of preferred stock for conversion (in shares)         2,111,188 220,439     2,331,627      
Carrying value of preferred stock to reclassified common stock         $ 700,000 $ 100,000            
Stock price (in dollars per share)         $ 1.08       $ 1.08      
Common Stock [Member] | Subsequent Event [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)   332,667                    
Number of preferred stock for conversion (in shares)   332,667                    
Preferred Stock [Member] | Subsequent Event [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Carrying value of preferred stock   $ 100,000                    
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)                 (2,501)      
Number of preferred stock for conversion (in shares)                 (2,501)      
Preferred Stock [Member] | Series G Convertible Preferred Stock [Member]                        
Equity and Liability Warrants, Additional Disclosures [Abstract]                        
Preferred shares converted into common stock (in shares)                 (700)      
Number of preferred stock for conversion (in shares)                 (700)      
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2017
USD ($)
$ / shares
shares
Aug. 31, 2017
shares
Jul. 31, 2017
USD ($)
Jun. 30, 2017
shares
Feb. 28, 2017
USD ($)
$ / shares
shares
Sep. 30, 2017
USD ($)
Installment
$ / shares
shares
Jun. 30, 2017
Installment
$ / shares
shares
Mar. 31, 2017
$ / shares
shares
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
$ / shares
shares
Sep. 30, 2016
USD ($)
Dec. 31, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Warrants to purchase shares of common stock (in shares) | shares           22,678,940       22,678,940   10,838,978
Loss on extinguishment of debt     $ 6,600,000     $ (6,610,000)     $ 0 $ (8,290,000) $ 0  
Proceeds from issuance of debt and warrants, net of issuance costs                   5,518,000 300,000  
Repayment of subordinated note $ 500,000                      
Repayment of debt                   $ 19,728,000 $ 24,124,000  
2014 Equity Incentive Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Increase in common shares authorized (in shares) | shares       1,700,000                
Number of shares authorized (in shares) | shares           3,300,000       3,300,000    
Warrants [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Warrants to purchase shares of common stock (in shares) | shares 2,327,919       2,327,919 781,252       781,252   1,489,868
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96       $ 0.96             $ 1.50
Warrants [Member] | Expiration February, 2022 [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Warrants to purchase shares of common stock (in shares) | shares 1,423,488       1,423,488              
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96       $ 0.96              
Series F Preferred Stock [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Preferred stock issued (in shares) | shares           499       499    
Series G Convertible Preferred Stock [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Preferred stock issued (in shares) | shares 2,000       2,000 1,300       1,300    
Preferred shares converted into common stock (in shares) | shares 1,897,983       1,897,983              
Preferred stock conversion ratio to common stock         948.9915              
Preferred stock, dividend         $ 1,000              
Debt conversion amount         $ 100,000              
Debt conversion, stock (in shares) | shares         180              
Net proceeds from the exchange of subordinated notes         $ 1,700,000              
Cash offering expenses         100,000              
Proceeds allocated to derivative warrant liability         1,000,000              
Warrants recorded at fair value         100,000              
Loss on extinguishment of debt         (100,000)              
Decrease in subordinated debt         (100,000)              
Proceed recorded as preferred stock         1,200,000              
Recorded dividend for preferred stock         $ 800,000              
Subordinated Debt [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Warrants to purchase shares of common stock (in shares) | shares 3,484,675       3,484,675              
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96       $ 0.96              
Loss on extinguishment of debt         $ (1,500,000)              
Decrease in subordinated debt         (900,000)              
Fair value of derivative warrant liabilities         2,300,000              
Fair value increase in common stock         $ 100,000              
Annual interest rate 7.00%       7.00%             11.75%
Repayment of debt         $ 500,000              
Subordinated Debt [Member] | Warrants [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96       $ 0.96             $ 5.25
Amendment of existing warrants (in shares) | shares         289,669              
Chief Executive Officer [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Granted (in shares) | shares               100,000        
Granted exercise price (in dollars per share) | $ / shares               $ 0.76        
Options vested (in shares) | shares   25,000                    
Grant date fair value (in dollars per share) | $ / shares                   $ 0.56    
Executive Officer and Employees [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Granted (in shares) | shares             355,500          
Granted exercise price (in dollars per share) | $ / shares             $ 0.85          
Number of equal annual installments | Installment             4          
Grant date fair value (in dollars per share) | $ / shares             $ 0.62          
Employee [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Granted (in shares) | shares           20,000            
Granted exercise price (in dollars per share) | $ / shares           $ 1.09            
Number of equal annual installments | Installment           4            
Grant date fair value (in dollars per share) | $ / shares           $ 0.77            
Senior Secured Debt [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Proceeds from issuance of debt and warrants, net of issuance costs         $ 5,500,000              
Placement fees and allocation expenses         $ 500,000              
Warrants exercisable term                   2 years 1 month 6 days    
Senior Secured Debt [Member] | Warrants [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Warrants to purchase shares of common stock (in shares) | shares 6,875,000       6,875,000              
Exercise price per warrant (in dollars per share) | $ / shares $ 0.96       $ 0.96              
Aggregate subscription amount $ 6,000,000       $ 6,000,000              
Aggregate principal amount $ 6,600,000       $ 6,600,000              
Amendment of existing warrants (in shares) | shares         875,000              
Exercise price per warrant one (in dollars per share) | $ / shares $ 5.49       $ 5.49              
Warrants exercisable term                   5 years 6 months    
Fair value of derivative warrant liabilities         $ 4,600,000              
Fair value increase in common stock         500,000              
Debt issuance cost $ 400,000       400,000              
Extinguishment of term loan         3,800,000              
Repayment of subordinated note         200,000              
Interest expense debt         $ 300,000              
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Sep. 30, 2017
Warrant
$ / shares
shares
Dec. 31, 2016
$ / shares
shares
Summary of information related to outstanding and exercisable warrants [Abstract]        
Shares under warrants, outstanding (in shares) | shares     22,678,940 10,838,978
Weighted average exercise price (in dollars per share)     $ 2.21 $ 4.14
Weighted average remaining contractual life     3 years 7 months 6 days 2 years 9 months 18 days
Shares under warrants, exercisable cashless (in shares) | shares [1]     6,171,446  
Common stock issued (in shares) | shares     2,654,732  
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Common stock issued (in shares) | shares   1,175,000    
Number of trading days     65 days  
Grant date fair value | $   $ 0.2    
Expensed ratably term     3 years 6 months  
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $5.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   10.00%    
Vesting price (in dollars per share)   $ 5.00    
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $10.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   30.00%    
Vesting price (in dollars per share)   $ 10.00    
Equity Incentive Plan 2014 [Member] | Restricted Stock Award [Member] | Vesting Price Equals or Exceeds $15.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Vesting percentage   60.00%    
Vesting price (in dollars per share)   $ 15.00    
Equity Warrants [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Weighted average exercise price (in dollars per share)     $ 2.32 $ 5.77
Weighted average remaining contractual life     3 years 7 months 6 days 2 years 4 months 24 days
Equity Warrants [Member] | $0.96 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share)     $ 0.96  
Shares under warrants, outstanding (in shares) | shares     12,947,832 0
Weighted average exercise price (in dollars per share)     $ 0.96 $ 0
Weighted average remaining contractual life     4 years 7 months 6 days 0 years
Shares under warrants, exercisable cashless (in shares) | shares [1]     3,774,344  
Equity Warrants [Member] | $2.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share)     $ 2.00  
Shares under warrants, outstanding (in shares) | shares     2,660,000 0
Weighted average exercise price (in dollars per share)     $ 2.00 $ 0
Weighted average remaining contractual life     4 years 2 months 12 days 0 years
Shares under warrants, exercisable cashless (in shares) | shares [1]     0  
Equity Warrants [Member] | $5.25 to $5.87 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share)     $ 5.25  
Exercise price range, upper range limit (in dollars per share)     $ 5.87  
Shares under warrants, outstanding (in shares) | shares     3,156,670 4,296,339
Weighted average exercise price (in dollars per share)     $ 5.33 $ 5.36
Weighted average remaining contractual life     2 years 2 months 12 days 2 years 8 months 12 days
Shares under warrants, exercisable cashless (in shares) | shares [1]     359,536  
Equity Warrants [Member] | $6.55 to $16.80 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share)     $ 6.55  
Exercise price range, upper range limit (in dollars per share)     $ 16.80  
Shares under warrants, outstanding (in shares) | shares     2,067,771 2,067,771
Weighted average exercise price (in dollars per share)     $ 6.61 $ 6.61
Weighted average remaining contractual life     1 year 6 months 2 years
Shares under warrants, exercisable cashless (in shares) | shares [1]     190,899  
Liability Warrants [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Shares under warrants, outstanding (in shares) | shares 781,522      
Weighted average exercise price (in dollars per share) $ 0.96   $ 1.06 $ 1.82
Weighted average remaining contractual life     8 months 12 days 3 years 3 months 18 days
Common stock issued (in shares) | shares 103,008      
Conversion price (in dollars per share) $ 0.98      
Number of warrants | Warrant     1  
Conversion loss between fair value liability and fair value of common stock | $ $ (0.1)      
Liability Warrants [Member] | $0.96 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [2]     $ 0.96  
Shares under warrants, outstanding (in shares) | shares [2]     1,546,667 0
Weighted average exercise price (in dollars per share) [2]     $ 0.96 $ 0
Weighted average remaining contractual life [2]     4 months 24 days 0 years
Shares under warrants, exercisable cashless (in shares) | shares [1],[2]     1,546,667  
Liability Warrants [Member] | $1.50 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [3]     $ 1.50  
Shares under warrants, outstanding (in shares) | shares [3]     300,000 0
Weighted average exercise price (in dollars per share) [3]     $ 1.60 $ 0
Weighted average remaining contractual life [3]     2 years 10 months 24 days 0 years
Shares under warrants, exercisable cashless (in shares) | shares [1],[3]     300,000  
Liability Warrants [Member] | $1.50 to $1.60 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, lower range limit (in dollars per share)     $ 1.50  
Exercise price range, upper range limit (in dollars per share)     $ 1.60  
Shares under warrants, outstanding (in shares) | shares     0 1,789,868
Weighted average exercise price (in dollars per share)     $ 0 $ 1.52
Weighted average remaining contractual life     0 years 1 year 3 months 18 days
Shares under warrants, exercisable cashless (in shares) | shares [1]     0  
Liability Warrants [Member] | $2.00 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [4]     $ 2.00  
Shares under warrants, outstanding (in shares) | shares [4]     0 2,660,000
Weighted average exercise price (in dollars per share) [4]     $ 0 $ 2.00
Weighted average remaining contractual life [4]     0 years 4 years 7 months 6 days
Shares under warrants, exercisable cashless (in shares) | shares [1],[4]     0  
Liability Warrants [Member] | $5.25 [Member]        
Summary of information related to outstanding and exercisable warrants [Abstract]        
Exercise price range, upper range limit (in dollars per share) [4]     $ 5.25  
Shares under warrants, outstanding (in shares) | shares [4]     0 25,000
Weighted average exercise price (in dollars per share) [4]     $ 0 $ 5.25
Weighted average remaining contractual life [4]     0 years 3 years 7 months 6 days
Shares under warrants, exercisable cashless (in shares) | shares [1],[4]     0  
[1] Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature. The shares listed, represent the shares holders could exercise cashless as of September 30, 2017. If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise. Should we fail to maintain a registration statement for the resale of shares under certain other warrant, the shares under those warrants may be exercisable using a cashless exercise feature.
[2] Includes one warrant which contains full ratchet anti-dilution provisions and is classified as derivative warrant liabilities in our balance sheet. Under the anti-dilution clause contained in this warrant, in the event of equity issuances (i.e. issuances of our common stock, certain awards of stock options to employees, and issuances of warrants and/or other convertible instruments) at prices below the exercise price of this warrant, we are required to lower the exercise price on this warrant and increase the number of shares underlying this warrant.
[3] Includes a warrant to purchase of 300,000 shares of our common stock which contains a most favored nations anti-dilution provision. Under that provision, in the event we issue warrants and/or other convertible instruments with anti-dilution provisions with respect to the exercise price of the warrant or the conversion price of the convertible instrument, we will be required to provide the same anti-dilution provision in this warrant and may be required to lower the exercise price on this warrant and/or increase the number of shares underlying this warrant.
[4] The warrants were classified as derivative warrant liabilities in our balance sheets due to the Share Sequencing as of December 31, 2016, and were reclassified to equity (deficit) effective March 31, 2017.
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying value of debt $ 32 $ 9,027
Derivative Warrant Liabilities [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 769 $ 1,527
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate 1.20%  
Expected volatility   64.00%
Derivative Warrant Liabilities [Member] | Recurring [Member] | Minimum [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate   0.60%
Expected volatility 67.00%  
Derivative Warrant Liabilities [Member] | Recurring [Member] | Maximum [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate   1.90%
Expected volatility 72.00%  
Derivative Warrant Liabilities [Member] | Recurring [Member] | Weighted Average [Member]    
Additional assumptions used to calculate fair value [Abstract]    
Risk-free interest rate 1.20% 1.60%
Expected volatility 71.00% 64.00%
Derivative Warrant Liabilities [Member] | Level 1 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 0 $ 0
Derivative Warrant Liabilities [Member] | Level 2 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value 0 0
Derivative Warrant Liabilities [Member] | Level 3 [Member] | Recurring [Member]    
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]    
Total liabilities at fair value $ 769 $ 1,527
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) - Recurring [Member] - Derivative Warrant Liabilities [Member] - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Changes in level 3 items measured at fair value on a recurring basis [Roll Forward]    
Fair Value as of Beginning of Period $ (1,527) $ (678)
Total Realized and Unrealized Gains (Losses) [1] 808 314
Issuance of New Instruments (7,917) (2,474)
Reclassify to (Deficit) Equity 7,851 0
Conversion to Common Stock 16 0
Fair Value, at End of Period $ (769) $ (2,838)
[1] Included in change in fair value of derivative warrant liabilities in our unaudited condensed consolidated statements of operations.
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES (Details) - 9 months ended Sep. 30, 2017 - Irgovel [Member]
BRL in Millions, $ in Millions
BRL
USD ($)
Loss Contingencies [Line Items]    
Damages sought by plaintiff   $ 1.1
Contingent liability   $ 0.3
Minimum [Member]    
Irgovel - Events of Default [Abstract]    
EBITDA triggering default status | BRL BRL 4.0  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1
INCOME TAXES (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2017
USD ($)
INCOME TAXES [Abstract]  
Percentage of taxable income offset by net operating loss carryforwards 90.00%
Residual taxable income 10.00%
Income Tax Rate On Residual Taxable Income 20.00%
Estimated tax due $ 0.3
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1
RELATED PARTY TRANSACTIONS (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
Nominee
shares
Sep. 30, 2016
USD ($)
Related Party Transaction [Line Items]        
Percentage of outstanding debt retained by related party     16.00%  
Interest paid     $ 729 $ 780
Sale of common stock (in shares) | shares     2,654,732  
Halpern [Member]        
Related Party Transaction [Line Items]        
Percentage of outstanding debt retained by related party     43.00%  
Halpern [Member] | Subordinated Notes [Member]        
Related Party Transaction [Line Items]        
Interest paid $ 100 $ 100 $ 200 $ 200
Continental Grain Company [Member]        
Related Party Transaction [Line Items]        
Number of nominee for the Board of Directors related party can designate | Nominee     1  
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Aug. 18, 2016
FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS [Abstract]          
Nasdaq minimum stockholders' equity listing requirement         $ 2,500
Stockholders' equity (deficit) $ 12,392 $ 7,900 $ (632) $ (36)  
Nasdaq grant of extension period to regain compliance under minimum stockholders' equity requirement 180 days        
Nasdaq minimum bid price requirement (in dollars per share) $ 1.0        
Number of consecutive business days at minimum bid price to regain compliance 10 days        
Number of consecutive business days under minimum bid requirement, out of compliance 30 days        
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 290 349 1 true 81 0 false 11 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://ricebrantech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 020000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 3 false false R4.htm 030000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 4 false false R5.htm 030100 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ricebrantech.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 5 false false R6.htm 040000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ricebrantech.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 060100 - Disclosure - BASIS OF PRESENTATION Sheet http://ricebrantech.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 060200 - Disclosure - DISCONTINUED OPERATIONS Sheet http://ricebrantech.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS Notes 8 false false R9.htm 060300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Sheet http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlan LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN Notes 9 false false R10.htm 060400 - Disclosure - RECENT ACCOUNTING GUIDANCE Sheet http://ricebrantech.com/role/RecentAccountingGuidance RECENT ACCOUNTING GUIDANCE Notes 10 false false R11.htm 060500 - Disclosure - LOSS PER SHARE (EPS) Sheet http://ricebrantech.com/role/LossPerShareEps LOSS PER SHARE (EPS) Notes 11 false false R12.htm 060600 - Disclosure - CONCENTRATIONS OF RISK Sheet http://ricebrantech.com/role/ConcentrationsOfRisk CONCENTRATIONS OF RISK Notes 12 false false R13.htm 060700 - Disclosure - DEBT Sheet http://ricebrantech.com/role/Debt DEBT Notes 13 false false R14.htm 060800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrants EQUITY, SHARE-BASED COMPENSATION AND WARRANTS Notes 14 false false R15.htm 060900 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://ricebrantech.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 061000 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://ricebrantech.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 061100 - Disclosure - INCOME TAXES Sheet http://ricebrantech.com/role/IncomeTaxes INCOME TAXES Notes 17 false false R18.htm 061200 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://ricebrantech.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 061300 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Sheet http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirements FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS Notes 19 false false R20.htm 070100 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://ricebrantech.com/role/BasisOfPresentationPolicies BASIS OF PRESENTATION (Policies) Policies 20 false false R21.htm 070400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Policies) Sheet http://ricebrantech.com/role/RecentAccountingGuidancePolicies RECENT ACCOUNTING GUIDANCE (Policies) Policies 21 false false R22.htm 080200 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://ricebrantech.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://ricebrantech.com/role/DiscontinuedOperations 22 false false R23.htm 080500 - Disclosure - LOSS PER SHARE (EPS) (Tables) Sheet http://ricebrantech.com/role/LossPerShareEpsTables LOSS PER SHARE (EPS) (Tables) Tables http://ricebrantech.com/role/LossPerShareEps 23 false false R24.htm 080600 - Disclosure - CONCENTRATIONS OF RISK (Tables) Sheet http://ricebrantech.com/role/ConcentrationsOfRiskTables CONCENTRATIONS OF RISK (Tables) Tables http://ricebrantech.com/role/ConcentrationsOfRisk 24 false false R25.htm 080700 - Disclosure - DEBT (Tables) Sheet http://ricebrantech.com/role/DebtTables DEBT (Tables) Tables http://ricebrantech.com/role/Debt 25 false false R26.htm 080800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsTables EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables) Tables http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrants 26 false false R27.htm 080900 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://ricebrantech.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://ricebrantech.com/role/FairValueMeasurements 27 false false R28.htm 090200 - Disclosure - DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsInitialDistributionOfProceedsDetails DISCONTINUED OPERATIONS, Initial Distribution of Proceeds (Details) Details 28 false false R29.htm 090204 - Disclosure - DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsIncomeLossFromDiscontinuedOperationsDetails DISCONTINUED OPERATIONS, Income (Loss) from Discontinued Operations (Details) Details 29 false false R30.htm 090206 - Disclosure - DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsMajorClassesOfAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails DISCONTINUED OPERATIONS, Major Classes of Assets and Liabilities Classified as Held for Sale (Details) Details 30 false false R31.htm 090208 - Disclosure - DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsCashFlowsFromDiscontinuedOperationsDetails DISCONTINUED OPERATIONS, Cash Flows from Discontinued Operations (Details) Details 31 false false R32.htm 090210 - Disclosure - DISCONTINUED OPERATIONS, Other Data (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsOtherDataDetails DISCONTINUED OPERATIONS, Other Data (Details) Details 32 false false R33.htm 090212 - Disclosure - DISCONTINUED OPERATIONS, Components of Debt (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsComponentsOfDebtDetails DISCONTINUED OPERATIONS, Components of Debt (Details) Details 33 false false R34.htm 090214 - Disclosure - DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) Sheet http://ricebrantech.com/role/DiscontinuedOperationsRedeemableNoncontrollingInterestDetails DISCONTINUED OPERATIONS, Redeemable Noncontrolling Interest, (Details) Details 34 false false R35.htm 090300 - Disclosure - LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) Sheet http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlanDetails LIQUIDITY, GOING CONCERN AND MANAGEMENT'S PLAN (Details) Details http://ricebrantech.com/role/LiquidityGoingConcernAndManagementSPlan 35 false false R36.htm 090400 - Disclosure - RECENT ACCOUNTING GUIDANCE (Details) Sheet http://ricebrantech.com/role/RecentAccountingGuidanceDetails RECENT ACCOUNTING GUIDANCE (Details) Details http://ricebrantech.com/role/RecentAccountingGuidancePolicies 36 false false R37.htm 090500 - Disclosure - LOSS PER SHARE (EPS) (Details) Sheet http://ricebrantech.com/role/LossPerShareEpsDetails LOSS PER SHARE (EPS) (Details) Details http://ricebrantech.com/role/LossPerShareEpsTables 37 false false R38.htm 090600 - Disclosure - CONCENTRATIONS OF RISK (Details) Sheet http://ricebrantech.com/role/ConcentrationsOfRiskDetails CONCENTRATIONS OF RISK (Details) Details http://ricebrantech.com/role/ConcentrationsOfRiskTables 38 false false R39.htm 090700 - Disclosure - DEBT (Details) Sheet http://ricebrantech.com/role/DebtDetails DEBT (Details) Details http://ricebrantech.com/role/DebtTables 39 false false R40.htm 090800 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsSummaryOfEquityActivityDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Summary of Equity Activity (Details) Details 40 false false R41.htm 090802 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsWarrantActivityDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS, Warrant Activity (Details) Details 41 false false R42.htm 090804 - Disclosure - EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) Sheet http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsDetails EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Details) Details http://ricebrantech.com/role/EquitySharebasedCompensationAndWarrantsTables 42 false false R43.htm 090806 - Disclosure - EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) Sheet http://ricebrantech.com/role/EquityAndSharebasedCompensationWarrantsOutstandingDetails EQUITY AND SHARE-BASED COMPENSATION, Warrants Outstanding (Details) Details 43 false false R44.htm 090900 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://ricebrantech.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://ricebrantech.com/role/FairValueMeasurementsTables 44 false false R45.htm 090902 - Disclosure - FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) Sheet http://ricebrantech.com/role/FairValueMeasurementsUnobservableInputReconciliationDetails FAIR VALUE MEASUREMENTS, Unobservable Input Reconciliation (Details) Details 45 false false R46.htm 091000 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://ricebrantech.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://ricebrantech.com/role/CommitmentsAndContingencies 46 false false R47.htm 091100 - Disclosure - INCOME TAXES (Details) Sheet http://ricebrantech.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://ricebrantech.com/role/IncomeTaxes 47 false false R48.htm 091200 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://ricebrantech.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://ricebrantech.com/role/RelatedPartyTransactions 48 false false R49.htm 091300 - Disclosure - FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) Sheet http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirementsDetails FAILURE TO COMPLY WITH NASDAQ LISTING REQUIREMENTS (Details) Details http://ricebrantech.com/role/FailureToComplyWithNasdaqListingRequirements 49 false false All Reports Book All Reports ribt-20170930.xml ribt-20170930.xsd ribt-20170930_cal.xml ribt-20170930_def.xml ribt-20170930_lab.xml ribt-20170930_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 66 0001140361-17-041856-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-17-041856-xbrl.zip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